
<!DOCTYPE html>
<html dir="ltr" lang="en">
<head>
 
<link rel="preconnect" href="https://cdn.cookielaw.org">
<link href="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" rel="preload" as="script">
 <link href="https://www.googletagmanager.com/gtm.js?id=GTM-5MKXR9" rel="preload" as="script">
<!-- OneTrust Cookies Consent Notice start --> 
<script src="" type="text/javascript" charset="UTF-8" data-domain-script="7a4eae6f-1f57-4f7c-8a64-5aa159ee745e"></script>
<script type="text/javascript">
function OptanonWrapper() { }
</script>
<!-- OneTrust Cookies Consent Notice end -->
<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
<meta lang="en">
<meta http-equiv="content-type" content="text/html; charset=utf-8">
<meta http-equiv="content-language" content="en">
<meta name="viewport" content="width=device-width, height=device-height, initial-scale=1, minimum-scale=1, maximum-scale=5, user-scalable=1">
 <!-- Title and Description -->
 <title>Breast Cancer - Gynecology and Obstetrics - MSD Manual Professional Edition</title>
 
 <!-- Schema.org/Additional markup -->
 
 
 
 
 
 
 
 
 
 
 
 
 
 <!-- Twitter Card data -->
 
 
 
 
 
 <!-- Open Graph data -->
 
 
 
 
 
 
 
 
 
 
 
 
 
<!-- Google Tag Manager --> <script></script> <!-- End Google Tag Manager -->
 <script type="text/javascript">
 // Way froward settings. Strongly typed for Typescript code.
 // Typescript definition file is in \src\Foundation\Presentation\code\Scripts\typings\Settings.d.ts
 MManual = window.MManual || {};
 MManual.Foundation = MManual.Foundation || {};
 MManual.Feature = MManual.Feature || {};
 MManual.Foundation.Logging = {
 Level : "WARN"
 }
 MManual.Foundation.Context = {
 Language: {
 Name: "en",
 Code: "en"
 },
 Edition: "Professional"
 }
 MManual.Foundation.Context.Item = {}
 
 MManual.Foundation.Context.Item.SitecoreId = "9654b759-37ed-455c-8e45-1372e5bb9dac";
 MManual.Foundation.Context.Item.MediaId = "";
 MManual.Foundation.Context.Item.VasontId = "v1065705";
 MManual.Foundation.Context.Item.TemplateId = "9fe4ab09-1603-40e4-91f9-0ac01a474c58";
 
 
 MManual.Foundation.Context.Chapter = {
 SitecoreId : "fdb0aba7-84e2-434f-b7bf-85c79342198a",
 VasontId : "v77302424"
 }
 MManual.Foundation.Context.Section = {
 SitecoreId : "b0d75e20-e4c1-4752-bca2-5e83c01332e5",
 VasontId : "v878845"
 }
 
 MManual.Foundation.TemplateIds = {
 Topic : "9fe4ab09-1603-40e4-91f9-0ac01a474c58"
 }
 MManual.deferredScripts = [];
 // Below settings are obsolete. Please use MManual.Foundation.Context
 //////////////////
 // OBSOLETE START
 ///////////////////
 MManual.settings = MManual.settings || {};
 MManual.settings.edition = "Professional";
 MManual.settings.language = "en";
 MManual.settings.languageCode = "en";
 MManual.settings.displayDateFormat = "dd/MM/yy";
 MManual.settings.dateFormat = "dd/MM/yy";
 MManual.settings.loadLocationsGlobal = true;
 MManual.settings.LexicompEnabled = false;
 MManual.settings.topic = MManual.settings.topic || {};
 MManual.settings.topic.getTopicsForResourceUrl = "/Redesign/Topic/GetTopicsForResource";
 MManual.settings.topic.getTopicHelpfulUrl = "/Redesign/Topic/GetTopicHelpful";
 MManual.settings.topic.wasThisTopicHelpfulUrl = "/Redesign/Topic/WasThisTopicHelpful";
 MManual.settings.topic.getTableBodyUrl = "/Redesign/Topic/GetTableBody";
 MManual.settings.socialMedia = MManual.settings.socialMedia || {};
 MManual.settings.socialMedia.enableMultimediaPopupShareButton = true;
 MManual.CommonLetters = ['A', 'B', 'C', 'D', 'E', 'F', 'G', 'H', 'I', 'J', 'K', 'L', 'M', 'N', 'O', 'P', 'Q', 'R', 'S', 'T', 'U', 'V', 'W', 'X', 'Y', 'Z'];
 MManual.CommonNumbers = ['0', '1', '2', '3', '4', '5', '6', '7', '8', '9'];
 MManual.Context = MManual.settings;
 MManual.Context.Item = MManual.Foundation.Context.Item;
 /////////////////
 // OBSOLETE END
 /////////////////
 </script>
 <script src="./Content/Scripts/Redesign/Lib/jquery-3.5.1.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/jquery-ui-1.13.1.custom/jquery-ui.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Foundation/Presentation/Library/Knockout/knockout-3.5.1.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/hammer.2.0.7.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/polyfills/es5-shim.4.5.13.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/polyfills/es6-shim.0.35.4.min.js" type="text/javascript"></script>
 <script src="./Content/Scripts/Redesign/Lib/slick-1.8.0/slick.1.8.0.min.js" type="text/javascript"></script>
<!--[if (gte IE 9)|!(IE)]><!-->
<script src="./bundles/redesign/libsjsv4.1.2.2-13178e13ca.js?v=9oeWsccS0AXvU_mpLneFQpk81D2qyviYAadBAspEdRc1"></script>
<!--<![endif]-->
<!--[if lt IE 9]>
 <script src="/bundles/redesign/ie8libsjsv4.1.2.2-13178e13ca.js?v=NYMKNIKPtdByxJkp3-a4OoxrVMsYmUh3Th334huO0BY1"></script>
<![endif]-->
<!-- Add custom class to categorize all cookies as functional. -->
<script src='./bundles/redesign/mmanualjsv4.1.2.2-13178e13ca.js?v=qZy1l8ugVchOqoSbrCHnQvB_O3jXnpspHrGZgwDHF0I1' class='optanon-category-C0002'></script>
<script defer="" src='./bundles/redesign/mmanualTopicjsv4.1.2.2-13178e13ca.js?v=kSA_yN8XuMyhoVC1QLzYxWJE66uhmC-mSc_-tgT27II1' class='optanon-category-C0002'></script>
<script defer="" src='./bundles/redesign/mmanualTopicResourceSearchjsv4.1.2.2-13178e13ca.js?v=iHsFLQRu7O1_jYYodP5cLz5m6_oggwQ97PNvPDyRMrw1' class='optanon-category-C0002'></script>
<!--Region information -->
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
<link rel="preload" href="/Content/Fonts/Redesign/oldrambla/Rambla-Latin-webfont.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-700-Bold.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-700-Bold-Italic.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-400-Regular.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-400-Regular-Italic.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-300-Light.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link rel="preload" href="/Content/Fonts/Redesign/OpenSans/OpenSans-600-SemiBold.woff2" as="font" type="font/woff2" crossorigin="anonymous">
<link href="./bundles/redesign/mmanualcssv4.1.2.2-13178e13ca.css?v=RUczVKOp43QqHlIomZoV4XMWus4DZWBAeuESVt-1iCc1" rel="stylesheet" type="text/css" media="screen">
<link href="./bundles/redesign/jqueryuicssv4.1.2.2-13178e13ca.css?v=3k6hV5TZDiil7_Jv0lADrVVLB9hJfoX2PenhijDq_d81" rel="stylesheet" type="text/css" media="screen">
 <link href="./bundles/redesign/mmanualprofessionalcssv4.1.2.2-13178e13ca.css?v=mbUz3b7WGmUBumHpYEaEcWfHb1bxVAgvrA5uGMAlaJ81" rel="stylesheet" type="text/css">
<!--[if lt IE 9]><link href="/bundles/redesign/ie8cssv4.1.2.2-13178e13ca.css?v=" rel="stylesheet"/>
<![endif]-->
<link href="./bundles/redesign/mmanualcssprintv4.1.2.2-13178e13ca.css?v=2xJ7o27xwBLBtbGx65XzwLYcjgNEMec7qcBRi3GYAM01" rel="stylesheet" type="text/css" media="print">
<link href="./bundles/redesign/mmanualcsshybridv4.1.2.2-13178e13ca.css?v=LCUeOfwqiGi437ffhbWXxV6YW74rb9NUl93CESRStCs1" rel="stylesheet" type="text/css" media="hybrid">
<!--[if lt IE 9]>
 <script src="//html5shiv.googlecode.com/svn/trunk/html5.js"></script>
<![endif]-->
<script type="text/javascript">
 function msieversion() {
 var ua = window.navigator.userAgent;
 var msie = ua.indexOf("MSIE ");
 if (msie > 0 || !!navigator.userAgent.match(/Trident.*rv\:11\./) || msie == NaN)
 var test = $('li.no-children');
 test.addClass("noSpace");
 return false;
 };
 //msieversion();
</script>
<div style="display: none">
 <div class="confirmationpopup__container" id="access-confirmation-popup" style="z-index: 10000;">
 <div>
 <div>
 <div>
 <div class="confirmationpopup__container">
 <span class="confirmationpopup__logo"></span>
 <div class="confirmationpopup__title">
 <span class="confirmationpopup__text">MSD Manual</span>
 </div>
 <div class="confirmationpopup__description">
 <p>Please confirm that you are a health care professional</p>
 </div>
 <div class="confirmationpopup__answer">
 <a class="confirmationpopup__button confirmationpopup__button--yes" role="button">Yes</a>
 <a class="confirmationpopup__button confirmationpopup__button--no" role="button">No</a>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
<div style="display: none">
 <div class="confirmationpopup__container" id="external-link-confirmation-popup" style="z-index: 10000;">
 <div>
 <div>
 <div>
 <div class="confirmationpopup__container">
 <span class="confirmationpopup__logo"></span>
 <div class="confirmationpopup__title">
 <span class="confirmationpopup__text">Leave this Site?</span>
 </div>
 <div class="confirmationpopup__description">
 <p>The link you have selected will take you to a third-party website. We do not control or have responsibility for the content of any third-party site.</p>
 </div>
 <div class="confirmationpopup__answer">
 <a class="confirmationpopup__button confirmationpopup__button--yes" role="button">Continue </a>
 <a class="confirmationpopup__button confirmationpopup__button--no" role="button">Cancel</a>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
 <script> 
 var externalUrls = JSON.parse(atob('["www.cdc.gov/mmwr/preview/mmwrhtml/rr58e324a1.htm","www.cdc.gov/mmwr/preview/mmwrhtml/rr6403a1.htm","www.cdc.gov/vaccines/vpd/hepb/hcp/faqs-hcp-pediarix.html","cid.oxfordjournals.org/content/53/7/e25.full.pdf html?sid=67183860-0d8a-4d54-9d57-fd12d5682421","www.nature.com/articles/s41467-022-32936-3","pubmed.ncbi.nlm.nih.gov/35772465","pubmed.ncbi.nlm.nih.gov/31515408","www.ncbi.nlm.nih.gov/pmc/articles/PMC4028378","www.drugs-porphyria.org","porphyriafoundation.org/drugdatabase","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.31060","academic.oup.com/cid/article/58/1/e1/374007","www.cdc.gov/hepatitis/hav/havfaq.htm","journals.lww.com/ajg/Fulltext/2018/02000/ACG_Clinical_Guideline__Alcoholic_Liver_Disease.9.aspx","www.cdc.gov/mmwr/preview/mmwrhtml/rr6007a1.htm","jama.jamanetwork.com/article.aspx?articleid=2492881","www.nhlbi.nih.gov/health-pro/guidelines/current/cardiovascular-health-pediatric-guidelines","gi.org/guideline/genetic-testing-and-management-of-hereditary-gastrointestinal-cancer-syndromes","rheumatology.oxfordjournals.org/content/42/2/235.full.pdf","onlinelibrary.wiley.com/doi/10.1002/14651858.CD003448.pub4/abstract?systemMessage=Wiley Online Library will be unavailable on Saturday 17th December 2016 at 09:00 GMT/ 04:00 EST/ 17:00 SGT for 4hrs due to essential maintenance.Apologies for the inconvenience","cid.oxfordjournals.org/content/early/2016/11/03/cid.ciw670.full","www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm","onlinelibrary.wiley.com/doi/10.1111/apt.13148/abstract","onlinelibrary.wiley.com/doi/10.1359/jbmr.06s204/abstract","onlinelibrary.wiley.com/doi/10.1002/jbmr.438/abstract","journals.lww.com/infectdis/Fulltext/2013/05000/New_Guidelines_for_Antimicrobial_Prophylaxis_in.10.aspx","jama.jamanetwork.com/article.aspx?articleid=1487498","cid.oxfordjournals.org/content/46/12/1801.full","www.cdc.gov/mmwr/volumes/67/wr/mm6703a5.htm","www.cdc.gov/mmwr/volumes/68/wr/mm6832a3.htm","www.onlinejacc.org/content/64/22/e77","jamanetwork.com/journals/jamasurgery/fullarticle/2623725","www.cdc.gov/vaccines/hcp/acip-recs/general-recs/timing.html#t-01","www.cdc.gov/mmwr/preview/mmwrhtml/rr5911a1.htm","www.cdc.gov/mmwr/preview/mmwrhtml/rr5604a1.htm","www.cdc.gov/vaccines/hcp/acip-recs/general-recs/administration.html","www.cdc.gov/mmwr/volumes/65/rr/rr6503a1.htm","www.onlinejacc.org/content/56/22/1864","www.idsociety.org/practice-guideline/hap_vap","academic.oup.com/cid/article-lookup/doi/10.1086/649858","acp.silverchair-cdn.com/acp/content_public/journal/aim/937814/m183600ff3_panel_2.jpeg?Expires=1556744998&amp;Signature=Oc7aO8PzGrh4tsbJzhWwSTvws~WHIkN~BaNqycHCh1TDufduqpbjgojduPU-8q5Owv2tym0x3HekrEXjegtUiZ2C15Qag5cNuhdxGu84JMb5nLmefg~ofSQfhTAdRWr9ECrJt4a1nu0Rl2crQwlTdDcL4Q8k9MGLgeg6yqGHzJGmlul2E8fEWxiP1ivlR9GypBYLjQ-B3eUH4hi-SYVCDfitv2zjW01hFzUlZM6OSXb5yEGThsimV8yQSCxcSLwaaY~CnZZ96lrcrr87nkPmtyvM9iPUUs-ix3Be5lXTIDWuIRrY3xmWXTnpNu7fxROSemZYm5ESTXbpGdJH6gMyuA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA","www.cdc.gov/mmwr/preview/mmwrhtml/mm6203a3.htm","www.cdc.gov/mmwr/volumes/68/wr/mm6832a3.htm","www.ncbi.nlm.nih.gov/pubmed?term=Crit Care Med[Jour] AND 42[volume] AND 1157[page] AND 2014[pdat] AND Karvellas CJ[first author] AND Outcomes and complications of intracranial pressure monitoring in acute liver failure&amp;TransSchema=title&amp;cmd=detailssearch","www.ncbi.nlm.nih.gov/pubmed?term=\"Hepatology (Baltimore, Md.)\"[Jour] AND 66[volume] AND 1219[page] AND 2017[pdat] AND Albillos A[author] AND Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta-analysis. &amp;TransSchema=title&amp;cmd=detailssearch","fascrs.org/ascrs/media/files/downloads/Clinical Practice Guidelines/the-american-society-of-colon-practical-guideline-sinus-pilonidalis.pdf","fascrs.org/ascrs/media/files/downloads/Clinical Practice Guidelines/practice_parameters_for_the_management_of_hemorrhoids.pdf\"","www.cdc.gov/mmwr/preview/mmwrhtml/mm5803a4.htm","www.cdc.gov/mmwr/volumes/67/wr/mm6722a5.htm","pubmed.ncbi.nlm.nih.gov/21956720-evidence-report-genetic-and-metabolic-testing-on-children-with-global-developmental-delay-report-of-the-quality-standards-subcommittee-of-the-american-academy-of-neurology-and-the-practice-committee-of-the-child-neurology-society?from_term=\"Neurology\"[Jour] AND 2011[pdat]&amp;from_pos=7","www.nal.usda.gov/fnic/vitamins-and-minerals","www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management","www.willseye.org/doctor/melvin-roat-md-facs","faculty.mdanderson.org/profiles/pedro_ramirez.html","pharmacy.ucsf.edu/shalini-lynch","weillcornell.org/jwbarnhill","profiles.stanford.edu/david-spiegel","www.umc.edu/doctors/Huang_Juebin","www.chop.edu/doctors/moldenhauer-julie-s","www.urmc.rochester.edu/people/20996734-stephen-brian-sulkes","podiatry.temple.edu/kendrick-whitney","www.med.upenn.edu/apps/faculty/index.php/g275/p8178541","www.urmc.rochester.edu/people/21136627-ronald-rabinowitz","psychiatry.ubc.ca/person/rosemary-basson","profiles.utsouthwestern.edu/profile/48082/ravindra-sarode.html","sop.washington.edu/people/brian-werth","pharmacy.ucsd.edu/faculty/le","www.chop.edu/doctors/calabria-andrew-c","medicine.uiowa.edu/psychiatry/profile/william-coryell","www.chop.edu/doctors/mehta-jay","www.adelphi.edu/faculty/profiles/profile.php?PID=0649","www.ot.wustl.edu/about/our-people/peggy-barco-8","www.urmc.rochester.edu/people/21411717-jimena-cubillos","www.mlanet.org/resources/userguide.html","www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-vaccine-fact-sheet#how-effective-are-hpv-vaccines","www.ncbi.nlm.nih.gov/books/NBK25349","www.nichd.nih.gov/sites/default/files/2018-09/PRGLAC_Report.pdf","academic.oup.com/cid/article/45/7/941/544359","academic.oup.com/cid/article/55/10/e86/321183","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.29800","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","www.cdc.gov/hepatitis/hav/havfaq.htm","www.nejm.org/doi/10.1056/NEJMoa1613512?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0www.ncbi.nlm.nih.gov","www.ncbi.nlm.nih.gov/pmc/articles/PMC5848239","pubmed.ncbi.nlm.nih.gov/29260225","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","www.cdc.gov/hepatitis/hav/havfaq.htm","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.29800","jamanetwork.com/article.aspx?articleid=1487498","www.nejm.org/doi/10.1056/NEJMoa1613512?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0www.ncbi.nlm.nih.gov","circ.ahajournals.org/content/132/15/1435.long","www.porphyriafoundation.com","porphyriafoundation.org/for-healthcare-professionals/drug-safety","www.porphyria-europe.com","www.drugs-porphyria.org","profiles.stanford.edu/judith-prochaska","circ.ahajournals.org/content/132/15/1435.long","aasld.org/publications/practice-guidelines","www.uspreventiveservicestaskforce.org/Page/Topic/recommendation-summary/hepatitis-c-screening","aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.31065","www.ncbi.nlm.nih.gov/pubmed/22972059","aasldv2019stg.aasld.org/sites/default/files/2019-06/NAFLD Guidance 2018.pdf","academic.oup.com/cid/article/53/7/e25/424286","www.idsociety.org/practice-guideline/community-acquired-pneumonia-cap-in-adults","www.idsociety.org/practice-guideline/hap_vap","www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/pneumo.html","porphyriafoundation.org","www.ncbi.nlm.nih.gov/pmc/articles/PMC4695986","www.lajh.org/about/the-jewish-home-team/meet-our-clinicians","www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html","www.ncbi.nlm.nih.gov/pmc/articles/PMC7431966","www.the-scientist.com/news-opinion/vector-based-vaccines-come-to-the-fore-in-the-covid-19-pandemic-67915","www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)32661-1/fulltext","www.med.upenn.edu/apps/faculty/index.php/g275/p8841440","www.cdc.gov/mmwr/volumes/70/rr/rr7001a1.htm","www.essentialaccessibility.com/merck","www.menopause.org/docs/default-source/2017/nams-2017-hormone-therapy-position-statement.pdf","www.ncbi.nlm.nih.gov/pmc/articles/PMC4028378","www.nejm.org/doi/10.1056/NEJMoa2112435?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(21)00963-7/fulltext","www.ajog.org/article/S0002-9378(20)30861-9/fulltext","ascopubs.org/doi/full/10.1200/JCO.21.00006","www.nejm.org/doi/10.1056/NEJMoa2112435?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(21)00963-7/fulltext","www.thelancet.com/journals/lanonc/article/PIIS1470-2045(19)30020-8/fulltext","ascopubs.org/doi/full/10.1200/JCO.2014.58.3401?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","ascopubs.org/doi/full/10.1200/JCO.2017.76.5966?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ajog.org/article/S0002-9378(20)30861-9/fulltext","www.nejm.org/doi/full/10.1056/NEJMoa1910962?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","jamanetwork.com/journals/jamaoncology/fullarticle/2773114","ascopubs.org/doi/full/10.1200/JCO.21.00006","pubmed.ncbi.nlm.nih.gov/36107786","pubmed.ncbi.nlm.nih.gov/30304427","www.ncbi.nlm.nih.gov/pmc/articles/PMC5958910","www.ahajournals.org/doi/10.1161/HYP.0000000000000084","pubmed.ncbi.nlm.nih.gov/27195814","pubmed.ncbi.nlm.nih.gov/36130612","www.ncbi.nlm.nih.gov/pmc/articles/PMC9940918","pubmed.ncbi.nlm.nih.gov/36351458","pubmed.ncbi.nlm.nih.gov/36041474","pubmed.ncbi.nlm.nih.gov/29608107","pubmed.ncbi.nlm.nih.gov/35316839","pubmed.ncbi.nlm.nih.gov/36148880","pubmed.ncbi.nlm.nih.gov/37295445","www.ncbi.nlm.nih.gov/pmc/articles/PMC7652033","www.nejm.org/doi/10.1056/NEJMoa2032183?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub  0pubmed","www.ahajournals.org/doi/full/10.1161/CIR.0000000000000678?rfr_dat=cr_pub  0pubmed&url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org","diabetesjournals.org/care/article/42/1/126/36330/Racial-and-Ethnic-Differences-in-Anthropometric","agsjournals.onlinelibrary.wiley.com/doi/abs","www.ncbi.nlm.nih.gov/pubmed/31515408","opendata.ncats.nih.gov/covid19/variant/activity","opendata.ncats.nih.gov/variant/activity","diabetesjournals.org/care/article/41/12/2669/36544/Management-of-Hyperglycemia-in-Type-2-Diabetes","pubmed.ncbi.nlm.nih.gov/35772465","pubmed.ncbi.nlm.nih.gov/34004177","pubmed.ncbi.nlm.nih.gov/35973577","www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30925-9/fulltext","pubmed.ncbi.nlm.nih.gov/33349658","pubmed.ncbi.nlm.nih.gov/35834240","pubmed.ncbi.nlm.nih.gov/38319329","www.ncbi.nlm.nih.gov/pmc/articles/PMC10752259","pubmed.ncbi.nlm.nih.gov/35449407","pubmed.ncbi.nlm.nih.gov/19502645","pubmed.ncbi.nlm.nih.gov/35483753","pubmed.ncbi.nlm.nih.gov/3404868"]'));
 $(document).ready(function () {
 $("a").click(function() {
 var href = $(this).attr('href');
 if (MManual.Foundation.Url.IsAbsoluteUrl(href)) {
 var hrefWithoutProtocol = MManual.Foundation.Url.RemoveProtocol(href);
 var match = externalUrls.some(function(url) {
 return url.length > 0 && hrefWithoutProtocol.startsWith(url);
 });
 if (match) {
 externalLinkConfirmation.showConfirmationModal(href);
 } else {
 return true;
 }
 } else {
 return true;
 }
 return false;
 });
 });
 </script>
 <!-- AddToAny script remove-->
<script></script>
 
<script type="text/html" id="audio-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__audio hide-on-print">
 <div class="multimedia__audio--wrapper">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content">
 <p data-bind="html: Description"></p>
 </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits">
 <p data-bind="html: Credits"></p>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/html" id="inlinemedia-audio-template">
 <!-- ko if: isSideline-->
 <div class="inlinebox inlinebox--right inlinebox--clickable" data-bind="attr: {id: ItemId}, css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Audio</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl}">
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses(), attr: {id: ItemId}">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 <!-- ko if: detailsAvailable -->
 <div class="inlinemedia__more">
 <div class="inlinemedia__action inlinemedia__action--show" data-bind="event: {click: toggleDetailsFunction, keypress: toggleDetailsFunction}">
 <i class="inlinemedia__eye"></i>
 <span class="inlinemedia__details hide" role="button" tabindex="0">
 Show Details
 </span>
 <span class="inlinemedia__details show" role="button" tabindex="0">
 Hide Details
 </span>
 <div class="inlinemedia__information" data-bind="html: Description"></div>
 <div class="inlinemedia__credits" data-bind="html: Credits"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="biodigital-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, iOSresizeIframeToParent : attachResizeCallback, swipe: {next: parentContext.showNext, prev: parentContext.showPrev}" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description" data-bind="getDivRef : $parent.descriptionDivRef">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="inlinemedia-biodigital-template">
 <!-- ko ifnot: isText-->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title, width:ImageWidth, height:ImageHeight}" />
 <div class="box__action"></div>
 <div class="box__label">3D MODEL</div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 <!-- ko ifnot: isInline -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
 
<script type="text/html" id="image-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__image" data-bind="css: zoomClass">
 <div class="multimedia__image--spacer hide-on-print"></div>
 <div class="multimedia__image--wrapper">
 <img oncontextmenu="return false;" loading="lazy" data-bind="attr: { src: ImageUrl, alt: Alt}, getImageDimensions: imageDimensions, pinchZoom: { pinchZoomActive: pinchZoomActive, isZoomed: isZoomed}">
 </div>
 <!-- ko if: zoomEnabled -->
 
 <!-- /ko -->
 <div class="multimedia__image--spacer hide-on-print"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content" data-bind="html: Description"> </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits" data-bind="html: Credits"> </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/javascript">
 (function (MManual) {
 var deferredScripts = [];
 
 deferredScripts.push("./bundles/redesign/imageplayerv4.1.2.2-13178e13ca.js?v=sWgoLvG7zFKbYfkOiaTYY5tBk5gefAsRS0qs0ENFdUc1");
 
 MManual.ImagePlayerScripts = deferredScripts;
 }(window.MManual = window.MManual || {}));
</script>
<script type="text/html" id="inlinemedia-photo-template">
 <!-- ko ifnot: isText-->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__innerwrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 </div>
 <div class="inlinemedia__content">
 <div class="inlinemedia__image--container">
 <img class="h-nocopy" loading="lazy" oncontextmenu="return false;" data-bind="attr: { src: ThumbnailUrl, alt: Alt, width:ImageWidth, height:ImageHeight }" />
 </div>
 <!-- ko if: isSideline -->
 <div class="inlinemedia__subtitle" data-bind="html: Credits"></div>
 <!-- /ko -->
 </div>
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isInline() && detailsAvailable() -->
 <div class="inlinemedia__more">
 <div class="inlinemedia__action inlinemedia__action--show" data-bind="event: {click: toggleDetailsFunction, keypress: toggleDetailsFunction}">
 <i class="inlinemedia__eye"></i>
 <span class="inlinemedia__details hide" role="button" tabindex="0">
 Show Details
 </span>
 <span class="inlinemedia__details show" role="button" tabindex="0">
 Hide Details
 </span>
 <div class="inlinemedia__information" data-bind="html: Description"></div>
 <div class="inlinemedia__credits" data-bind="html: Credits"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="infographic-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__image" data-bind="css: zoomClass">
 <div class="multimedia__image--spacer hide-on-print"></div>
 <div class="multimedia__image--wrapper h-nocopy">
 <img oncontextmenu="return false;" loading="lazy" data-bind="attr: { src: ImageUrl, alt: Title}, getImageDimensions: imageDimensions, pinchZoom: { pinchZoomActive: pinchZoomActive, isZoomed: isZoomed}">
 </div>
 <!-- ko if: zoomEnabled -->
 <div class="multimedia__image--actions hide-on-print">
 <div class="multimedia__image--actionzoom" data-bind="click: toggleZoom"></div>
 </div>
 <!-- /ko -->
 <div class="multimedia__image--spacer hide-on-print"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: CitationLink -->
 <div class="multimedia__description--source">
 <span class="multimedia__description--sourcetitle">Source:</span>
 <!-- ko if: CitationText -->
 <a href="#" class="multimedia__description--citation" data-bind="text: CitationText, attr: { href: CitationLink }"></a>
 <!-- /ko -->
 <!-- ko ifnot: CitationText -->
 <a href="#" class="multimedia__description--citation" data-bind="text: CitationLink, attr: { href: CitationLink }"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 </div>
 </div>
 </div>
</script>
<script type="text/html" id="inlinemedia-labtest-template">
 <!-- ko if: isSideline -->
 <div class="inlinebox inlinebox--clickable" data-bind="css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Lab Test</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img class="labtest-icon" loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl }" width="55" height="55" />
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="yes" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script><script type="text/html" id="labtest-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, setIframePrintTarget: setIframePrintTarget" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">Â«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">â€¹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">â€º</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">Â»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<script type="text/html" id="mediawidget-labtest-template">
 <!-- ko component: {name: 'multimedia-link-text', params: { item: ko.mapping.fromJS({
 ItemId: ItemId,
 IframeSrc: MediaUrl,
 Title: Title,
 ShareUrlTitle: ShareUrlTitle,
 Description: Description,
 ThumbnailUrl: ThumbnailUrl,
 Credits: Credits,
 MediaType: 'labest',
 MediaNameTranslated: 'Lab Test' ,
 UniqueId: UniqueId
 }),
 linkText: Title,
 showTooltip: false,
 listName: 'LabTestResources' + $parent.key
 } } -->
 <!-- /ko -->
</script>
<script type="text/html" id="mediawidget-labtest-list-template">
 <!-- ko component: {name: 'multimedia-link-text', params: { item: ko.mapping.fromJS({
 ItemId: ItemId,
 IframeSrc: MediaUrl,
 Title: Title,
 ShareUrlTitle: ShareUrlTitle,
 Description: Description,
 ThumbnailUrl: ThumbnailUrl,
 Credits: Credits,
 MediaType: 'labtest',
 MediaNameTranslated: 'Lab Test',
 UniqueId: UniqueId
 }),
 linkText: Title,
 showTooltip: false,
 listName: 'LabTestResources' + $parent.key
 } } -->
 <!-- /ko -->
</script>
<script type="text/html" id="inlinemedia-featuredlink-template">
 <!-- ko ifnot: isText-->
 <!-- ko ifnot: isModal -->
 <a data-bind="attr: {href: IframeSrcComputed, target: Target}">
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title}" />
 <div class="box__action"></div>
 <div class="box__label" data-bind="text:MediaNameTranslated"></div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 </div>
 </div>
 </a>
 <!-- /ko -->
 <!-- /ko -->
 <!-- ko if: isModal -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 <!-- ko if: isSideline() && !IsInCarousel() -->
 <div class="inlinemedia__open hide-on-print">
 <i class="inlinemedia__icon--open"></i>
 </div>
 <!-- /ko -->
 </div>
 <div class="inlinemedia__content">
 <!-- ko if: isSideline -->
 <figure class="box__figure">
 <img oncontextmenu="return false;" loading="lazy" class="box__picture" data-bind="attr: {src: ThumbnailUrl, alt: Title}" />
 <div class="box__action"></div>
 <div class="box__label" data-bind="text:MediaNameTranslated"></div>
 </figure>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <!-- /ko -->
 </div>
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }">
 </div>
 <!-- /ko -->
</script><script type="text/html" id="featuredlink-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="yes" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, iOSresizeIframeToParent : attachResizeCallback" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description" data-bind="getDivRef : $parent.descriptionDivRef">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="iframe-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="multimedia-thumbnail-template">
 <div class="modalcarousel__item" data-bind="event:{click: $parentContext.$parent.navToClick.bind($index()), keypress: $parentContext.$parent.navToClickKeyPress.bind($index())}, css: {'modalcarousel__item--active' : $parentContext.$parent.activeIndex() == $index()}, attr: { title: item.Title}, modalCarousel, css-static: 'modalcarousel__item--' + item.MediaType()" tabindex="0" role="button">
 <div class="modalcarousel__item--wrapper">
 <div class="modalcarousel__item--imagewrapper h-nocopy">
 <img oncontextmenu="return false;" data-bind="lazyload: {src: item.ThumbnailUrl, options: {loadOnlyInViewport: true} , updateTick: $parentContext.$parent.carouselScrollTick}, attr: {alt: item.Title }, scrollIntoView:$parentContext.$parent.activeIndex() == $index()" />
 </div>
 <div class="modalcarousel__item--text" data-bind="html: item.Title"> </div>
 </div>
 <div class="modalcarousel__item--number" data-bind="text: ($index() + 1)"></div>
 </div>
</script>
<script type="text/html" id="text-player-template">
 <div class="multimedia">
 <div class="multimedia__text" data-bind="html: Text"> </div>
 </div>
</script>
<script type="text/html" id="multimedia-link-block-template">
 <i class="inlinemedia__icon--open"
 data-bind="hoverVisible: enableHover, hoverTargetId: '.multimedia__link'"></i>
 <button class="multimedia__link--block" aria-expanded="false" data-bind="shortClick: showPlayer, attr : {'aria-label':'Expand the'+' '+ item.MediaNameTranslated()}"></button>
</script>
<script type="text/html" id="multimedia-link-text-template">
 <a class="multimedia__link--text" role="button" tabindex="0" aria-expanded="false" data-bind="shortClick: showPlayer, html: linkText, css: cssClass"></a>
</script><div class="multimedia__popup l-viewport" data-bind="component: { name: 'multimedia-popup'}">
 <!-- Placeholder for media players. -->
</div>
<script type="text/html" id="multimedia-popup-template">
 <!-- ko if: playerVisible -->
 <div class="modal" role="dialog" tabindex="-1" aria-labelledby="exampleModalLabel">
 <div class="modal--shade" data-bind="click: hidePopup"></div>
 <div class="modaldialog" data-bind=" arrowKeys: {left: showPrev, right: showNext}, css : {'h-expanded' : expanded }">
 <div class="modaldialog__header hide-on-print">
 <div class="modaldialog__header--wrapper">
 <div class="modaldialog__header--title modaldialog__header--element" data-bind="html: popupTitle(), scaleText: popupTitle"></div>
 <div tabindex="0" role="button" class="modaldialog__header--close modaldialog__header--element" data-bind="event: { click: hidePopup, keypress: hidePopupKeyPress }">
 Close
 </div>
 </div>
 </div>
 <div class="modaldialog__content">
 <div class="modaldialog__content--wrapper" data-bind="swipe: {next: showNext, prev: showPrev, canSwipe: canSwipe}">
 <div class="modaldialog__media" data-bind="css :{ 'modaldialog__media--withcarousel': !(displaySingle() || hideCarousel()), 'modaldialog__media--single': displaySingle }">
 <!-- ko ifnot: (displaySingle() || hideMainArrows()) -->
 <div class="modaldialog__media--sidemargin hide-on-print">
 <div class="modaldialog__media--nav modaldialog__media--prev" tabindex="0" role="button" aria-label="Previous" data-bind="event: { click: showPrev, keypress: showPrevKeyPress }">
 <div class="mm-icon" data-bind="css : showPrevClass()"></div>
 </div>
 </div>
 <!-- /ko -->
 <div class="modaldialog__media--wrapper">
 
 <!-- ko component: {name: activeEntry().item.MediaType() + '-player', params: activeEntry} -->
 <!-- /ko -->
 
 </div>
 <!-- ko ifnot: (displaySingle() || hideMainArrows()) -->
 <div class="modaldialog__media--sidemargin hide-on-print">
 <div class="modaldialog__media--nav modaldialog__media--next" tabindex="0" role="button" aria-label="Next" data-bind="event: { click: showNext, keypress: showNextKeyPress }">
 <div class="mm-icon" data-bind="css: showNextClass()"></div>
 </div>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko ifnot: (displaySingle() || hideCarousel()) -->
 <div class="modaldialog__carousel hide-on-print">
 <div class="modaldialog__carousel--sidemargin modaldialog__carousel--prev" tabindex="0" role="button" data-bind="event:{click: carouselShowPrev, keypress:carouselShowPrevKeyPress}, css : { 'modaldialog__carousel--sidemargin--disabled' : isCarouselShowPrevDisabled() } "></div>
 <div class="modaldialog__carousel--wrapper">
 <div class="modalcarousel" data-bind="scrollTick : carouselScrollTick, scroll : carouselIsScrolled ">
 <!-- ko foreach: {data: activeList, as: 'entry'} -->
 <!-- ko template: {name: 'multimedia-thumbnail-template', data: entry} -->
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
 <div class="modaldialog__carousel--sidemargin modaldialog__carousel--next" tabindex="0" role="button" data-bind="event:{click: carouselShowNext, keypress:carouselShowNextKeyPress}, css : { 'modaldialog__carousel--sidemargin--disabled' : isCarouselShowNextDisabled() }"></div>
 </div>
 <!-- /ko -->
 <div class="modaldialog__toolbar hide-on-print">
 <!-- ko ifnot: displaySingle -->
 <div class="modaldialog__pager">
 <a class="modaldialog__pager--nav modaldialog__pager--navfirst" data-bind="click: showFirst">«</a>
 <a class="modaldialog__pager--nav modaldialog__pager--navleft" data-bind="click: showPrev">‹</a>
 <span class="modaldialog__pager--number" data-bind="text: activeEntry().index + 1"></span>/<span class="modaldialog__pager--number" data-bind="text: activeList().length"></span>
 <a class="modaldialog__pager--nav modaldialog__pager--navright" data-bind="click: showNext">›</a>
 <a class="modaldialog__pager--nav modaldialog__pager--navlast" data-bind="click: showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="modaldialog__actions">
 <!-- ko if: detailsAvailable -->
 <div class="modaldialog__action modaldialog__action--description modaldialog__action--description-show" data-bind="click: toggleExpanded">
 <i class="modaldialog__icon--show"></i>
 <span class="modaldialog__action--text">
 Show Details
 </span>
 </div>
 <div class="modaldialog__action modaldialog__action--description modaldialog__action--description-hide" data-bind="click: toggleExpanded">
 <i class="modaldialog__icon--hide"></i>
 <span class="modaldialog__action--text">
 Hide Details
 </span>
 </div>
 <!-- /ko -->
 <!-- ko if: MManual.settings.socialMedia.enableMultimediaPopupShareButton -->
 <div class="modaldialog__action modaldialog__action--share a2a_kit" data-a2a-icon-color="transparent,transparent" data-bind="attr:{'data-a2a-url': shareUrl}">
 <a class="modaldialog__icon--share a2a_dd" href="https://www.addtoany.com/share" data-a2a-icon-color="transparent,transparent" role="button"></a>
 </div>
 <!-- /ko -->
 <div class="modaldialog__action modaldialog__action--print" data-bind="event:{click: printPopupContent, keypress:printPopupContentKeyPress}" tabindex="0" role="button" aria-label="print">
 <div class="modaldialog__icon--print"></div>
 </div>
 </div>
 </div>
 <div class="modaldialog__copyright-print">
 <div class="modaldialog__copyright-print--logo">
<img src="/Content/Images/msd_foot_logo.png" alt="" class="badge msd" loading="lazy" width="240" height="71" />
 </div>
 <div class="modaldialog__copyright-print--text">
 © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
</script>
<script type="text/html" id="podcast-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__audio hide-on-print">
 <div class="multimedia__audio--wrapper">
 <audio>
 <source data-bind="attr: { src: AudioUrl, type: MimeType }" />
 </audio>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content">
 <p data-bind="html: Description"></p>
 </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits">
 <p data-bind="html: Credits"></p>
 </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
 <script type="text/html" id="quiz-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <h3 class="multimedia__title" data-bind="html: Title"> </h3>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe frameBorder="0" scrolling="auto" data-bind="attr: { src: IframeSrcComputed, title: Title }" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation, swipe: {left: parentContext.showNext, right: parentContext.showPrev}"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 </div>
</script>
<script type="text/html" id="table-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__table">
 <div class="multimedia__table--wrapper">
 <div data-bind="html: tableBody, stickyHeaderTable: tableBody" class="modaltable"> </div>
 </div>
 </div>
 <div class="multimedia__description">
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="m-link-text-template">
 <!-- ko if: isModal -->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="shortClick: showPlayer, html: linkText, css: cssClass, attr: { title: item.Title }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target }"></a>
 <!-- /ko -->
 <!-- ko ifnot: isModal -->
 <!--ko if: item.MediaType()=='podcast'-->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="html: linkText, css: cssClass, attr: { title: item.Title, target: target, href: target=='_blank'? url :'https://www.msdmanuals.com/'+ url }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target, url:url}"></a>
 <!-- /ko -->
 <!--ko ifnot: item.MediaType()=='podcast'-->
 <a class="multimedia__link--text" tabindex="0" role="button" data-bind="html: linkText, css: cssClass, attr: { title: item.Title, target: target, href: 'https://www.msdmanuals.com/'+'/professional/multimedia'+ url }, mlinkToolTip: { thumbnail: item.ThumbnailUrl, title: item.Title, show: showTooltip, target: target, url:'/professional/multimedia'+ url}"></a>
 <!-- /ko -->
 <!-- /ko -->
</script>
<script type="text/html" id="clinicalcalculator-player-template">
 <div class="multimedia" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__iframe">
 <div class="multimedia__iframe--spacer"></div>
 <div class="multimedia__iframe--wrapper h-ios-iframe-scroll">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="auto" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }, setIframePrintTarget: setIframePrintTarget" sandbox="allow-modals allow-scripts allow-same-origin allow-forms allow-popups allow-top-navigation"></iframe>
 </div>
 <div class="multimedia__iframe--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">‹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">›</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">»</a>
 </div>
 <!-- /ko -->
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script><script type="text/html" id="inlinemedia-calculator-template">
 <!-- ko if: isSideline -->
 <div class="inlinebox inlinebox--clickable" data-bind="css: {'inlinebox--right': !IsInCarousel(), 'inlinebox--full': IsInCarousel}">
 <div class="inlinebox__wrapper">
 <!-- ko ifnot: IsInCarousel-->
 <div class="inlinebox__header">Clinical Calculator:</div>
 <!-- /ko -->
 <div class="inlinebox__content">
 <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: multimediaLinkModel }"></div>
 <div class="inlinebox__button">
 <img class="labtest-icon" loading="lazy" alt="icon" data-bind="attr: {src: ThumbnailUrl }" width="48" height="48" />
 </div>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isInline -->
 <div data-bind="css: componentClasses()">
 <div class="inlinemedia__wrapper">
 <div class="inlinemedia__header">
 <div class="inlinemedia__title" data-bind="html: Title"></div>
 </div>
 <div class="inlinemedia__content">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrc, title: Title }"></iframe>
 </div>
 </div>
 </div>
 <!-- /ko -->
 <!-- ko if: isText -->
 <div class="multimedia__link" data-bind="component: { name: multimediaLinkComponentName, params: multimediaLinkModel }"></div>
 <!-- /ko -->
</script>
<script type="text/html" id="video-player-template">
 <div class="multimedia multimedia--withdescription" data-bind="css: {'multimedia--single': parentContext.displaySingle}">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__title" data-bind="html: Title"> </div>
 <!-- /ko -->
 <div class="multimedia__video">
 <div class="multimedia__video--spacer"></div>
 <div class="multimedia__video--wrapper">
 <iframe allowfullscreen webkitallowfullscreen mozallowfullscreen scrolling="no" seamless="seamless" frameBorder="0" data-bind="attr: { src: IframeSrcComputed, title: Title }"></iframe>
 <div class="multimedia__video--print" onclick="$(this).hide(); return true;">
 <img loading="lazy" data-bind="attr: { src: ThumbnailUrl, alt: Title }">
 </div>
 </div>
 <div class="multimedia__video--spacer"></div>
 </div>
 <div class="multimedia__description">
 <!-- ko ifnot: hideTitle -->
 <div class="multimedia__description--title" data-bind="html: Title"></div>
 <!-- /ko -->
 <!-- ko ifnot: parentContext.displaySingle -->
 <div class="multimedia__pager hide-on-print">
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showFirst">Â«</a>
 <a class="multimedia__pager--nav multimedia__pager--navleft" data-bind="click: parentContext.showPrev">â€¹</a>
 <span class="multimedia__pager--number" data-bind="text: $parent.activeEntry().index + 1"></span>/<span class="multimedia__pager--number" data-bind="text: $parent.activeList().length"></span>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showNext">â€º</a>
 <a class="multimedia__pager--nav multimedia__pager--navright" data-bind="click: parentContext.showLast">Â»</a>
 </div>
 <!-- /ko -->
 <div class="multimedia__description--wrapper">
 <!-- ko if: $data.Description -->
 <div class="multimedia__description--content" data-bind="html: Description"> </div>
 <!-- /ko -->
 <!-- ko if: $data.Credits -->
 <div class="multimedia__description--credits" data-bind="html: Credits"> </div>
 <!-- /ko -->
 </div>
 <!-- ko if: loadLocations -->
 <!-- ko ifnot: topicsWithResource().length == 0 -->
 <div id="multimedia__locations" class="multimedia__description--locations" data-bind="modalLocations: topicsWithResource().length">
 <div class="multimedia__description--readmore">In these topics</div>
 <!-- ko foreach: topicsWithResource-->
 <a class="multimedia__description--location" data-bind="attr: { href: PublicUrl }, html: Title"></a>
 <!-- /ko -->
 </div>
 <!-- /ko -->
 <!-- /ko -->
 </div>
 </div>
</script>
<link rel="stylesheet" href="./Content/Styles/fa/fonts/font-awesome.css" type="text/css" media="screen"><link rel="stylesheet" href="./CustomCss/custom_mobile_styles.css"><script type="text/javascript" src="./customscript/videodetail.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/VideoPath.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/Appdetail.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script><script type="text/javascript" src="./customscript/customscript.js?v=j6lqWQ_gaVddXSzk8oBfSqpw8iTwpNFAslFpddsSyrM1"></script></head>
<body class="professional msd ">
 <a href="/n3wbr@nds" rel="nofollow" style="display:none" arial-hidden="true">honeypot link</a>
 <!-- Google Tag Manager (noscript) --> <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-5MKXR9" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript> <!-- End Google Tag Manager (noscript) --> 
 <div id="testone"> <div class="l-viewport">
 
<input type="hidden" id="currentSitecoreItemId" value="9654b759-37ed-455c-8e45-1372e5bb9dac">
<input type="hidden" id="wasThisTopicHelpfulUrl" value="/Custom/Topic/WasThisTopicHelpful">
<input type="hidden" id="getTopicHelpfulUrl" value="/Custom/Topic/GetTopicHelpful">
<input type="hidden" id="languageSwitchUrl" value="/professional/LanguageSwitch">
<input type="hidden" id="resourceServiceUrl" value="/custom/Topic/GetTopicsForResource">
<input type="hidden" id="tableBodyServiceUrl" value="/custom/Topic/GetTableBody">
<input type="hidden" id="getAlphabetUrl" value="/Redesign/Widgets/GetAlphabet">
<input type="hidden" id="landingPageUrl" value="https://www.msdmanuals.com/">
<input type="hidden" id="standaloneMultimediaBaseUrl" value="/professional/multimedia">
<input type="hidden" id="currentEdition" value="Professional">
<input type="hidden" id="currentLanguage" value="en">
<input type="hidden" id="currentLanguage2LetterISO" value="en">
<input type="hidden" id="oldRestrictedBrightcovePlayer" value="3851244774001">
<input type="hidden" id="restrictedBrightcovePlayer" value="5qrY5f1MK_default">
<input type="hidden" id="shareableBrightcovePlayer" value="6CaKiGXJD_default">
<input type="hidden" id="selectLanguageLabel" value="Select Language">
<input type="hidden" id="commonCloseText" value="close">
<input type="hidden" id="readAllText" value="Read All">
 
 <!-- New div groups for LetterSpine and Header has been created
 due to problems with existing styling
 ToDo rewrite whole header and letter spine as one component -->
 <div id="l-group--header-letterpine" class="main-header sticky-header">
 <div class="l-group l-group--header">
 <div id="l-layer--header" class="l-layer l-layer--header" data-header-element-position="static" data-header-element-order="0">
 
 
 
 </div>
 </div>
 </div>
 
 
<script>
 MManual.Feature = MManual.Feature || {};
 MManual.Feature.LetterSpine = MManual.Feature.LetterSpine || {};
 MManual.Feature.LetterSpine.Id = '16d5d563-7463-4cba-b10a-3f2c7b1e99bb';
</script>
 <!-- <div id="l-group--header-letterpine--fixed" class="main-header l-group--header-letterpine-fixed l-group--header-letterpine-fixed--hidden l-group--header-letterpine-fixed--animate">
 <div class="l-group l-group--headerfixed hide-on-print">
 <div class="l-layer l-layer--header l-layer--fixed" data-header-element-position="fixed" data-header-element-order="0">
 
 
 </div>
 </div>
 <div class="l-group l-group--letterspinefixed"></div>
 </div>
 <div class="l-layer l-layer--underskirt">
 </div>-->
 
 
 
 <div class="l-layer l-layer--actiontoolbar">
 
 <div class="l-layer__content">
 <aside class="actiontoolbar hide-on-print">
 <!--<a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--bookmark" onclick="bookmarkPage(this);" href="#"></a>-->
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--download" style="display: none" href="#"></a>
 
 <ul>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--share a2a_dd" href="https://www.addtoany.com/share" rel="noopener" role="button" aria-expanded="false" aria-label="Share in"></a>
 </li>
 <li>
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--print" href="#" onclick="window.print(); MManual.analytics.notifyOpenModal(MManual.analytics.eventPrintAnArticle);" role="button" title="print"></a>
 </li>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--email a2a_button_email" href="#" role="button" title="Mail"></a>
 </li>
 <li class="scroll-to-top">
 <a href="#top" role="button" aria-label="Go To Top" title="Go To Top"><span class="scroll-to-top-img"></span></a>
 </li>
 <li class="scroll-to-bottom">
 <a href="#" role="button" aria-label="Go To Top"><span class="scroll-to-bottom-img"></span></a>
 </li>
 </ul>
 </aside>
 </div>
 
 </div>
 <main id="maincontent" class="l-layer l-layer--main">
 
 <section class="l-layer__content main">
 
 <div class="orderize"></div>
<div class="main__content">
 <div class="topic__wrapper">
 
<script type="text/javascript">
 var resources = [];
 var resourcesIdList = [];
 $.each(resources, function() {
 if (this.MultimediaItem != null) {
 resourcesIdList.push({"itemId": this.MultimediaItem.ItemId, "uniqueId": this.MultimediaItem.UniqueId});
 }
 });
 $('a[href="#also-of-interest-news"],a[href="#also-of-interest-video"],a[href="#also-of-interest-biodigital"],a[href="#also-of-interest-student-stories"]').click(function ()
 {
 window.scrollTo(0, $("#Ph-Item-Lazyloading").offset().top - 230);
 });
</script>
<div class="orderize__candidate" data-orderize="100" itemscope="" itemtype="http://schema.org/MedicalCondition" data-preview-container='.topic__article'>
 <input type="hidden" value="" id="hdnTopicTopTile">
 <div class="autoload-placeholder-top hide-on-print" style="display:none">
 <a class="pre-topic hide-on-print" role="button" aria-hidden="true"></a>
 </div>
 <div class="autoloadSettings" name="Up Next:">
 <a id="autoloadEnable" class="false" role="button" tabindex="-1"></a>
 <a id="autoloadChapter" class="false" role="button" tabindex="-1"></a>
 <a id="autoloadSection" class="false" role="button" tabindex="-1"></a>
 <a id="stopAutoloadChapterCircular" class="false" role="button" tabindex="-1"></a>
 </div>
 <article class="topic__article">
 
<div class="tablebox tablebox--headings">
 <div class="tablebox__cell tablebox__cell--headings">
 <div class="topic__headings">
 <span itemprop="code" itemscope="" itemtype="http://schema.org/MedicalCode">

 </span>
 <span itemprop="code" itemscope="" itemtype="http://schema.org/MedicalCode">

 </span>
 <div class="topic__header--container">
 <div class="topic__authors topic__authors--container">
 <a id="top" role="button" tabindex="-1"></a>
 <h1 class="topic__header__headermodify--title topic__header__headermodify--title--animate" itemprop="name">
 Breast Cancer
 </h1>
 <div class="topic__authors-main-cont">
 <p class="topic__authors--description">By </p>
 
 <strong class="topic__label topic__label--author"><a href="./Contributors/choi-lydia.html">Lydia Choi</a></strong>
 <p class="topic__authors--description">, MD, Karmanos Cancer Center</p>
 <div class="topic__revision">
 <div class="topic__authors">
 Reviewed/Revised Jul 2023 
 </div>
 </div>
 </div>
 </div>
 <div class="topic__buttons hide-on-print">
 <div class="topicswitch topic__patient-education topic__patient-education--top" data-icd9="174;175;198.81;233.0;198.2" tabindex="0" role="link">
 <div class="topic__patient-education--container">
 <div class="topic__patient-education--icon"></div>
 <div class="topic__patient-education--text">
 View PATIENT EDUCATION
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
 </div>
</div>
 <div class="box topicmenu hide-on-print">
 <div class="topic-section-heading-list">
 <ul>
 <li>
 <a href="#v1065717" class="topicmenu_mobile__paragraph">Risk Factors</a>
 </li>
 <li>
 <a href="#v1065825" class="topicmenu_mobile__paragraph">Pathology</a>
 </li>
 <li>
 <a href="#v1065837" class="topicmenu_mobile__paragraph">Pathophysiology</a>
 </li>
 <li>
 <a href="#v1065851" class="topicmenu_mobile__paragraph">Symptoms and Signs</a>
 </li>
 <li>
 <a href="#v1065856" class="topicmenu_mobile__paragraph">Diagnosis</a>
 </li>
 <li>
 <a href="#v1066173" class="topicmenu_mobile__paragraph">Treatment</a>
 </li>
 <li>
 <a href="#v1065920" class="topicmenu_mobile__paragraph">Prognosis</a>
 </li>
 <li>
 <a href="#v9009413" class="topicmenu_mobile__paragraph">Key Points</a>
 </li>
 <li>
 <a href="#v26442816" class="topicmenu_mobile__paragraph">More Information</a>
 </li>
 </ul>
 </div>
 </div>
<div class="topic__resources--title hide-on-print">
 Topic Resources
</div>
<div id="topicResources" class="hero hide-on-print">
 <div class="hero__tabs">
 <ul class="hero__header">
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Biodigitals'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 3D Models (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Biodigitals" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Biodigitals'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Audios'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Audios (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Audios" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Audios'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Calculators'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Calculators (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Calculators" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Calculators'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell " data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Images'}">
 <a data-bind="event: { click: function() { $data.activateGroup('Images'); }, keypress: function() { $data.activateGroup('Images'); }}" class="hero__link" tabindex="0" role="tab" aria-expanded="false" false="">
 <span class="hero__title">
 Images (9)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Images" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Images'}">
 <div class="floatbox">
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--image" data-group-name="image" title="Anatomy of the Breast (Front and Side Views)">
 <div class="hero__image--image">
 <div class="hero__container">
 <img class="hero__image--image" src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?mw=350&amp;thn=0&amp;sc_lang=en" width="778" height="1000" loading="lazy">
 </div>
 <span class="hero__description">
 Anatomy of the Breast (Front...
 </span>
 </div>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"Alt":"Anatomy of the Breast (Front and Side Views)","Credits":"\u003cspan id=\u0022v87530025\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eGwen Shockey/SCIENCE PHOTO LIBRARY\u003c/p\u003e\u003c/div\u003e","IsRestricted":false,"ItemId":"4adb7367-ab0f-468a-9ee7-440f94ed8883","Title":"Anatomy%20of%20the%20Breast%20%28Front%20and%20Side%20Views%29","ShareUrlTitle":"anatomy-of-the-breast-front-and-side-views","Description":"","ImageUrl":"./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v72309239","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"778","ImageHeight":"1000","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Anatomy%20of%20the%20Breast%20%28Front%20and%20Side%20Views%29","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--image" data-group-name="image" title="Anatomy of the Breast (Side View)">
 <div class="hero__image--image">
 <div class="hero__container">
 <img class="hero__image--image" src="./~/media/manual/professional/images/f/0/3/f0317392-breast-anatomy-side-spl-sized.jpg?mw=350&amp;thn=0&amp;sc_lang=en" width="988" height="1000" loading="lazy">
 </div>
 <span class="hero__description">
 Anatomy of the Breast (Side...
 </span>
 </div>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"Alt":"Anatomy of the Breast (Side View)","Credits":"\u003cspan id=\u0022v87530028\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eGwen Shockey/SCIENCE PHOTO LIBRARY\u003c/p\u003e\u003c/div\u003e","IsRestricted":false,"ItemId":"1cf1c19f-1266-4487-9446-b4b833a3239e","Title":"Anatomy%20of%20the%20Breast%20%28Side%20View%29","ShareUrlTitle":"anatomy-of-the-breast-side-view","Description":"","ImageUrl":"./~/media/manual/professional/images/f/0/3/f0317392-breast-anatomy-side-spl-sized.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/f/0/3/f0317392-breast-anatomy-side-spl-sized.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v72309223","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"988","ImageHeight":"1000","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Anatomy%20of%20the%20Breast%20%28Side%20View%29","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--image" data-group-name="image" title="Peau d’Orange">
 <div class="hero__image--image">
 <div class="hero__container">
 <img class="hero__image--image" src="./~/media/manual/professional/images/p/a/t/patient-with-inflammatory-breast-cancer-sized.jpg?mw=350&amp;thn=0&amp;sc_lang=en" width="1000" height="742" loading="lazy">
 </div>
 <span class="hero__description">
 Peau d’Orange
 </span>
 </div>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"Alt":"Peau d’Orange","Credits":"\u003cspan id=\u0022v85660298\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003e\u0022Creative Commons Patient with inflammatory breast cancer\u0022 by Epidemiology and surgical management of breast cancer in gynecological department of Douala General Hospital (Scientific Figure on ResearchGate) is licensed under \u003ca rel=\u0022nofollow\u0022 target=\u0022_blank\u0022 href=\u0022https://creativecommons.org/licenses/by/2.0/legalcode\u0022\u003eCreative Commons 2.0\u003c/a\u003e. Available from: https://www.researchgate.net/figure/Patient-with-inflammatory-breast-cancer_fig2_234162338 [accessed 3 Oct, 2019].\u003c/p\u003e\u003c/div\u003e","IsRestricted":false,"ItemId":"cf9ed085-1191-46bb-bbb1-24caba71a6b7","Title":"Peau%20d%E2%80%99Orange","ShareUrlTitle":"peau-dorange","Description":"%3Cp%3ESometimes%20in%20inflammatory%20breast%20cancer%20and%20very%20advanced%20cancers%2C%20the%20breast%20appears%20inflamed%2C%20and%20the%20skin%20appears%20thickened%2C%20resembling%20orange%20peel%20%28peau%20d%E2%80%99orange%29.%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/p/a/t/patient-with-inflammatory-breast-cancer-sized.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/p/a/t/patient-with-inflammatory-breast-cancer-sized.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v44885154","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"1000","ImageHeight":"742","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Peau%20d%E2%80%99Orange","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--image" data-group-name="image" title="Paget Disease of the Nipple">
 <div class="hero__image--image">
 <div class="hero__container">
 <img class="hero__image--image" src="./~/media/manual/professional/images/m/1/2/m1220351-paget-disease-of-the-breast-2-science-photo-library-high.jpg?mw=350&amp;thn=0&amp;sc_lang=en" width="1000" height="647" loading="lazy">
 </div>
 <span class="hero__description">
 Paget Disease of the Nipple
 </span>
 </div>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"Alt":"Paget Disease of the Nipple","Credits":"\u003cspan id=\u0022v87250437\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eDR M.A. ANSARY/SCIENCE PHOTO LIBRARY \u003c/p\u003e\u003c/div\u003e","IsRestricted":true,"ItemId":"cb7a2e39-b85d-40f1-947b-e685f8464dec","Title":"Paget%20Disease%20of%20the%20Nipple","ShareUrlTitle":"paget-disease-of-the-nipple","Description":"%3Cp%3EIn%20Paget%20disease%20of%20the%20nipple%2C%20ductal%20carcinoma%20in%20situ%20extends%20over%20the%20nipple%20and%20areola%20and%20causes%20scaling%2C%20pruritus%2C%20and%20burning%20pain%20in%20the%20affected%20nipple.%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/m/1/2/m1220351-paget-disease-of-the-breast-2-science-photo-library-high.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/m/1/2/m1220351-paget-disease-of-the-breast-2-science-photo-library-high.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v34441598","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"1000","ImageHeight":"647","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Paget%20Disease%20of%20the%20Nipple","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--image" data-group-name="image" title="Breast Lymph Nodes">
 <div class="hero__image--image">
 <div class="hero__container">
 <img class="hero__image--image" src="./~/media/manual/professional/images/f/0/3/f0317400-breast-lymph-nodes-spl-sized.jpg?mw=350&amp;thn=0&amp;sc_lang=en" width="1000" height="866" loading="lazy">
 </div>
 <span class="hero__description">
 Breast Lymph Nodes
 </span>
 </div>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"Alt":"Breast Lymph Nodes","Credits":"\u003cspan id=\u0022v87530031\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eGwen Shockey/SCIENCE PHOTO LIBRARY\u003c/p\u003e\u003c/div\u003e","IsRestricted":false,"ItemId":"0db0a8ce-b499-48c1-97e4-b72a48b0bda4","Title":"Breast%20Lymph%20Nodes","ShareUrlTitle":"breast-lymph-nodes","Description":"","ImageUrl":"./~/media/manual/professional/images/f/0/3/f0317400-breast-lymph-nodes-spl-sized.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/f/0/3/f0317400-breast-lymph-nodes-spl-sized.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v72309207","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"1000","ImageHeight":"866","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Breast%20Lymph%20Nodes","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--image" data-group-name="image" title="Breast Mass">
 <div class="hero__image--image">
 <div class="hero__container">
 <img class="hero__image--image" src="./~/media/manual/professional/images/c/0/2/c0259641-breast-mass-science-photo-library-high.jpg?mw=350&amp;thn=0&amp;sc_lang=en" width="1000" height="664" loading="lazy">
 </div>
 <span class="hero__description">
 Breast Mass
 </span>
 </div>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"Alt":"Breast Mass","Credits":"\u003cspan id=\u0022v87530056\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eMID ESSEX HOSPITAL SERVICES NHS TRUST/SCIENCE PHOTO LIBRARY \u003c/p\u003e\u003c/div\u003e","IsRestricted":true,"ItemId":"99290462-be45-4fdc-93be-6ddd37aecb3d","Title":"Breast%20Mass","ShareUrlTitle":"breast-mass","Description":"%3Cp%3EThis%20photo%20shows%20an%20irregular%20mass%20on%20the%20lateral%20aspect%20of%20the%20left%20breast.%20The%20mass%20was%20later%20diagnosed%20as%20breast%20cancer.%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/c/0/2/c0259641-breast-mass-science-photo-library-high.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/c/0/2/c0259641-breast-mass-science-photo-library-high.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v34441606","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"1000","ImageHeight":"664","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Breast%20Mass","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--image" data-group-name="image" title="Inflammatory Breast Cancer">
 <div class="hero__image--image">
 <div class="hero__container">
 <img class="hero__image--image" src="./~/media/manual/professional/images/c/0/3/c0333618-breast-cancer-science-photo-library-high.jpg?mw=350&amp;thn=0&amp;sc_lang=en" width="1000" height="667" loading="lazy">
 </div>
 <span class="hero__description">
 Inflammatory Breast Cancer
 </span>
 </div>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"Alt":"Inflammatory Breast Cancer","Credits":"\u003cspan id=\u0022v85657367\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eMID ESSEX HOSPITAL SERVICES NHS TRUST/SCIENCE PHOTO LIBRARY\u003c/p\u003e\u003c/div\u003e","IsRestricted":false,"ItemId":"e21b8295-61b4-493b-bba3-ffdde5444744","Title":"Inflammatory%20Breast%20Cancer","ShareUrlTitle":"inflammatory-breast-cancer","Description":"%3Cp%3EThis%20photo%20shows%20diffuse%20erythema%20and%20edema%20in%20the%20left%20breast%20of%20patient%20with%20inflammatory%20breast%20cancer.%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/c/0/3/c0333618-breast-cancer-science-photo-library-high.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/c/0/3/c0333618-breast-cancer-science-photo-library-high.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v34441583","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"1000","ImageHeight":"667","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Inflammatory%20Breast%20Cancer","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--image" data-group-name="image" title="Lymphedema">
 <div class="hero__image--image">
 <div class="hero__container">
 <img class="hero__image--image" src="./~/media/manual/professional/images/c/0/2/c0238940-lymphoedema-science-photo-library-high.jpg?mw=350&amp;thn=0&amp;sc_lang=en" width="1000" height="776" loading="lazy">
 </div>
 <span class="hero__description">
 Lymphedema
 </span>
 </div>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"Alt":"Lymphedema","Credits":"\u003cspan id=\u0022v85658579\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eSCIENCE PHOTO LIBRARY\u003c/p\u003e\u003c/div\u003e","IsRestricted":true,"ItemId":"3429c029-efc9-4dd1-8c36-2d5d3872edb9","Title":"Lymphedema","ShareUrlTitle":"lymphedema","Description":"%3Cp%3EThis%20photo%20shows%20the%20arms%20of%20a%20patient%20with%20lymphedema%20of%20the%20right%20%28top%29%20arm.%20Lymphedema%20is%20an%20accumulation%20of%20lymph%20fluid%20in%20the%20tissues%20that%20occurs%20when%20lymphatic%20vessels%20are%20blocked%2C%20removed%2C%20or%20damaged.%20Here%2C%20it%20is%20a%20result%20of%20surgery%20for%20breast%20cancer.%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/c/0/2/c0238940-lymphoedema-science-photo-library-high.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/c/0/2/c0238940-lymphoedema-science-photo-library-high.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v35583092","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"1000","ImageHeight":"776","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Lymphedema","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--image" data-group-name="image" title="Breast Reconstruction Using the Transverse Rectus Abdominis Muscle (TRAM) Flap Procedure">
 <div class="hero__image--image">
 <div class="hero__container">
 <img class="hero__image--image" src="./~/media/manual/professional/images/b/r/e/breast_reconstruction_tram_high_blausen.jpg?mw=350&amp;thn=0&amp;sc_lang=en" width="937" height="1000" loading="lazy">
 </div>
 <span class="hero__description">
 Breast Reconstruction Using...
 </span>
 </div>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"Alt":"Breast Reconstruction Using the Transverse Rectus Abdominis Muscle (TRAM) Flap Procedure","Credits":"","IsRestricted":true,"ItemId":"686ad35f-91d8-4531-badb-f1267296f291","Title":"Breast%20Reconstruction%20Using%20the%20Transverse%20Rectus%20Abdominis%20Muscle%20%28TRAM%29%20Flap%20Procedure","ShareUrlTitle":"breast-reconstruction-using-the-transverse-rectus-abdominis-muscle-tram-flap-procedure","Description":"%3Cp%3EMuscle%20flap%20transfer%20using%20the%20lower%20rectus%20abdominis.%3C%2Fp%3E","ImageUrl":"./~/media/manual/professional/images/b/r/e/breast_reconstruction_tram_high_blausen.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/b/r/e/breast_reconstruction_tram_high_blausen.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v13383484","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":"937","ImageHeight":"1000","IframeSrc":null,"Target":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Breast%20Reconstruction%20Using%20the%20Transverse%20Rectus%20Abdominis%20Muscle%20%28TRAM%29%20Flap%20Procedure","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Image","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell " data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Tables'}">
 <a data-bind="event: { click: function() { $data.activateGroup('Tables'); }, keypress: function() { $data.activateGroup('Tables'); }}" class="hero__link" tabindex="0" role="tab" aria-expanded="false" false="">
 <span class="hero__title">
 Tables (4)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Tables" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Tables'}">
 <div class="floatbox">
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--table" data-group-name="table" title="Risk of Being Diagnosed With Invasive Breast Cancer">
 <div class="hero__table">
 <img class="hero__table--image" src="./Content/Images/Redesign/table/icon_table_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Risk of Being Diagnosed With...
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"ItemId":"01265db3-ae89-476c-907e-f8256d12e7bb","Title":"Risk%20of%20Being%20Diagnosed%20With%20Invasive%20Breast%20Cancer","ShareUrlTitle":"risk-of-being-diagnosed-with-invasive-breast-cancer","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v56201155","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Risk%20of%20Being%20Diagnosed%20With%20Invasive%20Breast%20Cancer","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--table" data-group-name="table" title="Anatomic Staging of Breast Cancer*">
 <div class="hero__table">
 <img class="hero__table--image" src="./Content/Images/Redesign/table/icon_table_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Anatomic Staging of Breast...
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"ItemId":"2be010f6-55f6-4cb6-8376-c0ef2bd061bf","Title":"Anatomic%20Staging%20of%20Breast%20Cancer%2A","ShareUrlTitle":"anatomic-staging-of-breast-cancer","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v56201424","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Anatomic%20Staging%20of%20Breast%20Cancer%2A","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--table" data-group-name="table" title="Treatment by Type of Breast Cancer">
 <div class="hero__table">
 <img class="hero__table--image" src="./Content/Images/Redesign/table/icon_table_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Treatment by Type of Breast...
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"ItemId":"3ad5aa23-49f9-4cdf-aaa2-bdaf7da13ef0","Title":"Treatment%20by%20Type%20of%20Breast%20Cancer","ShareUrlTitle":"treatment-by-type-of-breast-cancer","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v56201626","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Treatment%20by%20Type%20of%20Breast%20Cancer","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 <div class="floatbox__item floatbox__item--hero">
 
<a class="hero__figure hero__figure--table" data-group-name="table" title="Preferred Breast Cancer Adjuvant Systemic Therapy*">
 <div class="hero__table">
 <img class="hero__table--image" src="./Content/Images/Redesign/table/icon_table_red.png" loading="lazy">
 </div>
 <span class="hero__description">
 Preferred Breast Cancer Adjuvant...
 </span>
 
<div class="multimedia__link" data-bind="component: { name: 'multimedia-link-block', params: {data: $data, root: $root, element: $element} }" data-popup-model='{"ItemId":"2eb040f4-eeae-43e1-a5d0-5c151510751c","Title":"Preferred%20Breast%20Cancer%20Adjuvant%20Systemic%20Therapy%2A","ShareUrlTitle":"preferred-breast-cancer-adjuvant-systemic-therapy","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v56201727","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicResources","LinkText":"Preferred%20Breast%20Cancer%20Adjuvant%20Systemic%20Therapy%2A","CssClass":null,"LoadLocations":true,"ShowTooltip":false,"SingleItem":false,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Topic%20Resources%20%3A%20Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":null,"Url":null,"HideMainArrows":false}'>
</div>
</a>
 </div>
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 <li class="hero__cell hero__cell--empty" data-bind="css:{'hero__cell--active': $root.activeGroup() === 'Videos'}">
 <a data-bind="" class="hero__link" tabindex="0" role="tab" aria-expanded="false" aria-disabled="true">
 <span class="hero__title">
 Videos (0)
 </span>
 </a>
 <!-- ko if: $data.activeGroup() === "Videos" -->
 <div class="hero__content" data-bind="css:{'hero__content--active': $root.activeGroup() === 'Videos'}">
 <div class="floatbox">
 </div>
 <br class="floatbox__clear">
 </div>
 <!-- /ko -->
 </li>
 </ul>
 </div>
</div>
<div class="topic__accordion">
 <span id="v1065714" class="anchor"></span><div class="para"> <p><div class='topic__explanation'>Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis is made by biopsy. Treatment usually includes surgical excision, often with radiation therapy, and with or without adjuvant chemotherapy, endocrine therapy, or both.</div></p></div><span id="v37583932" class="anchor"></span><div class="para"> <p>In the United States, breast cancer is the most common cancer in women, except for skin cancers (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v37583936" data-toggle="tooltip" title="General references" data-id="9dbad379-580a-474c-9203-245845da86d6" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">1</a><span id="9dbad379-580a-474c-9203-245845da86d6" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v37583936"> <span class="tooltip-content"> <span class="tooltip-heading"> General references </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="General references" loading="lazy"> </span> </a> </span> </span>). Breast cancer is the 2nd leading cause of cancer death (the most common is lung cancer) in the overall female population but is the leading cause of cancer death in Black women. Black women are more likely to die from breast cancer than any other race or ethnicity; Asian and Pacific Islander women have the lowest death rate from breast cancer. </p></div><span id="v82328324" class="anchor"></span><div class="para"> <p>In 2023, in women in the United States, it is estimated there will be</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v63233936" class="anchor"></span><div class="para"> <p>297,790 new cases of invasive breast cancer </p></div></li><li class="topic__listitem"><span id="v63233940" class="anchor"></span><div class="para"> <p>55,720 new cases of in situ breast cancer </p></div></li><li class="topic__listitem"><span id="v63233938" class="anchor"></span><div class="para"> <p>43,700 breast cancer deaths</p></div></li></ul></div><span id="v26442406" class="anchor"></span><div class="para"> <p>In 2023, in men in the United States, it is estimated there will be 2800 new cases of invasive breast cancer and 530 deaths from it (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v37583936" data-toggle="tooltip" title="General references" data-id="427797a9-c30b-452b-ad0d-041b2c9bb505" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">2</a><span id="427797a9-c30b-452b-ad0d-041b2c9bb505" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v37583936"> <span class="tooltip-content"> <span class="tooltip-heading"> General references </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="General references" loading="lazy"> </span> </a> </span> </span>). Manifestations, diagnosis, and management are the same in men and women, although men tend to present at a later stage.</p></div> <section id="v37583935" class="topic__section GHead"> <span></span> <h2 id="" class="topic__header--section"> <span id="v37583936" class="anchor"></span> General references </h2> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v82328327" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://www.cancer.org/cancer/types/breast-cancer/about/how-common-is-breast-cancer.html">American Cancer Society</a>: Key Statistics for Breast Cancer. Accessed May 4, 2023.</p></div></li><li class="topic__listitem"><span id="v82328330" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://www.cancer.org/cancer/types/breast-cancer-in-men/about/key-statistics.html">American Cancer Society</a>: Key Statistics for Breast Cancer in Men. Accessed May 4, 2023.</p></div></li></ul></div> </div> </section> <section id="v1065717" class="topic__section FHead"> <h2 id="RiskFactors_v1065718" class="topic__header--section" data-originaltitle="Risk Factors"> <span id="v1065718" class="anchor"></span> Risk Factors for Breast Cancer </h2> <div class="topic__content"> <span id="v1065720" class="anchor"></span><div class="para"> <p>For women in the United States, cumulative lifetime risk of developing breast cancer is about 13% (1 in 8 [ <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v26442438" data-toggle="tooltip" title="Risk factor references" data-id="d23b9627-1ef7-402f-b86f-fde737ce27ae" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">1</a><span id="d23b9627-1ef7-402f-b86f-fde737ce27ae" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v26442438"> <span class="tooltip-content"> <span class="tooltip-heading"> Risk factor references </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Risk factor references" loading="lazy"> </span> </a> </span> </span>]). Much of the risk is incurred after age 60 (see table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"01265db3-ae89-476c-907e-f8256d12e7bb","Title":"Risk%20of%20Being%20Diagnosed%20With%20Invasive%20Breast%20Cancer","ShareUrlTitle":"risk-of-being-diagnosed-with-invasive-breast-cancer","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v56201155","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3ERisk%20of%20Being%20Diagnosed%20With%20Invasive%20Breast%20Cancer%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>). Risk of dying of breast cancer is about 10% by 5 years after diagnosis (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v26442438" data-toggle="tooltip" title="Risk factor references" data-id="de3349d8-c339-4daa-88ad-a6e9d17de503" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">2</a><span id="de3349d8-c339-4daa-88ad-a6e9d17de503" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v26442438"> <span class="tooltip-content"> <span class="tooltip-heading"> Risk factor references </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Risk factor references" loading="lazy"> </span> </a> </span> </span>).</p></div> <span id="v1065722"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--right inlinebox--table inlinebox--clickable illustrativeMaterialTable "> <div class="inlinebox__wrapper" id="v1065726"> <div class="inlinebox__header">Table</div> <div class="inlinebox__content"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: $data }" data-popup-model='{"ItemId":"01265db3-ae89-476c-907e-f8256d12e7bb","Title":"Risk%20of%20Being%20Diagnosed%20With%20Invasive%20Breast%20Cancer","ShareUrlTitle":"risk-of-being-diagnosed-with-invasive-breast-cancer","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v56201155","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"","LinkText":"Risk%20of%20Being%20Diagnosed%20With%20Invasive%20Breast%20Cancer","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <div class="inlinebox__button"> <img src="./Content/Images/Redesign/table/icon_table_red.png" alt="" loading="lazy" width="55" height="42"> </div> <div class="inlinebox__content--print" id="01265db3-ae89-476c-907e-f8256d12e7bb"> </div> </div> </div> <!-- Type: Table --> </div> <script type="text/javascript"> $(document).ready(function () { var url = window.location; if (url.search.includes("media=print")) { $.ajax({ url: '/Redesign/Topic/GetTableBody', type: "GET", dataType: "json", data: { tableId: '01265db3-ae89-476c-907e-f8256d12e7bb' }, async: true, success: function (data) { $('#01265db3-ae89-476c-907e-f8256d12e7bb').html('<div class="modaldialog">'+ data.TableBody + '</div>'); }, error: function (jqxhr, textStatus, errorThrown) { console.error(errorThrown); } }); } }); </script><span id="v1065793" class="anchor"></span><div class="para"> <p>Factors that may affect breast cancer risk include the following:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v26442431" class="anchor"></span><div class="para"> <p><b>Age:</b> The incidence is highest among women ages 65 to 74 years. Median age at diagnosis is 63 years (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v26442438" data-toggle="tooltip" title="Risk factor references" data-id="c918f303-c1bc-40ef-851e-90cb56d70f1b" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">1</a><span id="c918f303-c1bc-40ef-851e-90cb56d70f1b" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v26442438"> <span class="tooltip-content"> <span class="tooltip-heading"> Risk factor references </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Risk factor references" loading="lazy"> </span> </a> </span> </span>). </p></div></li><li class="topic__listitem"><span id="v82328334" class="anchor"></span><div class="para"> <p><b>Race and ethnicity:</b> The median age at diagnosis is slightly younger for Black women (60 years old) compared to White women 63 years old) (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v26442438" data-toggle="tooltip" title="Risk factor references" data-id="629e7543-ab1f-463b-99cc-f832e83fd3b4" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">1</a><span id="629e7543-ab1f-463b-99cc-f832e83fd3b4" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v26442438"> <span class="tooltip-content"> <span class="tooltip-heading"> Risk factor references </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Risk factor references" loading="lazy"> </span> </a> </span> </span>). Black women have the highest death rate from breast cancer compared with other races or ethnicities; this may be in part because they have a higher rate of triple-negative breast cancer (negative for <span class="genericDrug" data-showrollover="false">estrogen</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>progesterone</span> receptors and human epidermal growth factor receptor [HER2] oncogene), which has a poorer prognosis than other types. White, Asian, and Pacific Islander women are more likely to be diagnosed with localized breast cancer than Black, Hispanic, American Indian, and Alaska Native women. </p></div></li><li class="topic__listitem"><span id="v1065805" class="anchor"></span><div class="para"> <p><b>Family history:</b> Having a 1st-degree relative (mother, sister, daughter) with breast cancer doubles risk of developing the cancer, but breast cancer in more distant relatives increases risk only slightly (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v26442438" data-toggle="tooltip" title="Risk factor references" data-id="a73de645-b635-4b59-9457-1fc1ed5c9d0f" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">3</a><span id="a73de645-b635-4b59-9457-1fc1ed5c9d0f" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v26442438"> <span class="tooltip-content"> <span class="tooltip-heading"> Risk factor references </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Risk factor references" loading="lazy"> </span> </a> </span> </span>). When <span class='symbol'>≥</span> 2 1st-degree relatives have breast cancer, risk may be 3 to 4 times higher. </p></div></li><li class="topic__listitem"><span id="v1065807" class="anchor"></span><div class="para"> <p><b>Breast cancer gene mutations:</b> About 5 to 10% of women with breast cancer carry a mutation in one of the two known breast cancer genes, <i data-mmanualobjecttype='gene' '>BRCA1</i> or <i data-mmanualobjecttype='gene' '>BRCA2</i>. The risk of developing breast cancer by age 80 is about 72% with a <i data-mmanualobjecttype='gene' '>BRCA1</i> mutation and about 69% with a <i data-mmanualobjecttype='gene' '>BRCA2</i> mutation. Women with <i data-mmanualobjecttype='gene' '>BRCA1</i> mutations also have an approximate 44% lifetime risk of developing ovarian cancer; risk among women with <i data-mmanualobjecttype='gene' '>BRCA2</i> mutations is about 17% (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v26442438" data-toggle="tooltip" title="Risk factor references" data-id="ec6d6a50-7c78-41b3-b83c-5a4cb5421325" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">4</a><span id="ec6d6a50-7c78-41b3-b83c-5a4cb5421325" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v26442438"> <span class="tooltip-content"> <span class="tooltip-heading"> Risk factor references </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Risk factor references" loading="lazy"> </span> </a> </span> </span>, <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v26442438" data-toggle="tooltip" title="Risk factor references" data-id="9b789267-4a21-4548-a0fd-2bc9651f4bb9" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">5</a><span id="9b789267-4a21-4548-a0fd-2bc9651f4bb9" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v26442438"> <span class="tooltip-content"> <span class="tooltip-heading"> Risk factor references </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Risk factor references" loading="lazy"> </span> </a> </span> </span>). Men who carry a <i data-mmanualobjecttype='gene' '>BRCA</i> mutation have a 1 to 2% lifetime risk of developing breast cancer. The mutations are more common among people with Ashkenazi Jewish ancestry. Women with <i data-mmanualobjecttype='gene' '>BRCA1</i> or <i data-mmanualobjecttype='gene' '>BRCA2</i> mutations require closer surveillance or preventive measures, such as screening with both mammography and MRI, taking <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tamoxifen</span>, or undergoing risk-reducing mastectomy.</p></div></li><li class="topic__listitem"><span id="v1065809" class="anchor"></span><div class="para"> <p><b>Personal history of breast cancer:</b> Having had in situ or invasive breast cancer increases risk. Risk of developing cancer in the contralateral breast after mastectomy is about 0.4%/year of follow-up (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v26442438" data-toggle="tooltip" title="Risk factor references" data-id="ae075bf1-bda5-4b51-8628-1b9ee7757d53" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">6</a><span id="ae075bf1-bda5-4b51-8628-1b9ee7757d53" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v26442438"> <span class="tooltip-content"> <span class="tooltip-heading"> Risk factor references </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Risk factor references" loading="lazy"> </span> </a> </span> </span>).</p></div></li><li class="topic__listitem"><span id="v9009138" class="anchor"></span><div class="para"> <p><b>Lobular carcinoma in situ (LCIS):</b> Having LCIS increases the risk of developing invasive carcinoma in either breast by about 7 to 12 times (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v26442438" data-toggle="tooltip" title="Risk factor references" data-id="ab0eff36-54fc-488f-979a-a119738a0911" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">7</a><span id="ab0eff36-54fc-488f-979a-a119738a0911" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v26442438"> <span class="tooltip-content"> <span class="tooltip-heading"> Risk factor references </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Risk factor references" loading="lazy"> </span> </a> </span> </span>); invasive carcinoma develops in about 1 to 2% of patients with LCIS annually.</p></div></li><li class="topic__listitem"><span id="v1065811" class="anchor"></span><div class="para"> <p><b>Gynecologic history:</b> Early menarche or late menopause increases risk. Risk increases with increasing age at first pregnancy (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v26442438" data-toggle="tooltip" title="Risk factor references" data-id="e090fa08-797b-4aaf-a1c3-eab4575931a8" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">3</a><span id="e090fa08-797b-4aaf-a1c3-eab4575931a8" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v26442438"> <span class="tooltip-content"> <span class="tooltip-heading"> Risk factor references </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Risk factor references" loading="lazy"> </span> </a> </span> </span>). </p></div></li><li class="topic__listitem"><span id="v1065813" class="anchor"></span><div class="para"> <p><b>Benign breast disease:</b> History of a lesion that required a biopsy is associated with a slightly increased risk. Women with multiple breast masses but no histologic confirmation of a high-risk histology should not be considered at high risk. Benign lesions associated with a slightly increased risk of developing invasive breast cancer include complex fibroadenoma, moderate or florid hyperplasia (without atypia), sclerosing adenosis, and papilloma. Risk is about 3 to 5 times higher than average in patients with atypical ductal or lobular hyperplasia (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v26442438" data-toggle="tooltip" title="Risk factor references" data-id="7f356166-4d5e-424b-b762-9542c3f60d31" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">8</a><span id="7f356166-4d5e-424b-b762-9542c3f60d31" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v26442438"> <span class="tooltip-content"> <span class="tooltip-heading"> Risk factor references </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Risk factor references" loading="lazy"> </span> </a> </span> </span>). </p></div></li><li class="topic__listitem"><span id="v82328341" class="anchor"></span><div class="para"> <p><b>Dense breast tissue:</b> Dense breast tissue seen on screening mammography is associated with a 1.2- to 2.1-fold increased risk of breast cancer (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v26442438" data-toggle="tooltip" title="Risk factor references" data-id="84779e35-234f-463d-9d8f-5fc2c73fe69e" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">9</a><span id="84779e35-234f-463d-9d8f-5fc2c73fe69e" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v26442438"> <span class="tooltip-content"> <span class="tooltip-heading"> Risk factor references </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Risk factor references" loading="lazy"> </span> </a> </span> </span>).</p></div></li><li class="topic__listitem"><span id="v1065815" class="anchor"></span><div class="para"> <p><b>Use of oral contraceptives:</b> Study results vary regarding the use of oral contraceptives and risk of breast cancer. Some studies have found a small increased risk in current or recent users (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v26442438" data-toggle="tooltip" title="Risk factor references" data-id="d72f78a2-ff18-4888-b61a-6eb07416ff86" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">10</a><span id="d72f78a2-ff18-4888-b61a-6eb07416ff86" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v26442438"> <span class="tooltip-content"> <span class="tooltip-heading"> Risk factor references </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Risk factor references" loading="lazy"> </span> </a> </span> </span>). </p></div></li><li class="topic__listitem"><span id="v1065817" class="anchor"></span><div class="para"> <p><b> <a href="./{D7CC01E9-54F0-450D-923F-38543AADBD7C}.html#v25242237" data-toggle="tooltip" title="Menopausal Hormone Therapy" data-id="6f34553d-be08-423e-bee7-9b58a1e28112" data-itemid="d7cc01e9-54f0-450d-923f-38543aadbd7c">Hormone therapy</a><span id="6f34553d-be08-423e-bee7-9b58a1e28112" class="d-none xref"> <span class="tooltip-container"> <a href="./{D7CC01E9-54F0-450D-923F-38543AADBD7C}.html#v25242237"> <span class="tooltip-content"> <span class="tooltip-heading"> Menopausal Hormone Therapy </span> Menopause is the permanent cessation of menses (amenorrhea) due to loss of ovarian follicular function. Clinical manifestations may include hot flushes, night sweats, sleep disruption, and genitourinary... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>:</b> In the Women's Health Initiative randomized trial, menopausal hormone therapy (estrogen plus a progestin) increased risk modestly after only 3 years of use (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v26442438" data-toggle="tooltip" title="Risk factor references" data-id="c6463e9f-c050-4c26-b0e4-8b8492fa01f3" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">11</a><span id="c6463e9f-c050-4c26-b0e4-8b8492fa01f3" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v26442438"> <span class="tooltip-content"> <span class="tooltip-heading"> Risk factor references </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Risk factor references" loading="lazy"> </span> </a> </span> </span>). After 5 years of use, the increased risk is about 3 additional cases per 1000 women for each year of use (approximately a 24% increase in relative risk). Use of <span class="genericDrug" data-showrollover="false">estrogen</span> alone does not appear to increase risk of breast cancer. Selective <span class="genericDrug" data-showrollover="false">estrogen</span>-receptor modulators (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>raloxifene</span>) reduce the risk of developing breast cancer.</p></div></li><li class="topic__listitem"><span id="v1065821" class="anchor"></span><div class="para"> <p><b>Radiation therapy:</b> Exposure to radiation therapy of the chest up through 45 years old increases risk, with the highest increase for those exposed between ages 10 to 14 years (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v26442438" data-toggle="tooltip" title="Risk factor references" data-id="7b682222-2af3-4c8c-a5c3-fb62416370af" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">12</a><span id="7b682222-2af3-4c8c-a5c3-fb62416370af" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v26442438"> <span class="tooltip-content"> <span class="tooltip-heading"> Risk factor references </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Risk factor references" loading="lazy"> </span> </a> </span> </span>). Mantle-field radiation therapy for Hodgkin lymphoma about quadruples risk of breast cancer over the next 20 to 30 years.</p></div></li><li class="topic__listitem"><span id="v1065823" class="anchor"></span><div class="para"> <p><b>Diet:</b> Diet may contribute to development, growth, or prognosis of breast cancers, but conclusive evidence about the effect of a particular diet (eg, one high in fats) is lacking. </p></div></li><li class="topic__listitem"><span id="v82328345" class="anchor"></span><div class="para"> <p><b>Obesity:</b> Postmenopausal women with obesity are at increased risk of breast cancer; studies show a 10% increase in risk for each additional 5 body mass index (BMI) units above normal BMI (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v26442438" data-toggle="tooltip" title="Risk factor references" data-id="9a83a70f-2015-4479-a61e-edb18ddb5f6b" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">13</a><span id="9a83a70f-2015-4479-a61e-edb18ddb5f6b" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v26442438"> <span class="tooltip-content"> <span class="tooltip-heading"> Risk factor references </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Risk factor references" loading="lazy"> </span> </a> </span> </span>).</p></div></li><li class="topic__listitem"><span id="v27372894" class="anchor"></span><div class="para"> <p><b>Smoking and alcohol:</b> Smoking and alcohol use appear to be associated with an increase in breast cancer risk; the increase with alcohol intake is dose-dependent (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v26442438" data-toggle="tooltip" title="Risk factor references" data-id="06ee9d68-7808-4fc5-883d-92cffcef2154" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">14</a><span id="06ee9d68-7808-4fc5-883d-92cffcef2154" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v26442438"> <span class="tooltip-content"> <span class="tooltip-heading"> Risk factor references </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Risk factor references" loading="lazy"> </span> </a> </span> </span>, <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v26442438" data-toggle="tooltip" title="Risk factor references" data-id="490ad337-6902-4cb6-92d0-751cbac8b3fc" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">15</a><span id="490ad337-6902-4cb6-92d0-751cbac8b3fc" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v26442438"> <span class="tooltip-content"> <span class="tooltip-heading"> Risk factor references </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Risk factor references" loading="lazy"> </span> </a> </span> </span>). </p></div></li></ul></div><span id="v26442434" class="anchor"></span><div class="para"> <p>The <a rel="nofollow" target="_blank" href="https://www.cancer.gov/bcrisktool/">Breast Cancer Risk Assessment Tool</a> (BCRAT), or Gail model, can be used to calculate a women's 5-year and lifetime risk of developing breast cancer.</p></div> <section id="v26442437" class="topic__section GHead"> <span></span> <h3 id="RiskFactors_v1065718_v26442438" class="topic__header--subsection"> <span id="v26442438" class="anchor"></span> Risk factor references </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v82328350" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://www.cancer.org/cancer/types/breast-cancer/about/how-common-is-breast-cancer.html">American Cancer Society</a>: Key Statistics for Breast Cancer. Accessed May 4, 2023.</p></div></li><li class="topic__listitem"><span id="v26442441" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://www.cancer.org/cancer/breast-cancer/understanding-a-breast-cancer-diagnosis/breast-cancer-survival-rates.html">American Cancer Society</a>: Survival Rates for Breast Cancer. Accessed March 29, 2023.</p></div></li><li class="topic__listitem"><span id="v82328353" class="anchor"></span><div class="para"> <p>3. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/11705483/">Collaborative Group on Hormonal Factors in Breast Cancer</a>: Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease. <i>Lancet</i> 358(9291):1389-1399, 2001. doi:10.1016/S0140-6736(01)06524-2</p></div></li><li class="topic__listitem"><span id="v63233955" class="anchor"></span><div class="para"> <p>4. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/28632866/">Kuchenbaecker KB, Hopper JL, Barnes DR, et al</a>: Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. <i>JAMA</i> 317 (23):2402–2416, 2017. doi: 10.1001/jama.2017.7112</p></div></li><li class="topic__listitem"><span id="v63233959" class="anchor"></span><div class="para"> <p>5. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7611105/">Breast Cancer Association Consortium; Dorling L, Carvalho S, Allen J, et al</a>: Breast cancer risk genes — Association analysis in more than 113,000 women. <i>N Engl J Med</i> 4;384 (5):428–439, 2021. doi: 10.1056/NEJMoa1913948 </p></div></li><li class="topic__listitem"><span id="v82328356" class="anchor"></span><div class="para"> <p>6. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8368197/">Giannakeas V, Lim DW, Narod SA</a>: The risk of contralateral breast cancer: a SEER-based analysis. <i>Br J Cancer</i> 125(4):601-610, 2021. doi:10.1038/s41416-021-01417-7</p></div></li><li class="topic__listitem"><span id="v63233967" class="anchor"></span><div class="para"> <p>7. <a rel="nofollow" target="_blank" href="https://www.cancer.org/cancer/breast-cancer/non-cancerous-breast-conditions/lobular-carcinoma-in-situ.html">American Cancer Society (ACOG)</a>: Lobular Carcinoma in Situ (LCIS). Accessed May 4, 2023.</p></div></li><li class="topic__listitem"><span id="v82328359" class="anchor"></span><div class="para"> <p>8. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/17154175/">Collins LC, Baer HJ, Tamimi RM, et al</a>: Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses' Health Study. <i>Cancer</i> 109(2):180-187, 2007. doi:10.1002/cncr.22408</p></div></li><li class="topic__listitem"><span id="v63233963" class="anchor"></span><div class="para"> <p>9. <a rel="nofollow" target="_blank" href="https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2015/03/management-of-women-with-dense-breasts-diagnosed-by-mammography">American College of Obstetricians and Gynecologists (ACOG)</a>: Committee opinion no. 625: Management of women with dense breasts diagnosed by mammography. <i>Obstet Gynecol </i>125 (3):750–751, 2015. Reaffirmed 2020. doi: 10.1097/01.AOG.0000461763.77781.79 Accessed May 4, 2023.</p></div></li><li class="topic__listitem"><span id="v63233970" class="anchor"></span><div class="para"> <p>10. <a rel="nofollow" target="_blank" href="https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2018/01/hormonal-contraception-and-risk-of-breast-cancer">American College of Obstetricians and Gynecologists (ACOG) </a>: Hormonal contraception and risk of breast cancer: Practice advisory. Published 2018, reaffirmed 2022. Accessed May 4, 2023.</p></div></li><li class="topic__listitem"><span id="v37583953" class="anchor"></span><div class="para"> <p>11. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/12117397/">Rossouw JE, Anderson GL, Prentice RL, et al.</a>: Risks and benefits of <span class="genericDrug" data-showrollover="false">estrogen</span> plus <span class="genericDrug" data-showrollover="false">progestin</span> in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. <i>JAMA</i> 288 (3):321–333, 2002. doi:10.1001/jama.288.3.321</p></div></li><li class="topic__listitem"><span id="v82328364" class="anchor"></span><div class="para"> <p>12. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/8405198/">John EM, Kelsey JL</a>: Radiation and other environmental exposures and breast cancer. <i>Epidemiol Rev</i> 15(1):157-162, 1993. doi:10.1093/oxfordjournals.epirev.a036099</p></div></li><li class="topic__listitem"><span id="v82328367" class="anchor"></span><div class="para"> <p>13. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754861/">Lauby-Secretan B, Scoccianti C, Loomis D, et al</a>: Body Fatness and Cancer--Viewpoint of the IARC Working Group. <i>N Engl J Med</i> 375(8):794-798, 2016. doi:10.1056/NEJMsr1606602</p></div></li><li class="topic__listitem"><span id="v82328370" class="anchor"></span><div class="para"> <p>14. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4836396/">Gram IT, Park SY, Kolonel LN, et al</a>: Smoking and Risk of Breast Cancer in a Racially/Ethnically Diverse Population of Mainly Women Who Do Not Drink Alcohol: The MEC Study. <i>Am J Epidemiol</i> 182(11):917-925, 2015. doi:10.1093/aje/kwv092</p></div></li><li class="topic__listitem"><span id="v82328373" class="anchor"></span><div class="para"> <p>15. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/17204515/">Zhang SM, Lee IM, Manson JE, et al</a>: Alcohol consumption and breast cancer risk in the Women's Health Study. <i>Am J Epidemiol</i> 165(6):667-676, 2007. doi:10.1093/aje/kwk054</p></div></li></ul></div> </div> </section> </div> </section> <section id="v1065825" class="topic__section FHead"> <h2 id="Pathology_v1065826" class="topic__header--section" data-originaltitle="Pathology"> <span id="v1065826" class="anchor"></span> Pathology of Breast Cancer </h2> <div class="topic__content"> <span id="v1065827" class="anchor"></span><div class="para"> <p>Most breast cancers are epithelial tumors (carcinomas) that develop from cells lining ducts or lobules; nonepithelial cancers of the supporting stroma (eg, angiosarcoma, primary stromal sarcomas, phyllodes tumor) are less common.</p></div> <div class="inlinemedia-component " data-ko-rebind="v72309239" data-bind="component: {name: 'inlinemedia-photo', params: $data}" data-inline-model='{"Alt":"Anatomy of the Breast (Front and Side Views)","Credits":"\u003cspan id=\u0022v87530025\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eGwen Shockey/SCIENCE PHOTO LIBRARY\u003c/p\u003e\u003c/div\u003e","IsRestricted":false,"ItemId":"4adb7367-ab0f-468a-9ee7-440f94ed8883","Title":"Anatomy of the Breast (Front and Side Views)","ShareUrlTitle":"anatomy-of-the-breast-front-and-side-views","Description":"","ImageUrl":"./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v72309239","Placement":"sideline","IsInCarousel":false,"Edition":0,"ImageWidth":"778","ImageHeight":"1000","IframeSrc":null,"Target":null}'> </div> <div class="inlinemedia-component " data-ko-rebind="v72309223" data-bind="component: {name: 'inlinemedia-photo', params: $data}" data-inline-model='{"Alt":"Anatomy of the Breast (Side View)","Credits":"\u003cspan id=\u0022v87530028\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eGwen Shockey/SCIENCE PHOTO LIBRARY\u003c/p\u003e\u003c/div\u003e","IsRestricted":false,"ItemId":"1cf1c19f-1266-4487-9446-b4b833a3239e","Title":"Anatomy of the Breast (Side View)","ShareUrlTitle":"anatomy-of-the-breast-side-view","Description":"","ImageUrl":"./~/media/manual/professional/images/f/0/3/f0317392-breast-anatomy-side-spl-sized.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/f/0/3/f0317392-breast-anatomy-side-spl-sized.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v72309223","Placement":"sideline","IsInCarousel":false,"Edition":0,"ImageWidth":"988","ImageHeight":"1000","IframeSrc":null,"Target":null}'> </div><span id="v37583956" class="anchor"></span><div class="para"> <p>Epithelial cancers are divided into carcinoma in situ and invasive cancer.</p></div><span id="v1065828" class="anchor"></span><div class="para"> <p><b>Carcinoma in situ</b> is proliferation of cancer cells within ducts or lobules but without invasion of stromal tissue. There are 2 types:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v9009141" class="anchor"></span><div class="para"> <p><b>Ductal carcinoma in situ (DCIS):</b> DCIS refers to neoplastic epithelial lesions that are confined to the breast ducts; lesions may have varying histology and malignant potential. It is usually detected only by mammography. It may involve a small or wide area of the breast; if a wide area is involved, microscopic invasive foci may develop over time. DCIS accounts for approximately 20% of breast cancers (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v82328389" data-toggle="tooltip" title="References" data-id="37c2a668-4c38-4f1d-a134-769d9420d88e" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">1</a><span id="37c2a668-4c38-4f1d-a134-769d9420d88e" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v82328389"> <span class="tooltip-content"> <span class="tooltip-heading"> References </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="References" loading="lazy"> </span> </a> </span> </span>). Two randomized studies of DCIS comparing the addition of radiation and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tamoxifen</span> to local excision showed a low risk of death from DCIS, regardless of the treatment option chosen (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v82328389" data-toggle="tooltip" title="References" data-id="df9767ab-5ac5-4ee1-9505-062e8be63d0a" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">2</a><span id="df9767ab-5ac5-4ee1-9505-062e8be63d0a" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v82328389"> <span class="tooltip-content"> <span class="tooltip-heading"> References </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="References" loading="lazy"> </span> </a> </span> </span>).</p></div></li><li class="topic__listitem"><span id="v9009143" class="anchor"></span><div class="para"> <p><b>Lobular carcinoma in situ (LCIS):</b> LCIS is often multifocal and is bilateral in approximately 20 to 60% of cases (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v82328389" data-toggle="tooltip" title="References" data-id="95dab0d4-7030-4192-b736-72fc116d27f4" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">3</a><span id="95dab0d4-7030-4192-b736-72fc116d27f4" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v82328389"> <span class="tooltip-content"> <span class="tooltip-heading"> References </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="References" loading="lazy"> </span> </a> </span> </span>). There are 2 types: classic and pleomorphic (cells are larger and more atypical). Classic LCIS is not malignant but increases risk of developing invasive carcinoma in either breast. This nonpalpable lesion is usually suspected based on calcifications or a mass on mammography or ultrasonography and is diagnosed with biopsy. Pleomorphic LCIS behaves more like DCIS; it should be excised to negative margins.</p></div></li></ul></div><span id="v1065833" class="anchor"></span><div class="para"> <p><b> <a href="./{822B3915-1F3B-4A64-BB2D-CB9BBEED5777}.html" data-toggle="tooltip" title="Paget Disease of the Breast" data-id="cfba24d7-3a30-4772-a08d-0c7fbb14e733" data-itemid="822b3915-1f3b-4a64-bb2d-cb9bbeed5777">Paget disease of the nipple</a><span id="cfba24d7-3a30-4772-a08d-0c7fbb14e733" class="d-none xref"> <span class="tooltip-container"> <a href="./{822B3915-1F3B-4A64-BB2D-CB9BBEED5777}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Paget Disease of the Breast </span> Paget disease is a rare type of carcinoma that appears as a unilateral eczematous to psoriasiform plaque of the nipple and areola. It results from extension to the epidermis of an underlying... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/m/1/2/m1220351-paget-disease-of-the-breast-2-science-photo-library-high.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Paget Disease of the Breast" loading="lazy"> </span> </a> </span> </span></b> (not to be confused with the metabolic bone disease also called Paget disease) is a form of ductal carcinoma in situ that extends into the skin over the nipple and areola, manifesting with a skin lesion (eg, an eczematous or a psoriaform lesion). Characteristic malignant cells called Paget cells are present in the epidermis. Women with Paget disease of the nipple often have underlying invasive or in situ cancer.</p></div><span id="v1065832" class="anchor"></span><div class="para"> <p><b>Invasive carcinoma</b> is primarily adenocarcinoma. Approximately 75% are infiltrating ductal histology and 10% of the remaining cases are infiltrating lobular (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v82328389" data-toggle="tooltip" title="References" data-id="0c8cfb9f-0038-4315-a3e3-095548d0255e" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">4</a><span id="0c8cfb9f-0038-4315-a3e3-095548d0255e" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v82328389"> <span class="tooltip-content"> <span class="tooltip-heading"> References </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="References" loading="lazy"> </span> </a> </span> </span>). </p></div><span id="v82328379" class="anchor"></span><div class="para"> <p>Epithelial cancers may express <b>hormone receptors</b> (stromal tumors do not express hormone receptors, eg, phyllodes tumors). Approximately 80% of postmenopausal and 20% of premenopausal patients with breast cancer have an <span class="genericDrug" data-showrollover="false">estrogen</span> receptor–positive (ER<span class='symbol'>+</span>) tumor (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v82328389" data-toggle="tooltip" title="References" data-id="36669315-7ea0-432d-a79d-7bcd59395d06" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">5</a><span id="36669315-7ea0-432d-a79d-7bcd59395d06" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v82328389"> <span class="tooltip-content"> <span class="tooltip-heading"> References </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="References" loading="lazy"> </span> </a> </span> </span>); approximately 70% of all breast cancers are <span class="genericDrug" data-showrollover="false">progesterone</span> receptor-positive (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v82328389" data-toggle="tooltip" title="References" data-id="226e1906-d687-419e-adf8-29a902b00b4c" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">6</a><span id="226e1906-d687-419e-adf8-29a902b00b4c" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v82328389"> <span class="tooltip-content"> <span class="tooltip-heading"> References </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="References" loading="lazy"> </span> </a> </span> </span>). Another cellular receptor is <b>human epidermal growth factor receptor 2</b> (HER2; also called HER2/neu or ErbB2); its presence correlates with a poorer prognosis at any given stage of cancer. In approximately 15% of patients with breast cancer, HER2 receptors are overexpressed (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v82328389" data-toggle="tooltip" title="References" data-id="3ab1f7d4-eb26-4684-a6d4-6917d80df0e8" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">7</a><span id="3ab1f7d4-eb26-4684-a6d4-6917d80df0e8" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v82328389"> <span class="tooltip-content"> <span class="tooltip-heading"> References </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="References" loading="lazy"> </span> </a> </span> </span>). The majority of breast cancers are hormone receptor-positive and HER2 negative (approximately 70%); 12% are triple negative (hormone receptor-negative and HER2-negative) (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v82328389" data-toggle="tooltip" title="References" data-id="40ff9fbb-51a6-4ac8-bdc9-bfb4eb115e4d" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">7</a><span id="40ff9fbb-51a6-4ac8-bdc9-bfb4eb115e4d" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v82328389"> <span class="tooltip-content"> <span class="tooltip-heading"> References </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="References" loading="lazy"> </span> </a> </span> </span>, <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v82328389" data-toggle="tooltip" title="References" data-id="b14b451e-1659-4fbc-beb3-5b14fc45833f" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">8</a><span id="b14b451e-1659-4fbc-beb3-5b14fc45833f" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v82328389"> <span class="tooltip-content"> <span class="tooltip-heading"> References </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="References" loading="lazy"> </span> </a> </span> </span>). </p></div><span id="v63233972" class="anchor"></span><div class="para"> <p><b>Rare histologic types</b> that are usually associated with a favorable prognosis include medullary, mucinous, cribriform, and tubular carcinomas (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v82328389" data-toggle="tooltip" title="References" data-id="221563dd-8641-4eda-a214-8be4888ea5de" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">4</a><span id="221563dd-8641-4eda-a214-8be4888ea5de" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v82328389"> <span class="tooltip-content"> <span class="tooltip-heading"> References </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="References" loading="lazy"> </span> </a> </span> </span>). Mucinous carcinoma tends to develop in older women and be slow growing. </p></div> <div class="inlinemedia-component " data-ko-rebind="v44885154" data-bind="component: {name: 'inlinemedia-photo', params: $data}" data-inline-model='{"Alt":"Peau d’Orange","Credits":"\u003cspan id=\u0022v85660298\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003e\u0022Creative Commons Patient with inflammatory breast cancer\u0022 by Epidemiology and surgical management of breast cancer in gynecological department of Douala General Hospital (Scientific Figure on ResearchGate) is licensed under \u003ca rel=\u0022nofollow\u0022 target=\u0022_blank\u0022 href=\u0022https://creativecommons.org/licenses/by/2.0/legalcode\u0022\u003eCreative Commons 2.0\u003c/a\u003e. Available from: https://www.researchgate.net/figure/Patient-with-inflammatory-breast-cancer_fig2_234162338 [accessed 3 Oct, 2019].\u003c/p\u003e\u003c/div\u003e","IsRestricted":false,"ItemId":"cf9ed085-1191-46bb-bbb1-24caba71a6b7","Title":"Peau d’Orange","ShareUrlTitle":"peau-dorange","Description":"\u003cul\u003e\u003cspan id=\u0022v88843566\u0022 class=\u0022anchor\u0022\u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022\u003e \u003cp\u003eSometimes in inflammatory breast cancer and very advanced cancers, the breast appears inflamed, and the skin appears thickened, resembling orange peel (peau d’orange).\u003c/p\u003e\u003c/div\u003e\u003c/ul\u003e","ImageUrl":"./~/media/manual/professional/images/p/a/t/patient-with-inflammatory-breast-cancer-sized.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/p/a/t/patient-with-inflammatory-breast-cancer-sized.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v44885154","Placement":"sideline","IsInCarousel":false,"Edition":0,"ImageWidth":"1000","ImageHeight":"742","IframeSrc":null,"Target":null}'> </div><span id="v9009144" class="anchor"></span><div class="para"> <p>Rare types that typically have a poor prognosis include metaplastic and inflammatory breast cancer. <b>Inflammatory breast cancer</b> is a fast-growing, particularly aggressive, and often fatal cancer. Cancer cells block the lymphatic vessels in breast skin; as a result, the breast appears inflamed, and the skin appears thickened, resembling orange peel (peau d’orange). Usually, inflammatory breast cancer spreads to the lymph nodes in the armpit. The lymph nodes feel like hard lumps. However, often no mass is felt in the breast itself because this cancer is dispersed throughout the breast.</p></div> <div class="inlinemedia-component " data-ko-rebind="v34441598" data-bind="component: {name: 'inlinemedia-photo', params: $data}" data-inline-model='{"Alt":"Paget Disease of the Nipple","Credits":"\u003cspan id=\u0022v87250437\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eDR M.A. ANSARY/SCIENCE PHOTO LIBRARY \u003c/p\u003e\u003c/div\u003e","IsRestricted":true,"ItemId":"cb7a2e39-b85d-40f1-947b-e685f8464dec","Title":"Paget Disease of the Nipple","ShareUrlTitle":"paget-disease-of-the-nipple","Description":"\u003cul\u003e\u003cspan id=\u0022v88843568\u0022 class=\u0022anchor\u0022\u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022\u003e \u003cp\u003eIn Paget disease of the nipple, ductal carcinoma in situ extends over the nipple and areola and causes scaling, pruritus, and burning pain in the affected nipple.\u003c/p\u003e\u003c/div\u003e\u003c/ul\u003e","ImageUrl":"./~/media/manual/professional/images/m/1/2/m1220351-paget-disease-of-the-breast-2-science-photo-library-high.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/m/1/2/m1220351-paget-disease-of-the-breast-2-science-photo-library-high.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v34441598","Placement":"sideline","IsInCarousel":false,"Edition":0,"ImageWidth":"1000","ImageHeight":"647","IframeSrc":null,"Target":null}'> </div> <section id="v82328388" class="topic__section GHead"> <span></span> <h3 id="Pathology_v1065826_v82328389" class="topic__header--subsection"> <span id="v82328389" class="anchor"></span> References </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v82328392" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/36190501/">Giaquinto AN, Sung H, Miller KD, et al</a>: Breast Cancer Statistics, 2022. <i>CA Cancer J Clin</i> 72(6):524-541, 2022. doi:10.3322/caac.21754</p></div></li><li class="topic__listitem"><span id="v82328395" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3107729/">Wapnir IL, Dignam JJ, Fisher B, et al</a>: Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. <i>J Natl Cancer Inst</i> 103(6):478-488, 2011. doi:10.1093/jnci/djr027</p></div></li><li class="topic__listitem"><span id="v82328398" class="anchor"></span><div class="para"> <p>3. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841603/">Wen HY, Brogi E</a>: Lobular Carcinoma In Situ. <i>Surg Pathol Clin</i> 11(1):123-145, 2018. doi:10.1016/j.path.2017.09.009</p></div></li><li class="topic__listitem"><span id="v82328401" class="anchor"></span><div class="para"> <p>4. <a rel="nofollow" target="_blank" href="https://www.cancer.org/research/cancer-facts-statistics/breast-cancer-facts-figures.html">American Cancer Society</a>: Breast Cancer Facts & Figures. Accessed May 4, 2023</p></div></li><li class="topic__listitem"><span id="v82328404" class="anchor"></span><div class="para"> <p>5. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/12408373/">Anderson WF, Chatterjee N, Ershler WB, et al</a>: Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database. Breast Cancer Res Treat. 2002;76(1):27-36. doi:10.1023/a:1020299707510</p></div></li><li class="topic__listitem"><span id="v82328407" class="anchor"></span><div class="para"> <p>6. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6991239/">Li Y, Yang D, Yin X, et al</a>: Clinicopathological Characteristics and Breast Cancer-Specific Survival of Patients With Single Hormone Receptor-Positive Breast Cancer. <i>JAMA Netw Open</i> 3(1):e1918160, 2020. doi:10.1001/jamanetworkopen.2019.18160</p></div></li><li class="topic__listitem"><span id="v82328410" class="anchor"></span><div class="para"> <p>7. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4580552/">Howlader N, Altekruse SF, Li CI, et al</a>: US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. <i>J Natl Cancer Inst</i> 106(5):dju055, 2014. Published 2014 Apr 28. doi:10.1093/jnci/dju055</p></div></li><li class="topic__listitem"><span id="v82328413" class="anchor"></span><div class="para"> <p>8. <a rel="nofollow" target="_blank" href="https://seer.cancer.gov/statfacts/html/breast-subtypes.html">National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) Program </a>: Cancer Stat Facts: Female Breast Cancer Subtypes. Accessed May 4, 2023</p></div></li></ul></div> </div> </section> </div> </section> <section id="v1065837" class="topic__section FHead"> <h2 id="Pathophysiology_v1065838" class="topic__header--section" data-originaltitle="Pathophysiology"> <span id="v1065838" class="anchor"></span> Pathophysiology of Breast Cancer </h2> <div class="topic__content"> <span id="v1065839" class="anchor"></span><div class="para"> <p>Breast cancer invades locally and spreads through the regional lymph nodes, bloodstream, or both. Metastatic breast cancer may affect almost any organ in the body—most commonly, lungs, liver, bone, brain, and skin. Most skin metastases occur near the site of breast surgery; scalp metastases are uncommon. </p></div> <div class="inlinemedia-component " data-ko-rebind="v72309207" data-bind="component: {name: 'inlinemedia-photo', params: $data}" data-inline-model='{"Alt":"Breast Lymph Nodes","Credits":"\u003cspan id=\u0022v87530031\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eGwen Shockey/SCIENCE PHOTO LIBRARY\u003c/p\u003e\u003c/div\u003e","IsRestricted":false,"ItemId":"0db0a8ce-b499-48c1-97e4-b72a48b0bda4","Title":"Breast Lymph Nodes","ShareUrlTitle":"breast-lymph-nodes","Description":"","ImageUrl":"./~/media/manual/professional/images/f/0/3/f0317400-breast-lymph-nodes-spl-sized.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/f/0/3/f0317400-breast-lymph-nodes-spl-sized.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v72309207","Placement":"sideline","IsInCarousel":false,"Edition":0,"ImageWidth":"1000","ImageHeight":"866","IframeSrc":null,"Target":null}'> </div><span id="v49777784" class="anchor"></span><div class="para"> <p>Some breast cancers may recur sooner than others; recurrence can often be predicted based on tumor markers. For example, metastatic breast cancer may occur within 3 years in patients who are negative for tumor markers or occur > 10 years after initial diagnosis and treatment in patients who have an <span class="genericDrug" data-showrollover="false">estrogen</span>-receptor positive tumor.</p></div> <section id="v26442445" class="topic__section GHead"> <span></span> <h3 id="Pathophysiology_v1065838_v26442446" class="topic__header--subsection"> <span id="v26442446" class="anchor"></span> Hormone receptors </h3> <div class="topic__content"> <span id="v26442447" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Estrogen</span> and <span class="genericDrug" data-showrollover="false">progesterone</span> receptors are nuclear hormone receptors that promote DNA replication and cell division when the appropriate hormones bind to them. Thus, medications that block these receptors are useful in treating and preventing tumors with the receptors. </p></div><span id="v26442450" class="anchor"></span><div class="para"> <p>For tumors in which HER2 receptors are overexpressed, medications that block these receptors are part of standard treatment. HER2 overexpressing tumors respond well to these medications because HER2 is a significant driver of cancer cell progression.</p></div> </div> </section> <section id="v63233974" class="topic__section GHead"> <span></span> <h3 id="Pathophysiology_v1065838_v63233975" class="topic__header--subsection"> <span id="v63233975" class="anchor"></span> Breast cancer genes </h3> <div class="topic__content"> <span id="v63233976" class="anchor"></span><div class="para"> <p><i data-mmanualobjecttype='gene' '>BRCA1</i> and <i data-mmanualobjecttype='gene' '>BRCA2</i> gene mutations increase the risk of developing breast cancer to 70% (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v63233990" data-toggle="tooltip" title="Pathophysiology references" data-id="6d95177c-aa68-416b-84dd-ed6f29ec3008" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">1</a><span id="6d95177c-aa68-416b-84dd-ed6f29ec3008" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v63233990"> <span class="tooltip-content"> <span class="tooltip-heading"> Pathophysiology references </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Pathophysiology references" loading="lazy"> </span> </a> </span> </span>). Prophylactic bilateral mastectomy reduces the risk of breast cancer by 90% and should be offered to women with a <i data-mmanualobjecttype='gene' '>BRCA</i> mutation. Other genetic mutations that increase the risk of developing breast cancer include mutations in <i data-mmanualobjecttype='gene' '>CHEK2</i>, <i data-mmanualobjecttype='gene' '>PALB2</i>, <i data-mmanualobjecttype='gene' '>ATM</i>, <i data-mmanualobjecttype='gene' '>RAD51C</i>, <i data-mmanualobjecttype='gene' '>RAD51D</i>, <i data-mmanualobjecttype='gene' '>BARD1</i>, and <i data-mmanualobjecttype='gene' '>TP53</i>, which are usually included in panel genetic testing (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v63233990" data-toggle="tooltip" title="Pathophysiology references" data-id="8a8093bf-5286-4569-86e2-43040aaae079" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">2</a><span id="8a8093bf-5286-4569-86e2-43040aaae079" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v63233990"> <span class="tooltip-content"> <span class="tooltip-heading"> Pathophysiology references </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Pathophysiology references" loading="lazy"> </span> </a> </span> </span>).</p></div> </div> </section> <section id="v63233989" class="topic__section GHead"> <span></span> <h3 id="Pathophysiology_v1065838_v63233990" class="topic__header--subsection"> <span id="v63233990" class="anchor"></span> Pathophysiology references </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v63233993" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/28632866/">Kuchenbaecker KB, Hopper JL, Barnes DR, et al</a>: Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. <i>JAMA</i> 317 (23):2402–2416, 2017. doi: 10.1001/jama.2017.7112</p></div></li><li class="topic__listitem"><span id="v63233997" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7611105/">Breast Cancer Association Consortium; Dorling L, Carvalho S, Allen J, et al</a>: Breast cancer risk genes — Association analysis in more than 113,000 women. <i>N Engl J Med</i> 4;384 (5):428–439, 2021. doi: 10.1056/NEJMoa1913948 </p></div></li></ul></div> </div> </section> </div> </section> <section id="v1065851" class="topic__section FHead"> <h2 id="SymptomsAndSigns_v1065852" class="topic__header--section" data-originaltitle="Symptoms and Signs"> <span id="v1065852" class="anchor"></span> Symptoms and Signs of Breast Cancer </h2> <div class="topic__content"> <span id="v1065853" class="anchor"></span><div class="para"> <p>Many breast cancers are discovered as a mass by the patient or during routine physical examination or mammography. Infrequently, the presenting symptom is overall breast enlargement or a nondescript thickening of the breast. Breast pain may be present but is almost never the sole presenting symptom of breast cancer.</p></div><span id="v9009147" class="anchor"></span><div class="para"> <p>A few patients with breast cancer present with signs of metastatic disease (eg, pathologic fracture, abdominal pain, jaundice, dyspnea).</p></div><span id="v1065854" class="anchor"></span><div class="para"> <p>A common finding during physical examination is asymmetry or a dominant mass—a mass distinctly different from the surrounding breast tissue. Diffuse fibrotic changes in a quadrant of the breast, usually the upper outer quadrant, are more characteristic of benign disorders; a slightly firmer thickening in one breast but not the other may be a sign of cancer. </p></div><span id="v9009146" class="anchor"></span><div class="para"> <p>Some types of breast cancer manifest with notable skin changes:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v63234002" class="anchor"></span><div class="para"> <p><b>Paget disease of the nipple</b> is associated with an underlying in situ or invasive carcinoma and manifests as skin changes, including erythema, crusting, scaling, and discharge; these changes usually appear so benign that the patient ignores them, delaying diagnosis for a year or more. About 50% of patients with Paget disease of the nipple have a palpable mass at presentation.</p></div></li><li class="topic__listitem"><span id="v63234004" class="anchor"></span><div class="para"> <p><b>Inflammatory breast cancer</b> manifests as erythema and enlargement of the breast, often without a mass, and skin may be discolored or appear thickened, resembling orange peel (peau d’orange). A nipple discharge is common.</p></div></li></ul></div><span id="v9009148" class="anchor"></span><div class="para" itemprop="signOrSymptom" itemscope="" itemtype="http://schema.org/MedicalSignOrSymptom"> <p><b>More advanced breast cancers</b> are characterized by one or more of the following examination findings:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v37583959" class="anchor"></span><div class="para"> <p>Fixation of the mass to the chest wall or to overlying skin</p></div></li><li class="topic__listitem"><span id="v37583961" class="anchor"></span><div class="para"> <p>Satellite nodules or ulcers in the skin</p></div></li></ul></div><span id="v37583964" class="anchor"></span><div class="para"> <p>Matted or fixed axillary lymph nodes suggest tumor spread, as does supraclavicular or infraclavicular lymphadenopathy. </p></div> <div class="inlinemedia-component " data-ko-rebind="v44232442" data-bind="component: {name: 'inlinemedia-photo', params: $data}" data-inline-model='{"Alt":"Breast Mass","Credits":"\u003cspan id=\u0022v87530056\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eMID ESSEX HOSPITAL SERVICES NHS TRUST/SCIENCE PHOTO LIBRARY \u003c/p\u003e\u003c/div\u003e","IsRestricted":true,"ItemId":"99290462-be45-4fdc-93be-6ddd37aecb3d","Title":"Breast Mass","ShareUrlTitle":"breast-mass","Description":"\u003cul\u003e\u003cspan id=\u0022v88843614\u0022 class=\u0022anchor\u0022\u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022\u003e \u003cp\u003eThis photo shows an irregular mass on the lateral aspect of the left breast. The mass was later diagnosed as breast cancer.\u003c/p\u003e\u003c/div\u003e\u003c/ul\u003e","ImageUrl":"./~/media/manual/professional/images/c/0/2/c0259641-breast-mass-science-photo-library-high.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/c/0/2/c0259641-breast-mass-science-photo-library-high.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v34441606","Placement":"sideline","IsInCarousel":false,"Edition":0,"ImageWidth":"1000","ImageHeight":"664","IframeSrc":null,"Target":null}'> </div> <div class="inlinemedia-component " data-ko-rebind="v34441583" data-bind="component: {name: 'inlinemedia-photo', params: $data}" data-inline-model='{"Alt":"Inflammatory Breast Cancer","Credits":"\u003cspan id=\u0022v85657367\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eMID ESSEX HOSPITAL SERVICES NHS TRUST/SCIENCE PHOTO LIBRARY\u003c/p\u003e\u003c/div\u003e","IsRestricted":false,"ItemId":"e21b8295-61b4-493b-bba3-ffdde5444744","Title":"Inflammatory Breast Cancer","ShareUrlTitle":"inflammatory-breast-cancer","Description":"\u003cul\u003e\u003cspan id=\u0022v88843573\u0022 class=\u0022anchor\u0022\u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022\u003e \u003cp\u003eThis photo shows diffuse erythema and edema in the left breast of patient with inflammatory breast cancer.\u003c/p\u003e\u003c/div\u003e\u003c/ul\u003e","ImageUrl":"./~/media/manual/professional/images/c/0/3/c0333618-breast-cancer-science-photo-library-high.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/c/0/3/c0333618-breast-cancer-science-photo-library-high.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v34441583","Placement":"sideline","IsInCarousel":false,"Edition":0,"ImageWidth":"1000","ImageHeight":"667","IframeSrc":null,"Target":null}'> </div> </div> </section> <section id="v1065856" class="topic__section FHead"> <h2 id="Diagnosis_v1065857" class="topic__header--section" data-originaltitle="Diagnosis"> <span id="v1065857" class="anchor"></span> Diagnosis of Breast Cancer </h2> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v1065861" class="anchor"></span><div class="para"> <p>Initial detection with mammography and/or other imaging (breast tomosynthesis, ultrasonography, MRI) or clinical breast examination</p></div></li><li class="topic__listitem"><span id="v1065863" class="anchor"></span><div class="para"> <p>Biopsy, including analysis for <span class="genericDrug" data-showrollover="false">estrogen</span> and <span class="genericDrug" data-showrollover="false">progesterone</span> receptors and HER2 protein</p></div></li></ul></div><span id="v82328415" class="anchor"></span><div class="para"> <p>Symptoms, clinical breast examination, or imaging test results may prompt a diagnostic evaluation for breast cancer.</p></div><span id="v1065866" class="anchor"></span><div class="para"> <p>Patients who present with <b>breast symptoms </b>(eg, pain, nipple discharge) or a <b>palpable breast mass</b> or other abnormality on clinical breast examination are typically evaluated initially with breast ultrasonography. If ultrasound results are abnormal or indeterminate, mammography is done. If imaging findings suggest cancer, biopsy is done. </p></div><span id="v82328416" class="anchor"></span><div class="para"> <p>Even if imaging tests are negative, a biopsy should be performed if a palpable breast mass or other physical findings suggest cancer. If advanced cancer is suspected based on physical examination, biopsy is often done before imaging; however, a prebiopsy bilateral mammogram may help delineate other areas that should be biopsied and provides a baseline for future reference.</p></div><span id="v82328417" class="anchor"></span><div class="para"> <p>For patients with an <b>abnormal screening mammogram,</b> image-guided biopsy is performed. An <b>abnormal breast MRI</b> is typically evaluated with ultrasonography to determine whether biopsy should be performed under guidance with ultrasonography or MRI. </p></div> <a id="v26442608"></a> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--right inlinebox--pearlsandpitfalls "> <div class="inlinebox__wrapper" id="v26442610"> <div class="inlinebox__content"> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v26442610"></span> <div class="SidebarHalfPage" id="v56201401"> <h3 class="title">Pearls & Pitfalls</h3> <div class="tableWrapper"> <table> <tbody><tr class="odd"><td><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v56201410" class="anchor"></span><div class="para"> <p>Biopsy should be done if physical findings (eg, palpable mass) suggest breast cancer, even if mammogram results are negative.</p></div></li></ul></div></td></tr></tbody> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div> <div> </div> </div> </div> <!-- Type: PearlsAndPitfalls --> </div> <section id="v9009163" class="topic__section GHead"> <span></span> <h3 id="Diagnosis_v1065857_v9009164" class="topic__header--subsection"> <span id="v9009164" class="anchor"></span> Biopsy </h3> <div class="topic__content"> <span id="v9009166" class="anchor"></span><div class="para"> <p>Percutaneous core needle biopsy is preferred to surgical biopsy. Core biopsy can be done guided by imaging or palpation (freehand). Stereotactic biopsy (needle biopsy guided by mammography done in 2 planes and analyzed by computer to produce a 3-dimensional image) or ultrasound-guided biopsy is commonly used to improve accuracy. Clips are placed at the biopsy site so it can be identified with mammography.</p></div><span id="v26442619" class="anchor"></span><div class="para"> <p>If core biopsy is not possible (eg, the lesion is too posterior), surgical biopsy can be done; a guidewire or localizing metal seed is inserted, using imaging for guidance, to help identify the biopsy site.</p></div><span id="v26442620" class="anchor"></span><div class="para"> <p>Any skin taken with the biopsy specimen should be examined because it may show cancer cells in dermal lymphatic vessels.</p></div><span id="v9009167" class="anchor"></span><div class="para"> <p>The excised specimen should be x-rayed, and the x-ray should be compared with the prebiopsy mammogram to determine whether all of the lesion has been removed. If the original lesion contained microcalcifications, mammography is repeated when the breast is no longer tender, usually 6 to 12 weeks after biopsy, to check for residual microcalcifications. If radiation therapy is planned, mammography should be repeated before radiation therapy begins.</p></div> </div> </section> <section id="v1065869" class="topic__section GHead"> <span></span> <h3 id="Diagnosis_v1065857_v1065870" class="topic__header--subsection"> <span id="v1065870" class="anchor"></span> Evaluation after cancer diagnosis </h3> <div class="topic__content"> <span id="v1065871" class="anchor"></span><div class="para"> <p>After cancer is diagnosed, a multidisciplinary evaluation is usually done to plan further testing and treatment. The core multidisciplinary team typically includes a breast surgical oncologist, medical oncologist, and radiation oncologist.</p></div><span id="v9009168" class="anchor"></span><div class="para"> <p>A positive biopsy specimen should be analyzed for <span class="genericDrug" data-showrollover="false">estrogen</span> and <span class="genericDrug" data-showrollover="false">progesterone</span> receptors and for HER2 protein. </p></div> <section id="v82328418" class="topic__section HHead"> <h3 class="topic__header--subsection"> <span id="v82328419" class="anchor"></span> Genetic testing </h3> <div class="topic__content"> <span id="v82328420" class="anchor"></span><div class="para"> <p>The National Comprehensive Cancer Network (NCCN) recommends that patients with current or a personal history of breast cancer should be tested for inherited gene mutations that predispose to breast cancer, if they meet any of the following criteria (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v44232513" data-toggle="tooltip" title="Diagnosis references" data-id="e49c6cec-2611-462c-b207-c463138cbca2" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">1</a><span id="e49c6cec-2611-462c-b207-c463138cbca2" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v44232513"> <span class="tooltip-content"> <span class="tooltip-heading"> Diagnosis references </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Diagnosis references" loading="lazy"> </span> </a> </span> </span>):</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v82328424" class="anchor"></span><div class="para"> <p>Breast cancer diagnosed at age ≤ 50 years old</p></div></li><li class="topic__listitem"><span id="v82328426" class="anchor"></span><div class="para"> <p>Treatment indications to aid decisions about use of PARP inhibitors (for metastatic cancer) or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>olaparib</span> (for high-risk, HER2-negative tumors)</p></div></li><li class="topic__listitem"><span id="v82328428" class="anchor"></span><div class="para"> <p>Triple-negative breast cancer (tumor does not have <span class="genericDrug" data-showrollover="false">estrogen</span> or <span class="genericDrug" data-showrollover="false">progesterone</span> receptors or overexpression of HER2 protein)</p></div></li><li class="topic__listitem"><span id="v82328432" class="anchor"></span><div class="para"> <p>Multiple primary breast cancers (synchronous or metachronous)</p></div></li><li class="topic__listitem"><span id="v82328434" class="anchor"></span><div class="para"> <p>Lobular breast cancer plus a personal or family history of diffuse gastric cancer</p></div></li><li class="topic__listitem"><span id="v82328436" class="anchor"></span><div class="para"> <p>Male breast cancer</p></div></li><li class="topic__listitem"><span id="v82328438" class="anchor"></span><div class="para"> <p>Ashkenazi Jewish ancestry</p></div></li><li class="topic__listitem"><span id="v82328440" class="anchor"></span><div class="para"> <p>Family history (ie, first-, second-, and third-degree relatives on the same side of the family) with breast cancer at ≤ 50 years old, male breast cancer, ovarian cancer, pancreatic cancer, or metastatic or high-risk prostate cancer</p></div></li><li class="topic__listitem"><span id="v82328442" class="anchor"></span><div class="para"> <p>Family history with ≥ 3 relatives with either breast or prostate cancer</p></div></li></ul></div><span id="v82328443" class="anchor"></span><div class="para"> <p>Some experts have recommended that genetic testing be offered to all patients with breast cancer (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v44232513" data-toggle="tooltip" title="Diagnosis references" data-id="1b35a064-6bcf-42df-b1ab-e80930b824d7" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">2</a><span id="1b35a064-6bcf-42df-b1ab-e80930b824d7" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v44232513"> <span class="tooltip-content"> <span class="tooltip-heading"> Diagnosis references </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Diagnosis references" loading="lazy"> </span> </a> </span> </span>).</p></div><span id="v82328445" class="anchor"></span><div class="para"> <p>For these tests, the best approach is to refer patients to a genetic counselor, who can document a detailed family history, counsel the patient about the risks and benefits of genetic testing, choose the most appropriate tests, and help interpret the results.</p></div> </div> </section> <section id="v82328446" class="topic__section HHead"> <h3 class="topic__header--subsection"> <span id="v82328447" class="anchor"></span> Evaluation for metastatic disease </h3> <div class="topic__content"> <span id="v82328448" class="anchor"></span><div class="para"> <p>A complete blood count (CBC) and liver function tests can be done to check for metastatic disease.</p></div><span id="v82328449" class="anchor"></span><div class="para"> <p>An oncologist should determine whether to measure serum carcinoembryonic antigen (CEA), cancer antigen (CA) 15-3, or CA 27-29 and whether bone scanning should be done. </p></div><span id="v82328450" class="anchor"></span><div class="para"> <p>For <b>bone scanning,</b> common indications include the following:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v82328453" class="anchor"></span><div class="para"> <p>Bone pain</p></div></li><li class="topic__listitem"><span id="v82328455" class="anchor"></span><div class="para"> <p>Elevated serum alkaline phosphatase</p></div></li><li class="topic__listitem"><span id="v82328457" class="anchor"></span><div class="para"> <p>Stage III or IV cancer </p></div></li></ul></div><span id="v82328458" class="anchor"></span><div class="para"> <p><b>Abdominal CT</b> is done if patients have any of the following:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v82328461" class="anchor"></span><div class="para"> <p>Abnormal liver test results</p></div></li><li class="topic__listitem"><span id="v82328463" class="anchor"></span><div class="para"> <p>Abnormal abdominal or pelvic examination</p></div></li><li class="topic__listitem"><span id="v82328465" class="anchor"></span><div class="para"> <p>Stage III or IV cancer</p></div></li></ul></div><span id="v82328466" class="anchor"></span><div class="para"> <p><b>Chest CT</b> is done if patients have either of the following:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v82328469" class="anchor"></span><div class="para"> <p>Pulmonary symptoms such as shortness of breath</p></div></li><li class="topic__listitem"><span id="v82328471" class="anchor"></span><div class="para"> <p>Stage III or IV cancer</p></div></li></ul></div><span id="v82328472" class="anchor"></span><div class="para"> <p><b>MRI</b> is often used by surgeons for preoperative planning; it can accurately determine tumor size, chest wall involvement, and number of tumors.</p></div> </div> </section> </div> </section> <section id="v9009177" class="topic__section GHead"> <span></span> <h3 id="Diagnosis_v1065857_v9009178" class="topic__header--subsection"> <span id="v9009178" class="anchor"></span> Grading and staging </h3> <div class="topic__content"> <span id="v9009179" class="anchor"></span><div class="para"> <p><b>Grading</b> is based on histologic examination of the tissue taken during biopsy. Tumor grade describes how abnormal tumor cells and tissue look under a microscope.</p></div><span id="v9009180" class="anchor"></span><div class="para"> <p><b>Staging</b> follows the TNM (tumor, node, metastasis) classification (see table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"2be010f6-55f6-4cb6-8376-c0ef2bd061bf","Title":"Anatomic%20Staging%20of%20Breast%20Cancer%2A","ShareUrlTitle":"anatomic-staging-of-breast-cancer","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v56201424","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3EAnatomic%20Staging%20of%20Breast%20Cancer%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>). Because clinical examination and imaging have poor sensitivity for nodal involvement, staging is refined during surgery, when regional lymph nodes can be evaluated. However, if patients have palpably abnormal axillary nodes, preoperative ultrasonography-guided fine needle aspiration or core biopsy may be done: </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v26442632" class="anchor"></span><div class="para"> <p>If biopsy results are positive, axillary lymph node dissection is typically done during the definitive surgical procedure. However, use of neoadjuvant chemotherapy may make sentinel lymph node biopsy possible if chemotherapy changes node status from N1 to N0. (Results of intraoperative frozen section analysis determine whether axillary lymph node dissection will be needed.)</p></div></li><li class="topic__listitem"><span id="v26442634" class="anchor"></span><div class="para"> <p>If results are negative, a sentinel lymph node biopsy, a less aggressive procedure, may be done instead.</p></div></li></ul></div><span id="v44917592" class="anchor"></span><div class="para"> <p>Staging classification follows these models:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v44917595" class="anchor"></span><div class="para"> <p>The anatomic staging model, which is based on anatomy of the tumor and which is used in regions of the world where biomarkers cannot be routinely obtained (see table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"2be010f6-55f6-4cb6-8376-c0ef2bd061bf","Title":"Anatomic%20Staging%20of%20Breast%20Cancer%2A","ShareUrlTitle":"anatomic-staging-of-breast-cancer","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v56201424","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3EAnatomic%20Staging%20of%20Breast%20Cancer%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>)</p></div></li><li class="topic__listitem"><span id="v44917597" class="anchor"></span><div class="para"> <p>The prognostic staging model, which is based on anatomy of the tumor as well as status of biomarkers and which is predominantly used in the United States</p></div></li></ul></div> <span id="v9009182"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--full inlinebox--table inlinebox--clickable illustrativeMaterialTable "> <div class="inlinebox__wrapper" id="v9009185"> <div class="inlinebox__header">Table</div> <div class="inlinebox__content"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: $data }" data-popup-model='{"ItemId":"2be010f6-55f6-4cb6-8376-c0ef2bd061bf","Title":"Anatomic%20Staging%20of%20Breast%20Cancer%2A","ShareUrlTitle":"anatomic-staging-of-breast-cancer","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v56201424","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"","LinkText":"Anatomic%20Staging%20of%20Breast%20Cancer%2A","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <div class="inlinebox__button"> <img src="./Content/Images/Redesign/table/icon_table_red.png" alt="" loading="lazy" width="55" height="42"> </div> <div class="inlinebox__content--print" id="2be010f6-55f6-4cb6-8376-c0ef2bd061bf"> </div> </div> </div> <!-- Type: Table --> </div> <script type="text/javascript"> $(document).ready(function () { var url = window.location; if (url.search.includes("media=print")) { $.ajax({ url: '/Redesign/Topic/GetTableBody', type: "GET", dataType: "json", data: { tableId: '2be010f6-55f6-4cb6-8376-c0ef2bd061bf' }, async: true, success: function (data) { $('#2be010f6-55f6-4cb6-8376-c0ef2bd061bf').html('<div class="modaldialog">'+ data.TableBody + '</div>'); }, error: function (jqxhr, textStatus, errorThrown) { console.error(errorThrown); } }); } }); </script> </div> </section> <section id="v44232501" class="topic__section GHead"> <span></span> <h3 id="Diagnosis_v1065857_v44232502" class="topic__header--subsection"> <span id="v44232502" class="anchor"></span> Fertility preservation </h3> <div class="topic__content"> <span id="v44232503" class="anchor"></span><div class="para"> <p>Patients with breast cancer should not become pregnant while being treated for breast cancer. However, all patients who wish to preserve fertility should be referred to a reproductive endocrinologist to discuss fertility preservation before systemic therapy is initiated.</p></div><span id="v44232504" class="anchor"></span><div class="para"> <p>Options for fertility preservation include</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v44232507" class="anchor"></span><div class="para"> <p>Assisted reproductive techniques (ART) with ovarian stimulation and oocyte or embryo cryopreservation</p></div></li><li class="topic__listitem"><span id="v63234025" class="anchor"></span><div class="para"> <p>Ovarian or testicular tissue cryopreservation</p></div></li></ul></div><span id="v44232510" class="anchor"></span><div class="para"> <p>Type of breast cancer, anticipated treatment, and patient preferences affect the type of fertility preservation that can be used. Ovarian suppression (eg, with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>leuprolide</span>) has been used to minimize the destruction of ova by chemotherapy.</p></div> </div> </section> <section id="v44232512" class="topic__section GHead"> <span></span> <h3 id="Diagnosis_v1065857_v44232513" class="topic__header--subsection"> <span id="v44232513" class="anchor"></span> Diagnosis references </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v82328476" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1419">National Comprehensive Cancer Network (NCCN)</a>: Guidelines, Breast Cancer Version 4.2023. </p></div></li><li class="topic__listitem"><span id="v44232516" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733830/">Manahan ER, Kuerer HM, Sebastian M, et al</a>. Consensus Guidelines on Genetic Testing for Hereditary Breast Cancer from the American Society of Breast Surgeons.<i> Ann Surg Oncol</i> 26(10):3025-3031, 2019. doi:10.1245/s10434-019-07549-8</p></div></li></ul></div> </div> </section> </div> </section> <section id="v1066173" class="topic__section FHead" itemprop="possibleTreatment" itemscope="" itemtype="http://schema.org/MedicalTherapy"> <h2 id="Treatment_v1066174" class="topic__header--section" data-originaltitle="Treatment"> <span id="v1066174" class="anchor"></span> Treatment of Breast Cancer </h2> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v1066179" class="anchor"></span><div class="para"> <p>Surgery</p></div></li><li class="topic__listitem"><span id="v1066181" class="anchor"></span><div class="para"> <p>Radiation therapy</p></div></li><li class="topic__listitem"><span id="v1066183" class="anchor"></span><div class="para"> <p>Systemic chemotherapy</p></div></li><li class="topic__listitem"><span id="v82328480" class="anchor"></span><div class="para"> <p>Adjuvant endocrine therapy</p></div></li></ul></div><span id="v37584001" class="anchor"></span><div class="para"> <p>For more detailed information about treatment, see <a rel="nofollow" target="_blank" href="https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1419">National Comprehensive Cancer Network (NCCN) Clinical Practice Guideline: Breast Cancer</a>.</p></div><span id="v1066184" class="anchor"></span><div class="para"> <p>For most types of breast cancer, treatment involves surgery and radiation therapy; systemic therapy is given for lymph node involvement or metastatic disease. Choice of treatment depends on tumor and patient characteristics (see table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"3ad5aa23-49f9-4cdf-aaa2-bdaf7da13ef0","Title":"Treatment%20by%20Type%20of%20Breast%20Cancer","ShareUrlTitle":"treatment-by-type-of-breast-cancer","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v56201626","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3ETreatment%20by%20Type%20of%20Breast%20Cancer%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>). Recommendations for surgery are evolving and include early referral to a plastic or reconstruction surgeon for oncoplastic surgery (which combines cancer removal with reconstruction of the breast).</p></div> <span id="v1066186"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--full inlinebox--table inlinebox--clickable illustrativeMaterialTable "> <div class="inlinebox__wrapper" id="v1066195"> <div class="inlinebox__header">Table</div> <div class="inlinebox__content"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: $data }" data-popup-model='{"ItemId":"3ad5aa23-49f9-4cdf-aaa2-bdaf7da13ef0","Title":"Treatment%20by%20Type%20of%20Breast%20Cancer","ShareUrlTitle":"treatment-by-type-of-breast-cancer","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v56201626","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"","LinkText":"Treatment%20by%20Type%20of%20Breast%20Cancer","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <div class="inlinebox__button"> <img src="./Content/Images/Redesign/table/icon_table_red.png" alt="" loading="lazy" width="55" height="42"> </div> <div class="inlinebox__content--print" id="3ad5aa23-49f9-4cdf-aaa2-bdaf7da13ef0"> </div> </div> </div> <!-- Type: Table --> </div> <script type="text/javascript"> $(document).ready(function () { var url = window.location; if (url.search.includes("media=print")) { $.ajax({ url: '/Redesign/Topic/GetTableBody', type: "GET", dataType: "json", data: { tableId: '3ad5aa23-49f9-4cdf-aaa2-bdaf7da13ef0' }, async: true, success: function (data) { $('#3ad5aa23-49f9-4cdf-aaa2-bdaf7da13ef0').html('<div class="modaldialog">'+ data.TableBody + '</div>'); }, error: function (jqxhr, textStatus, errorThrown) { console.error(errorThrown); } }); } }); </script> <section id="v1066265" class="topic__section GHead"> <span></span> <h3 id="Treatment_v1066174_v1066266" class="topic__header--subsection"> <span id="v1066266" class="anchor"></span> Surgery </h3> <div class="topic__content"> <span id="v1066267" class="anchor"></span><div class="para"> <p>Surgery involves mastectomy or breast-conserving surgery.</p></div><span id="v26442660" class="anchor"></span><div class="para"> <p><b>Mastectomy</b> is removal of the entire breast and includes the following types:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v26442663" class="anchor"></span><div class="para"> <p><b>Skin-sparing mastectomy:</b> Spares the pectoral muscles and enough skin to cover the wound, making breast reconstruction much easier, and spares axillary lymph nodes</p></div></li><li class="topic__listitem"><span id="v26442665" class="anchor"></span><div class="para"> <p><b>Nipple-sparing mastectomy:</b> Same as skin-sparing mastectomy plus spares the nipple and areola</p></div></li><li class="topic__listitem"><span id="v26442667" class="anchor"></span><div class="para"> <p><b>Simple mastectomy:</b> Spares the pectoral muscles and axillary lymph nodes</p></div></li><li class="topic__listitem"><span id="v26442669" class="anchor"></span><div class="para"> <p><b>Modified radical mastectomy:</b> Spares the pectoral muscles and removes some axillary lymph nodes</p></div></li><li class="topic__listitem"><span id="v26442671" class="anchor"></span><div class="para"> <p><b>Radical mastectomy:</b> Removes axillary lymph nodes and the pectoral muscles</p></div></li></ul></div><span id="v26442672" class="anchor"></span><div class="para"> <p>Radical mastectomy is rarely done unless the cancer has invaded the pectoral muscle.</p></div><span id="v26442673" class="anchor"></span><div class="para"> <p><b>Breast-conserving surgery</b> involves determining the size of the tumor and the required margins (based on the tumor's size relative to the volume of the breast), then surgically removing the tumor with its margins. Various terms (eg, <b>lumpectomy,</b> wide excision, quadrantectomy) are used to describe how much breast tissue is removed.</p></div><span id="v26442682" class="anchor"></span><div class="para"> <p>For patients with invasive cancer, survival and recurrence rates with mastectomy do not differ significantly from those with breast-conserving surgery plus radiation therapy as long as the entire tumor can be removed (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v37584060" data-toggle="tooltip" title="Treatment references" data-id="22fdaaf9-dee2-4982-b294-22997774e376" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">1</a><span id="22fdaaf9-dee2-4982-b294-22997774e376" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v37584060"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>).</p></div><span id="v26442684" class="anchor"></span><div class="para"> <p>Thus, patient preference is part of shared decision-making. The main advantage of breast-conserving surgery plus radiation therapy is less extensive surgery and opportunity to keep the breasts. The need for total removal of the tumor with a tumor-free margin overrides any cosmetic considerations. Consulting a plastic surgeon about oncoplastic surgery may help if patients have ptotic (sagging) breasts, while also achieving good resection margins.</p></div><span id="v9009400" class="anchor"></span><div class="para"> <p>Some oncologists treat with neoadjuvant chemotherapy to shrink the tumor before removing it and applying radiation therapy; thus, some patients who might otherwise have required mastectomy can have breast-conserving surgery. </p></div> </div> </section> <section id="v37584005" class="topic__section GHead"> <span></span> <h3 id="Treatment_v1066174_v37584006" class="topic__header--subsection"> <span id="v37584006" class="anchor"></span> Lymph node evaluation </h3> <div class="topic__content"> <span id="v37584007" class="anchor"></span><div class="para"> <p>During both mastectomy and breast-conserving surgery, axillary lymph nodes are typically evaluated. Methods include</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v37584010" class="anchor"></span><div class="para"> <p>Axillary lymph node dissection (ALND)</p></div></li><li class="topic__listitem"><span id="v37584012" class="anchor"></span><div class="para"> <p>Sentinel lymph node biopsy (SLNB)</p></div></li></ul></div><span id="v37584013" class="anchor"></span><div class="para"> <p>ALND is a fairly extensive procedure that involves removal of as many axillary nodes as possible; adverse effects, particularly lymphedema, are common. Risk of lymphedema is increased for patients with a high preoperative body mass index (BMI ≥ 30) and for those with significant weight gain during and after breast cancer treatment (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v37584060" data-toggle="tooltip" title="Treatment references" data-id="6b16908e-616e-420a-8e79-1ac0835f79c0" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">2</a><span id="6b16908e-616e-420a-8e79-1ac0835f79c0" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v37584060"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>).</p></div><span id="v63234036" class="anchor"></span><div class="para"> <p>Most surgeons now first do SLNB unless biopsy of clinically suspect nodes detected cancer; risk of lymphedema is less with SLNB. Routine use of ALND is not justified because the main value of lymph node removal is diagnostic, not therapeutic, and SLNB has <span class='symbol'>≥</span> 95% sensitivity for axillary node involvement.</p></div> <div class="inlinemedia-component " data-ko-rebind="v35583092" data-bind="component: {name: 'inlinemedia-photo', params: $data}" data-inline-model='{"Alt":"Lymphedema","Credits":"\u003cspan id=\u0022v85658579\u0022 class=\u0022anchor\u0022 \u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022 \u003e \u003cp \u003eSCIENCE PHOTO LIBRARY\u003c/p\u003e\u003c/div\u003e","IsRestricted":true,"ItemId":"3429c029-efc9-4dd1-8c36-2d5d3872edb9","Title":"Lymphedema","ShareUrlTitle":"lymphedema","Description":"\u003cul\u003e\u003cspan id=\u0022v88843581\u0022 class=\u0022anchor\u0022\u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022\u003e \u003cp\u003eThis photo shows the arms of a patient with lymphedema of the right (top) arm. Lymphedema is an accumulation of lymph fluid in the tissues that occurs when lymphatic vessels are blocked, removed, or damaged. Here, it is a result of surgery for breast cancer.\u003c/p\u003e\u003c/div\u003e\u003c/ul\u003e","ImageUrl":"./~/media/manual/professional/images/c/0/2/c0238940-lymphoedema-science-photo-library-high.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/c/0/2/c0238940-lymphoedema-science-photo-library-high.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v35583092","Placement":"sideline","IsInCarousel":false,"Edition":0,"ImageWidth":"1000","ImageHeight":"776","IframeSrc":null,"Target":null}'> </div><span id="v37584015" class="anchor"></span><div class="para"> <p>For SLNB, blue dye and/or radioactive colloid is injected around the breast, and a gamma probe (and when dye is used, direct inspection) is used to locate the nodes the tracer drains into. Because these nodes are the first to receive the tracers, they are considered the most likely to receive any metastatic cells and are thus called sentinel nodes.</p></div><span id="v37584016" class="anchor"></span><div class="para"> <p>If any of the sentinel nodes contain cancer cells, ALND may be necessary, based on numerous factors such as</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v37584019" class="anchor"></span><div class="para"> <p>Tumor stage</p></div></li><li class="topic__listitem"><span id="v37584021" class="anchor"></span><div class="para"> <p>Hormone receptor status</p></div></li><li class="topic__listitem"><span id="v37584023" class="anchor"></span><div class="para"> <p>Number of involved nodes</p></div></li><li class="topic__listitem"><span id="v37584025" class="anchor"></span><div class="para"> <p>Extranodal extension</p></div></li><li class="topic__listitem"><span id="v37584027" class="anchor"></span><div class="para"> <p>Patient characteristics (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v37584060" data-toggle="tooltip" title="Treatment references" data-id="7a4b56c3-fc15-4f98-960a-3bafae2cda8c" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">3</a><span id="7a4b56c3-fc15-4f98-960a-3bafae2cda8c" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v37584060"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>)</p></div></li></ul></div><span id="v37584028" class="anchor"></span><div class="para"> <p>Some surgeons do frozen section analysis during mastectomy with SLNB and get prior agreement for ALND in case nodes are positive; others await standard pathology results and do ALND as a 2nd procedure if needed. Frozen section analysis is not routinely done with lumpectomy.</p></div><span id="v37584029" class="anchor"></span><div class="para"> <p><b>Impaired lymphatic drainage</b> of the ipsilateral arm often occurs after axillary node removal (ALND or SLNB) or radiation therapy, sometimes resulting in substantial swelling due to lymphedema. Magnitude of the effect is roughly proportional to the number of nodes removed; thus, SLNB causes less lymphedema than ALND. The lifetime risk of lymphedema after ALND is about 25%. However, even with SLNB, there is a 6% lifetime risk of lymphedema (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v37584060" data-toggle="tooltip" title="Treatment references" data-id="0a23ce64-1997-4a4e-b1b0-32af6adc75a8" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">4</a><span id="0a23ce64-1997-4a4e-b1b0-32af6adc75a8" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v37584060"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>). To reduce risk of lymphedema, clinicians usually avoid giving IV infusions on the affected side. Wearing compression garments and preventing infection in the affected limbs (eg, by wearing gloves during yard work) are important. Avoiding ipsilateral blood pressure measurement and venipuncture is sometimes also recommended, even though supporting evidence is minimal (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v37584060" data-toggle="tooltip" title="Treatment references" data-id="e3c34951-c24f-47de-af59-6c0cd1fd45f0" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">5</a><span id="e3c34951-c24f-47de-af59-6c0cd1fd45f0" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v37584060"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>). </p></div><span id="v37584030" class="anchor"></span><div class="para"> <p>If lymphedema develops, a specially trained therapist must treat it. Special massage techniques used once or twice a day may help drain fluid from congested areas toward functioning lymph basins; low-stretch bandaging is applied immediately after manual drainage, and patients should exercise daily as prescribed. After the lymphedema lessens, typically in 1 to 4 weeks, patients continue daily exercise and overnight bandaging of the affected limb indefinitely.</p></div> </div> </section> <section id="v37584031" class="topic__section GHead"> <span></span> <h3 id="Treatment_v1066174_v37584032" class="topic__header--subsection"> <span id="v37584032" class="anchor"></span> Reconstructive procedures </h3> <div class="topic__content"> <span id="v37584033" class="anchor"></span><div class="para"> <p>Reconstructive procedures include the following: </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v37584036" class="anchor"></span><div class="para"> <p><b>Prosthetic reconstruction:</b> Placement of a silicone or saline implant, sometimes after a tissue expander is used</p></div></li><li class="topic__listitem"><span id="v37584038" class="anchor"></span><div class="para"> <p><b>Autologous reconstruction:</b> Muscle flap transfer (using the latissimus dorsi, gluteus maximus, or the lower rectus abdominis) or muscle-free flap transfer</p></div></li></ul></div> <div class="inlinemedia-component " data-ko-rebind="v13383484" data-bind="component: {name: 'inlinemedia-photo', params: $data}" data-inline-model='{"Alt":"Breast Reconstruction Using the Transverse Rectus Abdominis Muscle (TRAM) Flap Procedure","Credits":"","IsRestricted":true,"ItemId":"686ad35f-91d8-4531-badb-f1267296f291","Title":"Breast Reconstruction Using the Transverse Rectus Abdominis Muscle (TRAM) Flap Procedure","ShareUrlTitle":"breast-reconstruction-using-the-transverse-rectus-abdominis-muscle-tram-flap-procedure","Description":"\u003cul\u003e\u003cspan id=\u0022v88843583\u0022 class=\u0022anchor\u0022\u003e\u003c/span\u003e\u003cdiv class=\u0022para\u0022\u003e \u003cp\u003eMuscle flap transfer using the lower rectus abdominis.\u003c/p\u003e\u003c/div\u003e\u003c/ul\u003e","ImageUrl":"./~/media/manual/professional/images/b/r/e/breast_reconstruction_tram_high_blausen.jpg?thn=0\u0026sc_lang=en","ThumbnailUrl":"./~/media/manual/professional/images/b/r/e/breast_reconstruction_tram_high_blausen.jpg?mw=350\u0026amp;thn=0\u0026amp;sc_lang=en","MediaType":"image","MediaNameTranslated":"Image","UniqueId":"v13383484","Placement":"sideline","IsInCarousel":false,"Edition":0,"ImageWidth":"937","ImageHeight":"1000","IframeSrc":null,"Target":null}'> </div><span id="v37584039" class="anchor"></span><div class="para"> <p>Breast reconstruction can be done during the initial mastectomy or breast-conserving surgery or later as a separate procedure. Timing of surgery depends on patient preference as well as the need for adjuvant therapy such as radiation therapy. However, doing radiation therapy first limits the types of reconstructive surgery that can be done. Thus, consulting a plastic surgeon early during treatment planning is recommended.</p></div><span id="v44232522" class="anchor"></span><div class="para"> <p>Advantages of breast reconstruction include improved mental health in patients who have a mastectomy. Disadvantages include surgical complications and possible long-term adverse effects of implants.</p></div> </div> </section> <section id="v44232523" class="topic__section GHead"> <span></span> <h3 id="Treatment_v1066174_v44232524" class="topic__header--subsection"> <span id="v44232524" class="anchor"></span> Contralateral prophylactic mastectomy </h3> <div class="topic__content"> <span id="v44232525" class="anchor"></span><div class="para"> <p>Contralateral prophylactic mastectomy is an option for some women with breast cancer (eg, those with a genetic mutation conferring a high risk of breast cancer).</p></div><span id="v44232528" class="anchor"></span><div class="para"> <p>In women with lobular carcinoma in situ in one breast, invasive cancer is equally likely to develop in either breast. Thus, the only way to eliminate the risk of breast cancer for these women is bilateral mastectomy. Some women, particularly those who are at high risk of developing invasive breast cancer, choose this option.</p></div><span id="v44232529" class="anchor"></span><div class="para"> <p>Advantages of contralateral prophylactic mastectomy include</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v44232532" class="anchor"></span><div class="para"> <p>Decreased risk of contralateral breast cancer (especially in women in a family history of breast or ovarian cancer)</p></div></li><li class="topic__listitem"><span id="v44232534" class="anchor"></span><div class="para"> <p>Improvement in survival in breast cancer patients with an inherited genetic mutation (eg, <i data-mmanualobjecttype='gene' '>BRCA1</i> or <i data-mmanualobjecttype='gene' '>BRCA2</i> mutation) and possibly in women diagnosed at age &lt; 50 years</p></div></li><li class="topic__listitem"><span id="v44232538" class="anchor"></span><div class="para"> <p>Decreased anxiety in some patients</p></div></li><li class="topic__listitem"><span id="v44232540" class="anchor"></span><div class="para"> <p>Decreased need for cumbersome follow-up imaging</p></div></li></ul></div><span id="v44232541" class="anchor"></span><div class="para"> <p>Disadvantages of contralateral prophylactic mastectomy include</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v44232544" class="anchor"></span><div class="para"> <p>An almost two-fold increase in surgical complication rates</p></div></li></ul></div><span id="v44232545" class="anchor"></span><div class="para"> <p>Contralateral prophylactic mastectomy is not mandatory for patients with the highest risk of developing cancer in the contralateral breast. Close surveillance is a reasonable alternative.</p></div> </div> </section> <section id="v37584043" class="topic__section GHead"> <span></span> <h3 id="Treatment_v1066174_v37584044" class="topic__header--subsection"> <span id="v37584044" class="anchor"></span> Radiation therapy </h3> <div class="topic__content"> <span id="v37584052" class="anchor"></span><div class="para"> <p>Radiation therapy after breast-conserving surgery significantly reduces incidence of local recurrence in the breast and in regional lymph nodes and may improve overall survival. However, if patients are > 70 and have early ER+ breast cancer, adding radiation therapy to lumpectomy plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tamoxifen</span> may not be necessary; adding radiation therapy does not significantly decrease the rate of mastectomy for local recurrence or the occurrence of distant metastases nor increase the survival rate (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v37584060" data-toggle="tooltip" title="Treatment references" data-id="1602ffc0-4a80-4dc5-91e0-6ce6e45ba4cd" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">6</a><span id="1602ffc0-4a80-4dc5-91e0-6ce6e45ba4cd" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v37584060"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>).</p></div><span id="v37584045" class="anchor"></span><div class="para"> <p>Radiation therapy is indicated after mastectomy if any of the following is present:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v37584048" class="anchor"></span><div class="para"> <p>The primary tumor is ≥ 5 cm.</p></div></li><li class="topic__listitem"><span id="v37584050" class="anchor"></span><div class="para"> <p>Axillary nodes are involved.</p></div></li><li class="topic__listitem"><span id="v63234038" class="anchor"></span><div class="para"> <p>Margins are positive for cancer in resected tissue.</p></div></li></ul></div><span id="v37584051" class="anchor"></span><div class="para"> <p>In such cases, radiation therapy after mastectomy significantly reduces incidence of local recurrence on the chest wall and in regional lymph nodes and improves overall survival.</p></div><span id="v37584054" class="anchor"></span><div class="para"> <p>Adverse effects of radiation therapy (eg, fatigue, skin changes) are usually transient and mild. Late adverse effects (eg, lymphedema, brachial plexopathy, radiation pneumonitis, rib damage, secondary cancers, cardiac toxicity) are less common.</p></div><span id="v38407180" class="anchor"></span><div class="para"> <p>To improve radiation therapy, researchers are studying several new procedures. Many of these procedures aim to target radiation to the cancer more precisely and spare the rest of the breast from the effects of radiation.</p></div> </div> </section> <section id="v1066307" class="topic__section GHead"> <span></span> <h3 id="Treatment_v1066174_v1066308" class="topic__header--subsection"> <span id="v1066308" class="anchor"></span> Adjuvant systemic therapy </h3> <div class="topic__content"> <span id="v26442694" class="anchor"></span><div class="para"> <p>(See also <a rel="nofollow" target="_blank" href="https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1419">National Comprehensive Cancer Network (NCCN) Clinical Practice Guideline: Breast Cancer</a>.)</p></div><span id="v63234039" class="anchor"></span><div class="para"> <p>Endocrine therapy, chemotherapy, or HER2-directed therapy delays or prevents recurrence in almost all patients and prolongs survival in some. Hormone positive cancer can be evaluated with Oncotype Dx, which allows targeting chemotherapy and endocrine therapy to the populations most likely to benefit. Hormone negative cancer and HER2 positive cancer are treated with chemotherapy and targeted therapy.</p></div><span id="v82328484" class="anchor"></span><div class="para"> <p>Decisions about the type of adjuvant therapy are made based on tumor characteristics, including <span class="genericDrug" data-showrollover="false">estrogen</span> receptor (ER) and <span class="genericDrug" data-showrollover="false">progesterone</span> receptor (PR) status, presence of human epidermal growth factor 2 (HER2) protein, grade and stage (including lymph node involvement), and genomic risk stratification. Some patients are treated with a combination of endocrine therapy and chemotherapy. </p></div><span id="v1066312" class="anchor"></span><div class="para"> <p>Chemotherapy is usually begun soon after surgery. If systemic chemotherapy is not required, endocrine therapy is usually begun soon after surgery and is continued for 5 to 10 years.</p></div><span id="v63234052" class="anchor"></span><div class="para"> <p> In higher stage disease, neoadjuvant chemotherapy may be started before surgery.</p></div> <span id="v26442703"></span> <div data-mmanualobjecttype="illustrativeMaterial" class="inlinebox--full inlinebox--table inlinebox--clickable illustrativeMaterialTable "> <div class="inlinebox__wrapper" id="v26442706"> <div class="inlinebox__header">Table</div> <div class="inlinebox__content"> <div class="multimedia__link" data-bind="component: { name: 'multimedia-link-text', params: $data }" data-popup-model='{"ItemId":"2eb040f4-eeae-43e1-a5d0-5c151510751c","Title":"Preferred%20Breast%20Cancer%20Adjuvant%20Systemic%20Therapy%2A","ShareUrlTitle":"preferred-breast-cancer-adjuvant-systemic-therapy","Description":"","ImageUrl":null,"ThumbnailUrl":"./Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v56201727","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"","LinkText":"Preferred%20Breast%20Cancer%20Adjuvant%20Systemic%20Therapy%2A","CssClass":null,"LoadLocations":false,"ShowTooltip":false,"SingleItem":true,"ExcludeFromBrand":null,"ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":true,"Target":null,"Url":null,"HideMainArrows":false}'> </div> <div class="inlinebox__button"> <img src="./Content/Images/Redesign/table/icon_table_red.png" alt="" loading="lazy" width="55" height="42"> </div> <div class="inlinebox__content--print" id="2eb040f4-eeae-43e1-a5d0-5c151510751c"> </div> </div> </div> <!-- Type: Table --> </div> <script type="text/javascript"> $(document).ready(function () { var url = window.location; if (url.search.includes("media=print")) { $.ajax({ url: '/Redesign/Topic/GetTableBody', type: "GET", dataType: "json", data: { tableId: '2eb040f4-eeae-43e1-a5d0-5c151510751c' }, async: true, success: function (data) { $('#2eb040f4-eeae-43e1-a5d0-5c151510751c').html('<div class="modaldialog">'+ data.TableBody + '</div>'); }, error: function (jqxhr, textStatus, errorThrown) { console.error(errorThrown); } }); } }); </script> </div> </section> <section id="v82328487" class="topic__section HHead"> <h3 class="topic__header--subsection"> <span id="v82328488" class="anchor"></span> Endocrine therapy </h3> <div class="topic__content"> <span id="v82328489" class="anchor"></span><div class="para"> <p>In patients with ER<span class='symbol'>+</span> tumors, particularly low-risk tumors, endocrine therapy is typically given. Predictive genomic testing of the primary breast cancer is used to stratify risk in patients and to determine whether combination chemotherapy or endocrine therapy alone is indicated. Common prognostic tests include</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v82328492" class="anchor"></span><div class="para"> <p>The 21-gene recurrence score assay (based on Oncotype Dx)</p></div></li><li class="topic__listitem"><span id="v82328494" class="anchor"></span><div class="para"> <p>The Amsterdam 70-gene profile (MammaPrint)</p></div></li><li class="topic__listitem"><span id="v82328496" class="anchor"></span><div class="para"> <p>The 50-gene risk of recurrence score (PAM50 assay) </p></div></li></ul></div><span id="v82328497" class="anchor"></span><div class="para"> <p>In the United States, most women with breast cancer have ER+/PR+/HER2- breast cancer with negative axillary nodes. In these women, a low or intermediate score on the 21-gene recurrence score assay predicts similar survival rates with chemotherapy plus endocrine therapy and with endocrine therapy alone. Therefore, in this subset of women with breast cancer, chemotherapy may not be necessary.</p></div><span id="v82328498" class="anchor"></span><div class="para"> <p>With endocrine therapy (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tamoxifen</span>, aromatase inhibitors), benefit depends on <span class="genericDrug" data-showrollover="false">estrogen</span> and <span class="genericDrug" data-showrollover="false">progesterone</span> receptor expression; benefit is greatest with the strongest level of hormone receptor expression (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v37584060" data-toggle="tooltip" title="Treatment references" data-id="7f4c6886-39e8-4f26-b893-37b11ee92c58" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">7</a><span id="7f4c6886-39e8-4f26-b893-37b11ee92c58" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v37584060"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>). Medications used for endocrine therapy include <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tamoxifen</span> and aromatase inhibitors. </p></div><span id="v82328502" class="anchor"></span><div class="para"> <p><b><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tamoxifen</span></b> is a selective <span class="genericDrug" data-showrollover="false">estrogen</span> receptor modulator that competitively binds with <span class="genericDrug" data-showrollover="false">estrogen</span> receptors. Adjuvant <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tamoxifen</span> reduces breast cancer mortality for women with tumors that have <span class="genericDrug" data-showrollover="false">estrogen</span> receptors. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tamoxifen</span> therapy for 5 years reduces annual odds of death by about 25% in premenopausal and postmenopausal women regardless of axillary lymph node involvement (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v37584060" data-toggle="tooltip" title="Treatment references" data-id="5d19feb1-0d13-492a-bcb1-c7227075b1ad" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">8</a><span id="5d19feb1-0d13-492a-bcb1-c7227075b1ad" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v37584060"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>). Treatment for 10 years appears to be even more effective; it prolongs survival and reduces recurrence risk compared with 5 years of treatment (15-year recurrence reduced to 21% from 25%) (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v37584060" data-toggle="tooltip" title="Treatment references" data-id="64c6cb29-44cf-43e9-b7bd-51559003a37c" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">9</a><span id="64c6cb29-44cf-43e9-b7bd-51559003a37c" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v37584060"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>). <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tamoxifen</span> can induce or exacerbate menopausal symptoms but reduces incidence of contralateral breast cancer and lowers serum cholesterol. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tamoxifen</span> increases bone density in postmenopausal women and may reduce risk of fractures and ischemic heart disease. However, it significantly increases risk of developing <a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html" data-toggle="tooltip" title="Endometrial Cancer" data-id="65166ebc-55a1-43d2-b1fc-26263afb4a9b" data-itemid="b70abee6-7ee0-4ca4-bbc4-d37298f9a946">endometrial cancer</a><span id="65166ebc-55a1-43d2-b1fc-26263afb4a9b" class="d-none xref"> <span class="tooltip-container"> <a href="./{B70ABEE6-7EE0-4CA4-BBC4-D37298F9A946}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Endometrial Cancer </span> Endometrial cancer is usually endometrioid adenocarcinoma. Typically, it manifests as postmenopausal uterine bleeding. Diagnosis is by biopsy. Staging is surgical. Treatment requires hysterectomy... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>; reported incidence is 1% in postmenopausal women after 5 years of use. Thus, if such women have spotting or bleeding, they must be evaluated for endometrial cancer. Nonetheless, the improved survival for women with breast cancer far outweighs increased risk of death due to endometrial cancer. Risk of thromboembolism is also increased.</p></div><span id="v82328509" class="anchor"></span><div class="para"> <p><b>Aromatase inhibitors</b> (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>anastrozole</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>exemestane</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>letrozole</span>) block peripheral production of <span class="genericDrug" data-showrollover="false">estrogen</span> in postmenopausal women. More effective than <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tamoxifen</span>, these medications are becoming the preferred treatment for early-stage hormone receptor–positive cancer in postmenopausal patients. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Letrozole</span> may be used in postmenopausal women who have completed <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tamoxifen</span> treatment. Optimal duration of aromatase inhibitor therapy is uncertain. A recent trial showed that extending treatment to 10 years resulted in a lower rate of breast cancer recurrence and higher rate of disease-free survival. There was no change in overall survival and a higher rate of fractures and osteoporosis in patients treated for an extended time.</p></div><span id="v82328511" class="anchor"></span><div class="para"> <p>Patients with DCIS are often treated with daily oral <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tamoxifen</span>. </p></div><span id="v82328512" class="anchor"></span><div class="para"> <p>Preferred therapy for premenopausal women with ER+ breast cancer is typically <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tamoxifen</span> or ovarian suppression (usually with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>leuprolide</span>, a GnRH agonist) combined with an aromatase inhibitor. For postmenopausal women, an aromatase inhibitor is preferred. CDK 4/6 inhibitors, such as <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>palbociclib</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>ribociclib</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>abemaciclib</span>, are also used for patients with hormone receptor-positive, HER2-negative cancer. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Olaparib</span> is used in patients with germline BRCA1 and 2 mutations with HER2-negative breast cancer. </p></div> </div> </section> <section id="v82328513" class="topic__section HHead"> <h3 class="topic__header--subsection"> <span id="v82328514" class="anchor"></span> Adjuvant chemotherapy </h3> <div class="topic__content"> <span id="v82328515" class="anchor"></span><div class="para"> <p>Usual indications for chemotherapy are one or more of the following:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v82328518" class="anchor"></span><div class="para"> <p><span class="genericDrug" data-showrollover="false">Estrogen</span> receptor (ER) and <span class="genericDrug" data-showrollover="false">progesterone</span> receptor (PR)-negative</p></div></li><li class="topic__listitem"><span id="v82328522" class="anchor"></span><div class="para"> <p>Human epidermal growth factor 2 (HER2) oncogene-positive (chemotherapy and HER2-directed therapy is given)</p></div></li><li class="topic__listitem"><span id="v82328524" class="anchor"></span><div class="para"> <p>ER/PR+ and positive lymph nodes in a premenopausal patient</p></div></li><li class="topic__listitem"><span id="v82328526" class="anchor"></span><div class="para"> <p>ER/PR+ and HER2- with high Oncotype Dx score</p></div></li></ul></div><span id="v82328527" class="anchor"></span><div class="para"> <p>However, studies have shown that chemotherapy is not necessary for many small (< 0.5 to 1 cm) tumors with no lymph node involvement (particularly in postmenopausal patients) because the prognosis is already excellent (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v37584060" data-toggle="tooltip" title="Treatment references" data-id="a0eb2508-8ce3-42c4-8843-949ef35fde4d" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">10</a><span id="a0eb2508-8ce3-42c4-8843-949ef35fde4d" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v37584060"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>).</p></div><span id="v82328529" class="anchor"></span><div class="para"> <p>Postmenopausal patients with ER− tumors benefit the most from adjuvant chemotherapy (see table <span class="multimedia__link mlinkBlock" data-bind="component: { name: 'm-link-text', params: $data }" data-popup-model='{"ItemId":"2eb040f4-eeae-43e1-a5d0-5c151510751c","Title":"Preferred%20Breast%20Cancer%20Adjuvant%20Systemic%20Therapy%2A","ShareUrlTitle":"preferred-breast-cancer-adjuvant-systemic-therapy","Description":"","ImageUrl":null,"ThumbnailUrl":"/Content/Images/Redesign/table/icon_table_red.png","MediaType":"table","MediaNameTranslated":"Table","UniqueId":"v56201727","Placement":null,"IsInCarousel":false,"Edition":0,"ImageWidth":null,"ImageHeight":null,"IframeSrc":null,"Target":null,"Alt":null}' data-popup-options='{"ListName":"TopicMultimedia","LinkText":"%3Cspan%20%3EPreferred%20Breast%20Cancer%20Adjuvant%20Systemic%20Therapy%3C%2Fspan%3E","CssClass":null,"LoadLocations":true,"ShowTooltip":true,"SingleItem":true,"ExcludeFromBrand":"","ShowCredits":true,"ShowDescription":true,"PopupTitle":"Table","ShowTitle":true,"ShowIcon":false,"ShowModalIndicator":false,"ShowTitleInHeader":false,"HideCarousel":false,"Target":"modal","Url":null,"HideMainArrows":false}'></span>). </p></div><span id="v82328531" class="anchor"></span><div class="para"> <p>Combination chemotherapy regimens are more effective than a single medication. Dose-dense regimens given for 4 to 6 months are preferred; in dose-dense regimens, the time between doses is shorter than that in standard-dose regimens. There are many regimens; a commonly used one is ACT (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>doxorubicin</span> plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>cyclophosphamide</span> followed by <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>paclitaxel</span>). Acute adverse effects depend on the regimen but usually include nausea, vomiting, mucositis, fatigue, alopecia, myelosuppression, cardiotoxicity, and thrombocytopenia. Growth factors that stimulate bone marrow (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>filgrastim</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>pegfilgrastim</span>) are commonly used to reduce risk of fever and infection due to chemotherapy. Long-term adverse effects are infrequent with most regimens; death due to infection or bleeding is rare (<span class='symbol'>&lt</span> 0.2%).</p></div> </div> </section> <section id="v82328532" class="topic__section HHead"> <h3 class="topic__header--subsection"> <span id="v82328533" class="anchor"></span> HER2-directed therapy </h3> <div class="topic__content"> <span id="v82328534" class="anchor"></span><div class="para"> <p>If the tumor overexpresses HER2 (HER2<span class='symbol'>+</span>), anti-HER2 monoclonal antibodies (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>trastuzumab</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>pertuzumab</span>) may be used. Adding the humanized monoclonal antibody <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>trastuzumab</span> to chemotherapy provides substantial benefit. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Trastuzumab</span> is usually continued for a year, although the optimal duration of therapy is unknown. If lymph nodes are involved, adding <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>pertuzumab</span> to <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>trastuzumab</span> improves disease-free survival. A serious potential adverse effect of both these anti-HER2 medications is a decreased cardiac ejection fraction.</p></div> </div> </section> <section id="v1066395" class="topic__section GHead"> <span></span> <h3 id="Treatment_v1066174_v1066396" class="topic__header--subsection"> <span id="v1066396" class="anchor"></span> Metastatic disease </h3> <div class="topic__content"> <span id="v1066398" class="anchor"></span><div class="para"> <p>Any indication of metastases should prompt immediate evaluation. Treatment of metastases increases median survival by 6 months or longer. These treatments (eg, chemotherapy), although relatively toxic, may palliate symptoms and improve quality of life. Thus, the decision to be treated may be highly personal.</p></div><span id="v1066399" class="anchor"></span><div class="para"> <p>Choice of therapy depends on the following:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v1066402" class="anchor"></span><div class="para"> <p>Hormone-receptor status of the tumor</p></div></li><li class="topic__listitem"><span id="v1066404" class="anchor"></span><div class="para"> <p>Length of the disease-free interval (from remission to manifestation of metastases)</p></div></li><li class="topic__listitem"><span id="v1066406" class="anchor"></span><div class="para"> <p>Number of metastatic sites and organs affected</p></div></li><li class="topic__listitem"><span id="v1066408" class="anchor"></span><div class="para"> <p>Patient’s menopausal status</p></div></li></ul></div><span id="v1066409" class="anchor"></span><div class="para"> <p>Systemic endocrine therapy or chemotherapy is usually used to treat symptomatic metastatic disease. Initially, patients with multiple metastatic sites outside the central nervous system (CNS) should be given systemic therapy. If metastases are asymptomatic, there is no proof that treatment substantially increases survival, and it may reduce quality of life.</p></div><span id="v1066410" class="anchor"></span><div class="para"> <p><b>Endocrine therapy</b> is preferred over chemotherapy for patients with any of the following: </p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v26442798" class="anchor"></span><div class="para"> <p>ER+ tumors</p></div></li><li class="topic__listitem"><span id="v26442800" class="anchor"></span><div class="para"> <p>A disease-free interval of > 2 years</p></div></li><li class="topic__listitem"><span id="v26442802" class="anchor"></span><div class="para"> <p>Disease that is not immediately life threatening</p></div></li></ul></div><span id="v26442803" class="anchor"></span><div class="para"> <p>In premenopausal women, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tamoxifen</span> is often used first. Reasonable alternatives include ovarian ablation by surgery, radiation therapy, and use of a luteinizing-releasing hormone agonist (eg, buserelin, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>goserelin</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>leuprolide</span>). Some experts combine ovarian ablation with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tamoxifen</span> or an aromatase inhibitor. In postmenopausal women, aromatase inhibitors are being increasingly used as primary endocrine therapy. If the cancer initially responds to endocrine therapy but progresses months or years later, additional forms of endocrine therapy (eg, progestins, the antiestrogen <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>fulvestrant</span>) may be used sequentially until no further response occurs.</p></div><span id="v1066412" class="anchor"></span><div class="para"> <p>The most effective <b>chemotherapy agents</b> are <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>capecitabine</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>doxorubicin</span> (including its liposomal formulation), <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>gemcitabine</span>, the taxanes <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>paclitaxel</span> and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>docetaxel</span>, and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>vinorelbine</span>. Response rate to a combination of agents is higher than that to a single agent, but survival is not improved and toxicity is increased. Thus, some oncologists use single agents sequentially. </p></div><span id="v1066413" class="anchor"></span><div class="para"> <p><b>Anti-HER2 monoclonal antibodies</b> (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>trastuzumab</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>pertuzumab</span>) are used to treat tumors that overexpress HER2. These are effective in treating and controlling visceral metastatic sites. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Trastuzumab</span> is used alone or with endocrine therapy, chemotherapy, or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>pertuzumab</span>. <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Trastuzumab</span> plus chemotherapy plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>pertuzumab</span> slows the growth of HER2+ metastatic breast cancer and increases survival more than <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>trastuzumab</span> plus chemotherapy (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v37584060" data-toggle="tooltip" title="Treatment references" data-id="d9f99edf-12fb-462e-9774-ed690a5ddd02" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">11</a><span id="d9f99edf-12fb-462e-9774-ed690a5ddd02" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v37584060"> <span class="tooltip-content"> <span class="tooltip-heading"> Treatment references </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Treatment references" loading="lazy"> </span> </a> </span> </span>).</p></div><span id="v26442804" class="anchor"></span><div class="para"> <p><b>Tyrosine kinase inhibitors</b> (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>lapatinib</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>neratinib</span>) are being increasingly used in women with HER2+ tumors.</p></div><span id="v1066414" class="anchor"></span><div class="para"> <p><b>Radiation therapy</b> alone may be used to treat isolated, symptomatic bone lesions or local skin recurrences not amenable to surgical resection. Radiation therapy is the most effective treatment for brain metastases, occasionally providing long-term control.</p></div><span id="v26442805" class="anchor"></span><div class="para"> <p><b>Palliative mastectomy</b> is sometimes an option for patients with stable metastatic breast cancer.</p></div><span id="v1066417" class="anchor"></span><div class="para"> <p><b>IV bisphosphonates</b> (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>pamidronate</span>, zoledronate) decrease bone pain and bone loss and prevent or delay skeletal complications due to bone metastases. About 10% of patients with bone metastases eventually develop hypercalcemia, which can also be treated with IV bisphosphonates.</p></div> </div> </section> <section id="v37584059" class="topic__section GHead"> <span itemscope="" itemtype="http://schema.org/MedicalTherapy"></span> <h3 id="Treatment_v1066174_v37584060" class="topic__header--subsection"> <span itemprop="name" id="v37584060" class="anchor"></span> Treatment references </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v82328536" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/12393820/">Fisher B, Anderson S, Bryant J, et al</a>. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. <i>N Engl J Med</i> 347(16):1233-1241, 2002. doi:10.1056/NEJMoa022152</p></div></li><li class="topic__listitem"><span id="v63234055" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873728/">Jammallo LS, Miller CL, Singer M, et al</a>: Impact of body mass index and weight fluctuation on lymphedema risk in patients treated for breast cancer. <i>Breast Cancer Res Treat</i> 142 (1):59–67, 2013. doi: 10.1007/s10549-013-2715-7</p></div></li><li class="topic__listitem"><span id="v37584063" class="anchor"></span><div class="para"> <p>3. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5389857/">Giuliano AE, Hunt KK, Ballman KV, et al</a>: Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: A randomized clinical trial. <i>JAMA</i> 305 (6):569-575, 2011. doi: 10.1001/jama.2011.90</p></div></li><li class="topic__listitem"><span id="v82328539" class="anchor"></span><div class="para"> <p>4. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3041644/">Krag DN, Anderson SJ, Julian TB, et al</a>: Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. <i>Lancet Oncol</i> 11(10):927-933, 2010. doi:10.1016/S1470-2045(10)70207-2</p></div></li><li class="topic__listitem"><span id="v44232552" class="anchor"></span><div class="para"> <p>5. <a rel="nofollow" target="_blank" href="https://lymphnet.org/position-papers">National Lymphedema Network Medical Advisory Committee</a>: Position Statement Paper: Lymphedema Risk Reduction Practices. May 2010. Accessed May 8, 2023.</p></div></li><li class="topic__listitem"><span id="v37584067" class="anchor"></span><div class="para"> <p>6. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/15342805/">Hughes KS, Schnaper LA, Berry D, et al</a>: Lumpectomy plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tamoxifen</span> with or without irradiation in women 70 years of age or older with early breast cancer. <i>N Engl J Med</i> 351 (10):971-977, 2004. doi:10.1056/NEJMoa040587</p></div></li><li class="topic__listitem"><span id="v82328542" class="anchor"></span><div class="para"> <p>7. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/11181655/">Fisher B, Anderson S, Tan-Chiu E, et al</a>: <span class="genericDrug" data-showrollover="false">Tamoxifen</span> and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23.<i> J Clin Oncol</i> 19(4):931-942, 2001. doi:10.1200/JCO.2001.19.4.931</p></div></li><li class="topic__listitem"><span id="v82328546" class="anchor"></span><div class="para"> <p>8. <a rel="nofollow" target="_blank" href="https://pubmed.ncbi.nlm.nih.gov/15894097/">Early Breast Cancer Trialists' Collaborative Group (EBCTCG)</a>: Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. <i>Lancet</i> 365(9472):1687-1717, 2005. doi:10.1016/S0140-6736(05)66544-0</p></div></li><li class="topic__listitem"><span id="v82328549" class="anchor"></span><div class="para"> <p>9. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596060/">Davies C, Pan H, Godwin J, et al</a>: Long-term effects of continuing adjuvant <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tamoxifen</span> to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial [published correction appears in <i>Lancet</i>. 2013 Mar 9;381(9869):804] [published correction appears in <i>Lancet</i>. 2017 May 13;389(10082):1884]. <i>Lancet</i> 381(9869):805-816, 2013. doi:10.1016/S0140-6736(12)61963-1</p></div></li><li class="topic__listitem"><span id="v82328552" class="anchor"></span><div class="para"> <p>10. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1344996/">Rosen PP, Saigo PE, Braun DW Jr, et al</a>: Predictors of recurrence in stage I (T1N0M0) breast carcinoma.<i> Ann Surg</i> 193(1):15-25, 1981. doi:10.1097/00000658-198101000-00003</p></div></li><li class="topic__listitem"><span id="v37584071" class="anchor"></span><div class="para"> <p>11. <a rel="nofollow" target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584549/">Swain SM, Baselga J, Kim SB, et al</a>: <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Pertuzumab</span>, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>trastuzumab</span>, and <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>docetaxel</span> in HER2-positive metastatic breast cancer. <i>N Engl J Med</i> 372 (8):724-734, 2015. doi: 10.1056/NEJMoa1413513</p></div></li></ul></div> </div> </section> </div> </section> <section id="v1065920" class="topic__section FHead"> <h2 id="Prognosis_v1065921" class="topic__header--section" data-originaltitle="Prognosis"> <span id="v1065921" class="anchor"></span> Prognosis for Breast Cancer </h2> <div class="topic__content"> <span id="v1065922" class="anchor"></span><div class="para"> <p>Long-term prognosis depends on tumor stage. Nodal status (including number and location of nodes) correlates with disease-free and overall survival better than any other prognostic factor. </p></div><span id="v9009367" class="anchor"></span><div class="para"> <p>The 5-year survival rate (from the National Cancer Institute's <a rel="nofollow" target="_blank" href="http://seer.cancer.gov/statfacts/html/breast.html">Surveillance, Epidemiology, and End Results (SEER) Program)</a> depends on cancer stage:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v26442641" class="anchor"></span><div class="para"> <p>Localized (confined to primary site): 99.0%</p></div></li><li class="topic__listitem"><span id="v26442643" class="anchor"></span><div class="para"> <p>Regional (confined to regional lymph nodes): 85.8%</p></div></li><li class="topic__listitem"><span id="v26442645" class="anchor"></span><div class="para"> <p>Distant (metastasized): 29.0%</p></div></li><li class="topic__listitem"><span id="v37584000" class="anchor"></span><div class="para"> <p>Unknown: 57.8%</p></div></li></ul></div><span id="v1066152" class="anchor"></span><div class="para"> <p><b>Poorer prognosis</b> is associated with the following other factors:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v1066161" class="anchor"></span><div class="para"> <p><b>Young age:</b> Prognosis appears worse for patients diagnosed with breast cancer during their 20s and 30s than for patients diagnosed during middle age.</p></div></li><li class="topic__listitem"><span id="v63234027" class="anchor"></span><div class="para"> <p><b>Race:</b> Breast cancer death rates from 2015 to 2019 were higher in the United States in non-Hispanic Black females (28 per 100,000) than in non-Hispanic White females (19.9 per 100,000 [ <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v63234030" data-toggle="tooltip" title="Prognosis references" data-id="0d12a5b0-026a-46de-8b70-671119670475" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">1</a><span id="0d12a5b0-026a-46de-8b70-671119670475" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v63234030"> <span class="tooltip-content"> <span class="tooltip-heading"> Prognosis references </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Prognosis references" loading="lazy"> </span> </a> </span> </span>]). Black women are diagnosed at a younger age compared with White women (median 60 versus 63 years) and are more likely to have triple negative disease (<a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v63234030" data-toggle="tooltip" title="Prognosis references" data-id="5afbd8fd-2a90-4b0d-a937-65ff8a6da9e2" data-itemid="9654b759-37ed-455c-8e45-1372e5bb9dac">2</a><span id="5afbd8fd-2a90-4b0d-a937-65ff8a6da9e2" class="d-none xref"> <span class="tooltip-container"> <a href="./{9654B759-37ED-455C-8E45-1372E5BB9DAC}.html#v63234030"> <span class="tooltip-content"> <span class="tooltip-heading"> Prognosis references </span> Breast cancers are most often epithelial tumors involving the ducts or lobules. Most patients present with an asymptomatic mass discovered during examination or screening mammography. Diagnosis... <span class="tooltip-readmore"> read more </span> </span> <span class="tooltip-img"> <img src="./~/media/manual/professional/images/f/0/3/f0317394-breast-anatomy-front-side-spl-sized.jpg?thn=0&sc_lang=en&mh=160&mw=160" class="tooltip-Preview" alt="Prognosis references" loading="lazy"> </span> </a> </span> </span>).</p></div></li><li class="topic__listitem"><span id="v1066163" class="anchor"></span><div class="para"> <p><b>Larger primary tumor:</b> Larger tumors are more likely to be node-positive, but they also confer a worse prognosis independent of nodal status.</p></div></li><li class="topic__listitem"><span id="v1066165" class="anchor"></span><div class="para"> <p><b>High-grade tumor:</b> Patients with poorly differentiated tumors have a worse prognosis.</p></div></li><li class="topic__listitem"><span id="v1066167" class="anchor"></span><div class="para"> <p><b>Absence of <span class="genericDrug" data-showrollover="false">estrogen</span> and <span class="genericDrug" data-showrollover="false">progesterone</span> receptors:</b> Patients with ER<span class='symbol'>+</span> tumors have a somewhat better prognosis and are more likely to benefit from endocrine therapy. Patients with <span class="genericDrug" data-showrollover="false">progesterone</span> receptors on a tumor may also have a better prognosis. Patients with both <span class="genericDrug" data-showrollover="false">estrogen</span> and <span class="genericDrug" data-showrollover="false">progesterone</span> receptors on a tumor may have a better prognosis than those who have only one of these receptors, but this benefit is not clear.</p></div></li><li class="topic__listitem"><span id="v1066170" class="anchor"></span><div class="para"> <p><b>Presence of HER2 protein:</b> When the <i data-mmanualobjecttype='gene' '>HER2</i> gene (<i data-mmanualobjecttype='gene' '>HER2/neu</i> [<i data-mmanualobjecttype='gene' '>erb-b2</i>]) is amplified, HER2 is overexpressed, increasing cell growth and reproduction and often resulting in more aggressive tumor cells. Overexpression of HER2 is an independent risk factor for a poor prognosis; it may also be associated with high histologic grade, ER− tumors, greater proliferation, and larger tumor size, which are all poor prognostic factors.</p></div></li><li class="topic__listitem"><span id="v1066172" class="anchor"></span><div class="para"> <p><b>Presence of <i data-mmanualobjecttype='gene' '>BRCA</i> gene mutations:</b> For any given stage, patients with the <i data-mmanualobjecttype='gene' '>BRCA1</i> gene mutation appear to have a worse prognosis than those with sporadic tumors, perhaps because they have a higher proportion of high-grade, hormone receptor–negative cancers. Patients with the <i data-mmanualobjecttype='gene' '>BRCA2</i> gene mutation probably have the same prognosis as those without the mutation if the tumors have similar characteristics. With either gene mutation, risk of a 2nd cancer in remaining breast tissue is increased (to perhaps as high as 40%).</p></div></li></ul></div> <section id="v82328555" class="topic__section GHead"> <span></span> <h3 id="Prognosis_v1065921_v82328556" class="topic__header--subsection"> <span id="v82328556" class="anchor"></span> End-of-life issues </h3> <div class="topic__content"> <span id="v82328557" class="anchor"></span><div class="para"> <p>For patients with metastatic breast cancer, quality of life may deteriorate, and the chances that further treatment will prolong life may be small. Palliation may eventually become more important than prolongation of life.</p></div><span id="v82328558" class="anchor"></span><div class="para"> <p>Cancer <a href="./{EAEDFB29-A81C-475E-8589-AE78E5267DE1}.html#v1129754" data-toggle="tooltip" title="Pain" data-id="4a887fc0-9a32-4cd5-8442-d54605bd6ea2" data-itemid="eaedfb29-a81c-475e-8589-ae78e5267de1">pain</a><span id="4a887fc0-9a32-4cd5-8442-d54605bd6ea2" class="d-none xref"> <span class="tooltip-container"> <a href="./{EAEDFB29-A81C-475E-8589-AE78E5267DE1}.html#v1129754"> <span class="tooltip-content"> <span class="tooltip-heading"> Pain </span> Physical, psychologic, emotional, and spiritual distress is common among patients living with fatal illness, and patients commonly fear protracted and unrelieved suffering. Health care providers... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span> can be adequately controlled with appropriate medications, including <a href="./{8547D22A-3ACE-40D1-B051-7181888831FD}.html#v1032990" data-toggle="tooltip" title="Opioid Analgesics" data-id="db97338a-fa33-4a1b-922b-3ab3bc2cee81" data-itemid="8547d22a-3ace-40d1-b051-7181888831fd">opioid analgesics</a><span id="db97338a-fa33-4a1b-922b-3ab3bc2cee81" class="d-none xref"> <span class="tooltip-container"> <a href="./{8547D22A-3ACE-40D1-B051-7181888831FD}.html#v1032990"> <span class="tooltip-content"> <span class="tooltip-heading"> Opioid Analgesics </span> Nonopioid and opioid analgesics are the main drugs used to treat pain. Antidepressants, antiseizure drugs, and other central nervous system (CNS)–active drugs may also be used for chronic or... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>. Other symptoms (eg, constipation, difficulty breathing, nausea) should also be treated.</p></div><span id="v82328561" class="anchor"></span><div class="para"> <p>Psychologic and spiritual counseling should be offered.</p></div><span id="v82328562" class="anchor"></span><div class="para"> <p>Patients with metastatic breast cancer should be encouraged to prepare <a href="./{30608D3A-CA38-4235-9778-B9CDA526592E}.html" data-toggle="tooltip" title="Advance Directives" data-id="2b0f5859-65dd-41f9-a556-b27b39de401e" data-itemid="30608d3a-ca38-4235-9778-b9cda526592e">advance directives</a><span id="2b0f5859-65dd-41f9-a556-b27b39de401e" class="d-none xref"> <span class="tooltip-container"> <a href="./{30608D3A-CA38-4235-9778-B9CDA526592E}.html"> <span class="tooltip-content"> <span class="tooltip-heading"> Advance Directives </span> Advance directives are legal documents that extend a person's control over health care decisions in the event that the person becomes incapacitated. They are called advance directives because... <span class="tooltip-readmore"> read more </span> </span> </a> </span> </span>, indicating the type of care they desire in case they are no longer able to make such decisions.</p></div> </div> </section> <section id="v63234029" class="topic__section GHead"> <span></span> <h3 id="Prognosis_v1065921_v63234030" class="topic__header--subsection"> <span id="v63234030" class="anchor"></span> Prognosis references </h3> <div class="topic__content"> <div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v63234033" class="anchor"></span><div class="para"> <p>1. <a rel="nofollow" target="_blank" href="https://www.cancer.org/research/cancer-facts-statistics/cancer-facts-figures-for-african-americans.html">American Cancer Society</a>: Cancer Facts & Figures or African American/Black People 2022-2024. Accessed May 4, 2023.</p></div></li><li class="topic__listitem"><span id="v82328565" class="anchor"></span><div class="para"> <p>2. <a rel="nofollow" target="_blank" href="https://www.cancer.org/cancer/types/breast-cancer/about/how-common-is-breast-cancer.html">American Cancer Society</a>: Key Statistics for Breast Cancer. Accessed May 4, 2023.</p></div></li></ul></div> </div> </section> </div> </section> <section id="v9009413" class="topic__section topic__section--keypoints FHead"> <h2 id="KeyPoints_v9009414" class="topic__header--section"> <span id="v9009414" class="anchor"></span> Key Points <span class="topic__keypoints--icon"></span> </h2> <div class="topic__content--keypoints"> <div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v9009417" class="anchor"></span><div class="para"> <p>Breast cancer is the second leading cause of cancer death in women; cumulative risk of developing breast cancer by age 95 is 12%.</p></div></li><li class="topic__listitem"><span id="v9009419" class="anchor"></span><div class="para"> <p>Factors that greatly increase risk include breast cancer in close relatives (particularly if a <i data-mmanualobjecttype='gene' '>BRCA</i> gene mutation is present), atypical ductal or lobular hyperplasia, lobular carcinoma in situ, and significant exposure to chest radiation therapy before age 30.</p></div></li><li class="topic__listitem"><span id="v9009424" class="anchor"></span><div class="para"> <p>Factors suggesting a poorer prognosis include younger age, absence of <span class="genericDrug" data-showrollover="false">estrogen</span> and <span class="genericDrug" data-showrollover="false">progesterone</span> receptors, and presence of HER2 protein or <i data-mmanualobjecttype='gene' '>BRCA</i> gene mutations.</p></div></li><li class="topic__listitem"><span id="v9009427" class="anchor"></span><div class="para"> <p>For most women, treatment requires surgical removal, lymph node sampling, systemic therapy (endocrine therapy or chemotherapy), and radiation therapy.</p></div></li><li class="topic__listitem"><span id="v9009429" class="anchor"></span><div class="para"> <p>Treat with endocrine therapy (eg, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tamoxifen</span>, aromatase inhibitor) if tumors have hormone receptors.</p></div></li><li class="topic__listitem"><span id="v9009431" class="anchor"></span><div class="para"> <p>Consider treating metastatic disease to relieve symptoms (eg, with chemotherapy, endocrine therapy, or, for bone metastases, radiation therapy or bisphosphonates), even though survival is unlikely to be prolonged.</p></div></li></ul></div> </div> </section> <section id="v26442816" class="topic__section FHead"> <h2 id="Further_v26442817" class="topic__header--section"> <span id="v26442817" class="anchor"></span> More Information </h2> <div class="topic__content"> <span id="v63320897" class="anchor"></span><div class="para"> <p>The following English-language resources may be useful. Please note that THE MANUAL is not responsible for the content of these resources.</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="nobulleted"><li class="topic__listitem"><span id="v26442820" class="anchor"></span><div class="para"> <p><a rel="nofollow" target="_blank" href="https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1419">NCCN Clinical Practice Guideline: </a>Breast Cancer: The National Comprehensive Cancer Network provides guidelines for the diagnosis, staging, and treatment of breast cancer (and other cancers).</p></div></li><li class="topic__listitem"><span id="v26442823" class="anchor"></span><div class="para"> <p><a rel="nofollow" target="_blank" href="http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/breast-cancer-medications-for-risk-reduction">U. S. Preventive Services Task Force: </a>Breast Cancer: Medication Use to Reduce Risk: This web site provides the rationale of using medications to reduce the risk of breast cancer in women at high risk and describes the risks of using these medications.</p></div></li><li class="topic__listitem"><span id="v26442826" class="anchor"></span><div class="para"> <p><a rel="nofollow" target="_blank" href="http://www.cancer.gov/types/breast/hp">National Cancer Institute</a>: Breast Cancer: This web site discusses the genetics of breast and gynecologic cancers and the screening for and prevention and treatment of breast cancer. It also includes evidence-based information about supportive and palliative care.</p></div></li></ul></div> </div> </section>
 
 <section class="topic__section">
 <div class="topicswitch topic__patient-education topic__patient-education--bottom hide-on-print" data-icd9="174;175;198.81;233.0;198.2">
 <div class="topic__patient-education--container">
 <div class="topic__patient-education--icon"></div>
 <div class="topic__patient-education--text">
 View PATIENT EDUCATION
 </div>
 </div>
 </div>
 </section>
</div>
<script type="text/javascript">
 $(document).ready(function () {
 $(document).on('click', '.topicswitch', function (e) {
 e.preventDefault();
 $.ajax({
 url: '/Custom/Edition/GetSwitchUrl',
 type: "GET",
 dataType: "json",
 data: {
 icd9: '174;175;198.81;233.0;198.2',
 title: 'Breast Cancer',
 itemGuid: '9654b759-37ed-455c-8e45-1372e5bb9dac'
 }
 }).done(function (data) {
 
 // redirect
 location.href = data.href;
 }).fail(function (jqxhr, textStatus, errorThrown) {
 console.error(errorThrown);
 });
 });
 });
</script>
 </article>
 <div class="copyright-print">
 <div class="copyright-print--logo">
<img src="./Content/Images/msd_foot_logo.png" alt="" class="badge msd" loading="lazy" width="240" height="71">
 </div>
 <div class="copyright-print--text">
 Copyright © 2024 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
 </div>
 </div>
 <section class="bottomnav__wrapper hide-on-print" style="display:none">
 
<div class="bottomnav no-print side-by-side">
 <div class="bottomnav__gotolink bottomnav__gotolink--previous">
 <a href="./{AD2514AC-2DB6-40D7-8BF8-E3B222359680}.html">
 <div class="bottomnav__gotolink--content">
 <div class="bottomnav__icon bottomnav__icon--previous"></div>
 <div class="bottomnav__linktext">Vaginal Itching and Discharge</div>
 </div>
 </a>
 </div>
 
 <div class="bottomnav__gotolink bottomnav__gotolink--next">
 <a href="./{A45BC05A-D9DA-40F1-A108-40D16B0065B1}.html">
 <div class="bottomnav__gotolink--content">
 <div class="bottomnav__linktext">Breast Cancer Screening and Prevention</div>
 <div class="bottomnav__icon bottomnav__icon--next"></div>
 </div>
 </a>
 </div>
</div>
 </section>
</div>
<span id="showpopup"></span>
<span id="showchildpopup"></span>
<div class="box box--marketing marketing-block orderize__candidate hide-on-print" data-orderize="1301">
 <div class="marketing-block-wrapper">
 <div class="box__header">
 <div class="box__headertext"></div>
 </div>
 <div class="box__content">
<div class="marketingblock-quiz hide-on-print">
<div class="marketingblock-quiz-img">
<img alt="quiz link" src="./Content/Images/Redesign/quizzes_lightbulb_red.png" loading="lazy" width="64" height="52">
</div>
<div class="marketingblock-quiz-desc">
<h4>Test your knowledge</h4>
<a href="./{976709AA-1FDC-4953-8B32-2A9E9973AC21}.html">Take a Quiz! </a></div>
</div> </div>
 </div>
</div>
<script type="text/javascript">
 $('img[usemap]').rwdImageMaps();
</script>
<div class="box box--marketing marketing-block orderize__candidate hide-on-print" data-orderize="1550">
 <div class="marketing-block-wrapper">
 <div class="box__header">
 <div class="box__headertext"></div>
 </div>
 <div class="box__content">
 <div class="box__content--mobile">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_pro_326.gif" alt="" id="d7d9c218-f4ae-4111-bbff-b0cf2c85f93b_mobile" usemap="#d7d9c218-f4ae-4111-bbff-b0cf2c85f93b_mobile" width="326" height="90">
 <map name="d7d9c218-f4ae-4111-bbff-b0cf2c85f93b_mobile">
 <area shape="RECT" coords="176,79,90,53" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="ANDROID">
 </map>
 </div>
 <div class="box__content--tablet">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_pro_326.gif" alt="" id="d7d9c218-f4ae-4111-bbff-b0cf2c85f93b_tablet" usemap="#d7d9c218-f4ae-4111-bbff-b0cf2c85f93b_tablet" width="326" height="90">
 <map name="d7d9c218-f4ae-4111-bbff-b0cf2c85f93b_tablet">
 <area shape="RECT" coords="176,79,90,53" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="ANDROID">
 </map>
 </div>
 <div class="box__content--desktop">
 <img loading="lazy" src="./~/media/manual/marketing/mobileqr/en_msd_mobile_qr_pro_326.gif" alt="" id="d7d9c218-f4ae-4111-bbff-b0cf2c85f93b_desktop" usemap="#d7d9c218-f4ae-4111-bbff-b0cf2c85f93b_desktop" width="326" height="90">
 <map name="d7d9c218-f4ae-4111-bbff-b0cf2c85f93b_desktop">
 <area shape="RECT" coords="176,79,90,53" href="https://apps.apple.com/app/msd-professional-version/id1123678257" target="_blank" alt="iOS">
<area shape="RECT" coords="202,51,297,80" href="https://play.google.com/store/apps/details?id=com.msd.professional&referrer=utm_source%3DMMWeb%26utm_medium%3Dbanner%26utm_content%3DTopic1Vertical%26utm_campaign%3DWebAppAds" target="_blank" alt="ANDROID">
 </map>
 </div>
 </div>
 </div>
</div>
<script type="text/javascript">
 $('img[usemap]').rwdImageMaps();
</script>
<a id="autoload" role="button" tabindex="-1"></a>
 <div class="autoload-placeholder hide-on-print" name="Up Next:"></div>
 <a class="next-topic hide-on-print" role="button" aria-hidden="true"></a>
 </div>
</div>
 </section>
 
 </main>
 
 <div class="l-layer l-layer--topscroll">
 <div class="topscroll topscroll--hidden">
 <div class="topscroll__container">
 <div class="topscroll__button">
 <div class="topscroll__content">
 <i class="topscroll__arrow"></i>
 TOP
 </div>
 </div>
 </div>
 <div class="topscroll__bar"></div>
</div>
 </div>
 </div>
 
 <div class="flyout hide-on-print" tabindex="0">
 <nav class="flyout__menu" role="application" aria-label="Menu">
 </nav>
 </div>
 <div class="print">
 <div id="print__content">
 </div>
 </div>
 <div class="multimedia__popup l-viewport" data-bind="component: { name: 'multimedia-popup'}">
 <!-- Placeholder for media players. -->
</div>
 <script type="text/javascript">
 //global value for translating the 'Read More' value
 var MMReadMore = "read more";
 var MMMaxTeaseCount = 250;
 </script>
 
 
<div class="sticky-footer hide-on-print">
 <ul>
 <li class="sticky-footer--topic">
 <button aria-label="Topic" class="sticky-footer-topicmenu" aria-expanded="false">
 <span class="footer-bar__icon topic-ico"></span>
 </button>
 <div class="footer-expand-cont footer-parent-cont topicList">
 <button aria-label="close" class="footer-expand-cont__close"></button>
 <div class="footer-topicList-wrapper">
 <div class="in-this-topic-sidebar">
 <div class="box__header">
 <span>IN THIS TOPIC</span>
 <span class="in-this-topic-togggle-btn" aria-label="IN THIS TOPIC" aria-expanded="false"></span>
 </div>
 </div>
 </div>
 </div>
 </li>
 <li class="sticky-footer--version-switcher nontopicpage">
 <a data-id="HE" href="/home" target="_self" aria-label="Version Switch">
 <span class="footer-bar__icon versionSwitcher-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--version-switcher topicpage">
 <a class="topicswitch" href="#" target="_self" aria-label="Version Switch">
 <span class="footer-bar__icon versionSwitcher-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--vetFilter"></li>
 <li>
 <a href="./{218352E5-01E6-4C81-9542-33CF998B22E9}.html" target="_self" aria-label="Resources">
 <span class="footer-bar__icon resources-ico"></span>
 </a>
 </li>
 <li class="sticky-footer--social">
 <aside class="actiontoolbar hide-on-print">
 <!--<a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--bookmark" onclick="bookmarkPage(this);" href="#"></a>-->
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--download" style="display: none" href="#"></a>
 
 <ul>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--share a2a_dd" href="https://www.addtoany.com/share" rel="noopener" role="button" aria-expanded="false" aria-label="Share in"></a>
 </li>
 <li>
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--print" href="#" onclick="window.print(); MManual.analytics.notifyOpenModal(MManual.analytics.eventPrintAnArticle);" role="button" title="print"></a>
 </li>
 <li class="a2a_kit a2a_kit_size_32 a2a_default_style" data-a2a-icon-color="transparent,transparent">
 <a class="actiontoolbar__button actiontoolbar__icon actiontoolbar__icon--email a2a_button_email" href="#" role="button" title="Mail"></a>
 </li>
 <li class="scroll-to-top">
 <a href="#top" role="button" aria-label="Go To Top" title="Go To Top"><span class="scroll-to-top-img"></span></a>
 </li>
 <li class="scroll-to-bottom">
 <a href="#" role="button" aria-label="Go To Top"><span class="scroll-to-bottom-img"></span></a>
 </li>
 </ul>
 </aside>
 </li>
 <li class="sticky-footer--moreCont">
 <button aria-label="More" class="sticky-footer--more" aria-expanded="false">
 <span class="footer-bar__icon more-ico"></span>
 </button>
 <div class="footer-expand-cont more-footer-container">
 <ul>
 <li>
 <a href="./{F01A9F26-96C0-45E2-8ACC-403ACDB78022}.html" target="_self" aria-label="Home">
 <span class="footer-bar__icon home-ico"></span>
 </a>
 </li>
 <li>
 <a href="./{FF41B506-E267-4A7F-8357-F8C0474115E2}.html" target="_self" aria-label="info">
 <span class="footer-bar__icon info-ico"></span>
 </a>
 </li>
 <li>
 <button aria-label="Settings" aria-expanded="false">
 <span class="footer-bar__icon settings-ico"></span>
 </button>
 <div class="footer-sub-cont settings-footer-cont"></div>
 </li>
 <li class="language-footer">
 <button aria-label="Select Language" aria-expanded="false">
 <span class="footer-bar__icon language-ico"></span>
 </button>
 <div class="footer-sub-cont language-footer-cont"></div>
 </li>
 </ul>
 </div>
 </li>
 </ul>
</div>
 
 
 
<!--[if (gte IE 9)|!(IE)]><!-->
<script type="text/javascript">
 function downloadJSAtOnload() {
 
 MManual.deferredScripts.push("./bundles/redesign/libsdeferredjsv4.1.2.2-13178e13ca.js?v=0HKp-yFnKaDEueCLP27J6D4rHb3-AAxm6cmzEE3Gmb41");
 
 
 MManual.deferredScripts.push("./bundles/redesign/mmanualdeferredjsv4.1.2.2-13178e13ca.js?v=-hMvtQA9NJy1WdyRhBfBFzrPaWL44SkinQI4pIY9AWk1");
 
 
 MManual.deferredScripts.push("./bundles/redesign/mmanualTopicdeferredjsv4.1.2.2-13178e13ca.js?v=wDzP134aC3i-5gwHvRAsARMyhcs_em3XWcSsRyzYpYQ1");
 
 MManual.utils.loadScripts(MManual.deferredScripts);
 }
 $(document).ready(downloadJSAtOnload);
</script>
<!--<![endif]-->
<!--[if lt IE 9]>
 
 <script src="/Content/Scripts/Lib/mediaelement-and-player.min.js?v4.1.2.2-13178e13ca" type="text/javascript"></script>
 <script src="/Content/Scripts/Lib/zoomerang.js?v4.1.2.2-13178e13ca" type="text/javascript"></script>
 <script type="text/javascript">
 function downloadJSAtOnload() {
 
 MManual.deferredScripts.push("/bundles/redesign/mmanualdeferredjsv4.1.2.2-13178e13ca.js?v=-hMvtQA9NJy1WdyRhBfBFzrPaWL44SkinQI4pIY9AWk1");
 
 
 MManual.deferredScripts.push("/bundles/redesign/ie8libsdeferredjsv4.1.2.2-13178e13ca.js?v=0HKp-yFnKaDEueCLP27J6D4rHb3-AAxm6cmzEE3Gmb41");
 
 
 MManual.deferredScripts.push("/bundles/redesign/mmanualTopicdeferredjsv4.1.2.2-13178e13ca.js?v=wDzP134aC3i-5gwHvRAsARMyhcs_em3XWcSsRyzYpYQ1");
 
 for (var i = 0; i < MManual.deferredScripts.length; i++) {
 var element = document.createElement("script");
 element.src = MManual.deferredScripts[i];
 element.classList.add("optanon-category-C0002");
 document.body.appendChild(element);
 }
 }
 $(document).ready(downloadJSAtOnload);
 </script>
<![endif]-->
 <!-- Current instance name : ue-p-sc-cd04
 Current application version : 4.1.2.2-13178e13ca
 -->
 <!--[if (gte IE 9)|!(IE)]><!-->
<script src="./bundles/redesign/libsEndjsv4.1.2.2-13178e13ca.js?v=NWrOPHpqntlKhYlvryw8nEPZpRaWQrScEY3i127KnfI1"></script>
<!--<![endif]-->
<input id="MediaFramework_ItemId" name="MediaFramework_ItemId" type="hidden" value="9654B75937ED455C8E451372E5BB9DAC">
<div id="hiddentblcontents" style="display:none"><div id='hidden_v56201424'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v9009185"></span> <div class="TableFullPage" id="v56201424"> <h3 class="title">Anatomic Staging of Breast Cancer*</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56201438" class="anchor"></span><div class="para"> <p>Stage</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56201441" class="anchor"></span><div class="para"> <p>Tumor</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56201444" class="anchor"></span><div class="para"> <p>Regional Lymph Node/Distant Metastasis†</p></div></p></th></tr></thead> <tbody><tr class="odd"><td><span id="v56201495" class="anchor"></span><div class="para"> <p>0</p></div></td><td><span id="v56201497" class="anchor"></span><div class="para"> <p>Tis</p></div></td><td><span id="v56201499" class="anchor"></span><div class="para"> <p>N0/M0</p></div></td></tr><tr class="even"><td><span id="v56201502" class="anchor"></span><div class="para"> <p>IA</p></div></td><td><span id="v56201504" class="anchor"></span><div class="para"> <p>T1‡</p></div></td><td><span id="v56201506" class="anchor"></span><div class="para"> <p>N0/M0</p></div></td></tr><tr class="odd"><td><span id="v56201509" class="anchor"></span><div class="para"> <p>IB</p></div></td><td><span id="v56201511" class="anchor"></span><div class="para"> <p>T0</p></div></td><td><span id="v56201513" class="anchor"></span><div class="para"> <p>N1mi/M0</p></div></td></tr><tr class="even"><td><span id="v56201516" class="anchor"></span><div class="para"> <p></div></td><td><span id="v56201518" class="anchor"></span><div class="para"> <p>T1‡</p></div></td><td><span id="v56201520" class="anchor"></span><div class="para"> <p>N1mi/M0</p></div></td></tr><tr class="odd"><td><span id="v56201523" class="anchor"></span><div class="para"> <p>IIA</p></div></td><td><span id="v56201525" class="anchor"></span><div class="para"> <p>T0</p></div></td><td><span id="v56201527" class="anchor"></span><div class="para"> <p>N1§M0</p></div></td></tr><tr class="even"><td><span id="v56201530" class="anchor"></span><div class="para"> <p></div></td><td><span id="v56201532" class="anchor"></span><div class="para"> <p>T1‡</p></div></td><td><span id="v56201534" class="anchor"></span><div class="para"> <p>N1§/M0</p></div></td></tr><tr class="odd"><td><span id="v56201537" class="anchor"></span><div class="para"> <p></div></td><td><span id="v56201539" class="anchor"></span><div class="para"> <p>T2</p></div></td><td><span id="v56201541" class="anchor"></span><div class="para"> <p>N0/M0</p></div></td></tr><tr class="even"><td><span id="v56201544" class="anchor"></span><div class="para"> <p>IIB</p></div></td><td><span id="v56201546" class="anchor"></span><div class="para"> <p>T2</p></div></td><td><span id="v56201548" class="anchor"></span><div class="para"> <p>N1/M0</p></div></td></tr><tr class="odd"><td><span id="v56201551" class="anchor"></span><div class="para"> <p></div></td><td><span id="v56201553" class="anchor"></span><div class="para"> <p>T3</p></div></td><td><span id="v56201555" class="anchor"></span><div class="para"> <p>N0/M0</p></div></td></tr><tr class="even"><td><span id="v56201558" class="anchor"></span><div class="para"> <p>IIIA</p></div></td><td><span id="x000123" class="anchor"></span><div class="para"> <p>T0</p></div></td><td><span id="x000124" class="anchor"></span><div class="para"> <p>N2/M0</p></div></td></tr><tr class="odd"><td><span id="x000120" class="anchor"></span><div class="para"> <p></div></td><td><span id="v56201560" class="anchor"></span><div class="para"> <p>TI‡</p></div></td><td><span id="v56201562" class="anchor"></span><div class="para"> <p>N2/M0</p></div></td></tr><tr class="even"><td><span id="v56201565" class="anchor"></span><div class="para"> <p></div></td><td><span id="v56201567" class="anchor"></span><div class="para"> <p>T2</p></div></td><td><span id="v56201569" class="anchor"></span><div class="para"> <p>N2/M0</p></div></td></tr><tr class="odd"><td><span id="v56201572" class="anchor"></span><div class="para"> <p></div></td><td><span id="v56201574" class="anchor"></span><div class="para"> <p>T3</p></div></td><td><span id="v56201576" class="anchor"></span><div class="para"> <p>N1/M0</p></div></td></tr><tr class="even"><td><span id="v56201579" class="anchor"></span><div class="para"> <p></div></td><td><span id="v56201581" class="anchor"></span><div class="para"> <p>T3</p></div></td><td><span id="v56201583" class="anchor"></span><div class="para"> <p>N2/M0</p></div></td></tr><tr class="odd"><td><span id="v56201586" class="anchor"></span><div class="para"> <p>IIIB</p></div></td><td><span id="v56201588" class="anchor"></span><div class="para"> <p>T4</p></div></td><td><span id="v56201590" class="anchor"></span><div class="para"> <p>N0/M0</p></div></td></tr><tr class="even"><td><span id="v56201593" class="anchor"></span><div class="para"> <p></div></td><td><span id="v56201595" class="anchor"></span><div class="para"> <p>T4</p></div></td><td><span id="v56201597" class="anchor"></span><div class="para"> <p>N1/M0</p></div></td></tr><tr class="odd"><td><span id="v56201600" class="anchor"></span><div class="para"> <p></div></td><td><span id="v56201602" class="anchor"></span><div class="para"> <p>T4</p></div></td><td><span id="v56201604" class="anchor"></span><div class="para"> <p>N2/M0</p></div></td></tr><tr class="even"><td><span id="v56201607" class="anchor"></span><div class="para"> <p>IIIC</p></div></td><td><span id="v56201609" class="anchor"></span><div class="para"> <p>Any T</p></div></td><td><span id="v56201611" class="anchor"></span><div class="para"> <p>N3/M0</p></div></td></tr><tr class="odd"><td><span id="v56201614" class="anchor"></span><div class="para"> <p>IV</p></div></td><td><span id="v56201616" class="anchor"></span><div class="para"> <p>Any T</p></div></td><td><span id="v56201618" class="anchor"></span><div class="para"> <p>Any N/M1</p></div></td></tr></tbody> <tfoot><tr><td colspan="3"><span id="v56201448" class="anchor"></span><div class="para"> <p>* Adapted from: Hortobagyi GN, Connolly JL, D’Orsi CJ, Edge SB, Mittendorf EA, et al: Breast. In: Amin MB, Edge S, Greene F, et al, eds; American Joint Committee on Cancer. AJCC cancer staging manual. 8th ed. New York, NY: Springer. 2017. Version 9 changes, when available, can be found on the American Joint Committee on Cancer (AJCC) site <a rel="nofollow" target="_blank" href="https://www.facs.org/quality-programs/cancer-programs/american-joint-committee-on-cancer/version-9/">AJCC Version 9 Cancer Staging System</a>.</p></div></td></tr><tr><td colspan="3"><span id="v56201454" class="anchor"></span><div class="para"> <p>† Classification of regional lymph nodes (N) is divided into clinical (cN) and pathologic (pN), which have slightly different descriptions.</p></div></td></tr><tr><td colspan="3"><span id="v56201457" class="anchor"></span><div class="para"> <p>‡ T1 includes T1mi.</p></div></td></tr><tr><td colspan="3"><span id="v56201460" class="anchor"></span><div class="para"> <p>§ Here, N1 excludes N1mi.</p></div></td></tr><tr><td colspan="3"><span id="v56201463" class="anchor"></span><div class="para"> <p>Tis <span class='symbol'>=</span> ductal carcinoma in situ or Paget disease of the nipple with no tumor (Paget disease with a tumor is classified by tumor size); T1 <span class='symbol'>=</span> tumor <span class='symbol'>≤</span> 2 cm; T1mi <span class='symbol'>=</span> tumor <span class='symbol'>≤</span> 0.1 cm; T2 <span class='symbol'>=</span> tumor <span class='symbol'>></span> 2 but <span class='symbol'>≤</span> 5 cm; T3 <span class='symbol'>=</span> tumor <span class='symbol'>></span> 5 cm; T4 <span class='symbol'>= </span>any size tumor with extension to chest wall and/or skin and with ulceration or skin nodules or inflammatory cancer.</p></div></td></tr><tr><td colspan="3"><span id="v56201466" class="anchor"></span><div class="para"> <p>NX <span class='symbol'>=</span> Nearby nodes not assessable (for example, because removed previously); N0 <span class='symbol'>=</span> no spread to nearby nodes or only isolated tumor cells; N1 <span class='symbol'>=</span> spread to 1–3 ipsilateral movable, low or midaxillary nodes and/or metastases detected by sentinel lymph node biopsy in clinically negative internal mammary lymph nodes (pN1); N1mi = N1 nodes with micrometastases (about 200 cells > 0.2 mm, but none > 2 mm); N2 <span class='symbol'>=</span> any of the following:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v56201469" class="anchor"></span><div class="para"> <p>Spread to ipsilateral low or midaxillary nodes that are fixed or matted, detected by clinical examination (cN2)</p></div></li><li class="topic__listitem"><span id="v56201471" class="anchor"></span><div class="para"> <p>Spread to 4–9 axillary lymph nodes, detected by testing (pN2)</p></div></li><li class="topic__listitem"><span id="v56201473" class="anchor"></span><div class="para"> <p>Spread to internal mammary nodes but not axillary nodes as detected by clinical examination or imaging</p></div></li></ul></div><span id="v56201474" class="anchor"></span><div class="para"> <p>N3 <span class='symbol'>=</span> any of the following:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v56201477" class="anchor"></span><div class="para"> <p>Spread to <span class='symbol'>ipsilateral internal mammary nodes plus axillary nodes as detected by clinical examination or imaging</span></p></div></li><li class="topic__listitem"><span id="v56201479" class="anchor"></span><div class="para"> <p>Spread to infraclavicular nodes</p></div></li><li class="topic__listitem"><span id="v56201481" class="anchor"></span><div class="para"> <p>Spread to supraclavicular nodes</p></div></li><li class="topic__listitem"><span id="v56201483" class="anchor"></span><div class="para"> <p>Spread to ≥ 10 axillary lymph nodes</p></div></li><li class="topic__listitem"><span id="v56201485" class="anchor"></span><div class="para"> <p>Spread to > 3 axillary lymph nodes and micrometastases or macrometastases by sentinel lymph node biopsy in clinically negative internal mammary nodes (pN3)</p></div></li></ul></div></td></tr><tr><td colspan="3"><span id="v56201488" class="anchor"></span><div class="para"> <p>M0 <span class='symbol'>=</span> no distant metastases; M1 <span class='symbol'>=</span> distant metastases present.</p></div></td></tr><tr><td colspan="3"><span id="v56201491" class="anchor"></span><div class="para"> <p>Adapted from the American Joint Committee on Cancer, <i>AJCC Cancer Staging Manual, Eighth Edition (2017)</i>. Springer New York, Inc. </p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div><div id='hidden_v56201727'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v26442706"></span> <div class="TableFullPage" id="v56201727"> <h3 class="title">Preferred Breast Cancer Adjuvant Systemic Therapy*</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56201739" class="anchor"></span><div class="para"> <p>Axillary Lymph Node</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56201742" class="anchor"></span><div class="para"> <p>ER+ and/or PR+</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56201745" class="anchor"></span><div class="para"> <p>ER− and PR−</p></div></p></th></tr></thead> <tbody><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v56201762" class="anchor"></span><div class="para"> <p>Premenopausal</p></div></p></td></tr><tr class="even"><td><span id="v56201765" class="anchor"></span><div class="para"> <p>Negative†</p></div></td><td><span id="v56201767" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tamoxifen</span> with or without chemotherapy</p></div><span id="v56201769" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Trastuzumab</span> if HER2+ (sometimes with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>pertuzumab</span>)</p></div></td><td><span id="v56201772" class="anchor"></span><div class="para"> <p>Chemotherapy</p></div><span id="v56201773" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Trastuzumab</span> if HER2+ (sometimes with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>pertuzumab</span> )</p></div></td></tr><tr class="odd"><td><span id="v56201776" class="anchor"></span><div class="para"> <p>Positive</p></div></td><td><span id="v56201778" class="anchor"></span><div class="para"> <p>Chemotherapy plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tamoxifen</span></p></div><span id="v56201779" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Trastuzumab</span> plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>pertuzumab</span> if HER2+</p></div></td><td><span id="v56201781" class="anchor"></span><div class="para"> <p>Chemotherapy </p></div><span id="v56201782" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Trastuzumab</span> plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>pertuzumab</span> if HER2+</p></div></td></tr><tr class="even" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v56201786" class="anchor"></span><div class="para"> <p>Postmenopausal</p></div></p></td></tr><tr class="odd"><td><span id="v56201790" class="anchor"></span><div class="para"> <p>Negative†</p></div></td><td><span id="v56201792" class="anchor"></span><div class="para"> <p>An aromatase inhibitor or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tamoxifen</span> (or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>raloxifene</span>) with or without chemotherapy</p></div><span id="v56201793" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Trastuzumab</span> if HER2+ (sometimes with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>pertuzumab</span>)</p></div></td><td><span id="v56201795" class="anchor"></span><div class="para"> <p>Chemotherapy</p></div><span id="v56201796" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Trastuzumab</span> if HER2+ (sometimes with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>pertuzumab</span> )</p></div></td></tr><tr class="even"><td><span id="v56201799" class="anchor"></span><div class="para"> <p>Positive</p></div></td><td><span id="v56201802" class="anchor"></span><div class="para"> <p>Chemotherapy plus an aromatase inhibitor or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tamoxifen</span> (or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>raloxifene</span>)</p></div><span id="v56201803" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Trastuzumab</span> plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>pertuzumab</span> if HER2+</p></div></td><td><span id="v56201805" class="anchor"></span><div class="para"> <p>Chemotherapy </p></div><span id="v56201807" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Trastuzumab</span> plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>pertuzumab</span> if HER2+</p></div></td></tr></tbody> <tfoot><tr><td colspan="3"><span id="v56201749" class="anchor"></span><div class="para"> <p>* For all protocols involving chemotherapy, enrollment in a clinical trial is often considered.</p></div></td></tr><tr><td colspan="3"><span id="v56201752" class="anchor"></span><div class="para"> <p>† Treatment of node-negative tumors also depends on tumor size and grade.</p></div></td></tr><tr><td colspan="3"><span id="v56201755" class="anchor"></span><div class="para"> <p>ER <span class='symbol'>= </span><span class="genericDrug" data-showrollover="false">estrogen</span> receptor; HER2 = human epidermal growth factor receptor 2; PR = <span class="genericDrug" data-showrollover="false">progesterone</span> receptor.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div><div id='hidden_v56201155'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v1065726"></span> <div class="TableHalfPage" id="v56201155"> <h3 class="title">Risk of Being Diagnosed With Invasive Breast Cancer</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56201168" class="anchor"></span><div class="para"> <p>Age (years)</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56201171" class="anchor"></span><div class="para"> <p>10-year Risk (%)</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56201174" class="anchor"></span><div class="para"> <p>20-year Risk (%)</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56201177" class="anchor"></span><div class="para"> <p>30-year Risk (%)</p></div></p></th><th style='text-align:left' scope='col'><span id="v56201179" class="anchor"></span><div class="para"> <p>Lifetime Risk (%)</p></div></th><th style='text-align:left' scope='col'><span id="v56201181" class="anchor"></span><div class="para"> <p>Lifetime Risk of Dying of Invasive Breast Cancer (%)</p></div></th></tr></thead> <tbody><tr class="odd"><td><span id="v56201190" class="anchor"></span><div class="para"> <p>30</p></div></td><td><span id="v56201192" class="anchor"></span><div class="para"> <p>0.5</p></div></td><td><span id="v56201194" class="anchor"></span><div class="para"> <p>2.0</p></div></td><td><span id="v56201196" class="anchor"></span><div class="para"> <p>4.3</p></div></td><td><span id="v56201198" class="anchor"></span><div class="para"> <p>13.0</p></div></td><td><span id="v56201200" class="anchor"></span><div class="para"> <p>2.6</p></div></td></tr><tr class="even"><td><span id="v56201203" class="anchor"></span><div class="para"> <p>40</p></div></td><td><span id="v56201205" class="anchor"></span><div class="para"> <p>1.6</p></div></td><td><span id="v56201207" class="anchor"></span><div class="para"> <p>3.9</p></div></td><td><span id="v56201209" class="anchor"></span><div class="para"> <p>7.1</p></div></td><td><span id="v56201211" class="anchor"></span><div class="para"> <p>12.7</p></div></td><td><span id="v56201213" class="anchor"></span><div class="para"> <p>2.6</p></div></td></tr><tr class="odd"><td><span id="v56201216" class="anchor"></span><div class="para"> <p>50</p></div></td><td><span id="v56201218" class="anchor"></span><div class="para"> <p>2.4</p></div></td><td><span id="v56201220" class="anchor"></span><div class="para"> <p>5.7</p></div></td><td><span id="v56201222" class="anchor"></span><div class="para"> <p>9.1</p></div></td><td><span id="v56201224" class="anchor"></span><div class="para"> <p>11.5</p></div></td><td><span id="v56201226" class="anchor"></span><div class="para"> <p>2.5</p></div></td></tr><tr class="even"><td><span id="v56201229" class="anchor"></span><div class="para"> <p>60</p></div></td><td><span id="v56201231" class="anchor"></span><div class="para"> <p>3.5</p></div></td><td><span id="v56201233" class="anchor"></span><div class="para"> <p>7.2</p></div></td><td><span id="v56201235" class="anchor"></span><div class="para"> <p>9.2</p></div></td><td><span id="v56201237" class="anchor"></span><div class="para"> <p>9.7</p></div></td><td><span id="v56201239" class="anchor"></span><div class="para"> <p>2.3</p></div></td></tr><tr class="odd"><td><span id="v56201242" class="anchor"></span><div class="para"> <p>70</p></div></td><td><span id="v56201244" class="anchor"></span><div class="para"> <p>4.1</p></div></td><td><span id="v56201246" class="anchor"></span><div class="para"> <p>6.4</p></div></td><td><span id="v56201248" class="anchor"></span><div class="para"> <p>—</p></div></td><td><span id="v56201250" class="anchor"></span><div class="para"> <p>7.0</p></div></td><td><span id="v56201252" class="anchor"></span><div class="para"> <p>1.9</p></div></td></tr><tr class="even"><td><span id="v56201255" class="anchor"></span><div class="para"> <p>80</p></div></td><td><span id="v56201257" class="anchor"></span><div class="para"> <p>3.0</p></div></td><td><span id="v56201259" class="anchor"></span><div class="para"> <p>—</p></div></td><td><span id="v56201261" class="anchor"></span><div class="para"> <p>—</p></div></td><td><span id="v56201263" class="anchor"></span><div class="para"> <p>3.8</p></div></td><td><span id="v56201265" class="anchor"></span><div class="para"> <p>1.5</p></div></td></tr></tbody> <tfoot><tr><td colspan="6"><span id="v56201185" class="anchor"></span><div class="para"> <p>Data from 2015–19. Based on <a rel="nofollow" target="_blank" href="https://seer.cancer.gov/">seer.cancer.gov</a>. Accessed April 17, 2023. </p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div><div id='hidden_v56201626'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v1066195"></span> <div class="TableFullPage" id="v56201626"> <h3 class="title">Treatment by Type of Breast Cancer</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56201635" class="anchor"></span><div class="para"> <p>Type</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56201638" class="anchor"></span><div class="para"> <p>Possible Treatments</p></div></p></th></tr></thead> <tbody><tr class="odd"><td><span id="v56201649" class="anchor"></span><div class="para"> <p>DCIS</p></div></td><td><span id="v56201651" class="anchor"></span><div class="para"> <p>Mastectomy </p></div><span id="v56201652" class="anchor"></span><div class="para"> <p>Breast-conserving surgery in some patients (with lesions confined to one quadrant) with or without* radiation therapy</p></div><span id="v56201653" class="anchor"></span><div class="para"> <p>Endocrine therapy for some patients</p></div></td></tr><tr class="even"><td><span id="v56201656" class="anchor"></span><div class="para"> <p>LCIS, classic</p></div></td><td><span id="v56201658" class="anchor"></span><div class="para"> <p>Surgical excision to exclude cancer in certain cases</p></div><span id="v56201659" class="anchor"></span><div class="para"> <p>If negative, observation with regular examinations and mammograms</p></div><span id="v56201660" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tamoxifen</span> or, for some postmenopausal women, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>raloxifene</span> or aromatase inhibitors to reduce risk of invasive cancer</p></div><span id="v56201661" class="anchor"></span><div class="para"> <p>Bilateral prophylactic mastectomy (rarely)</p></div></td></tr><tr class="odd"><td><span id="v56201664" class="anchor"></span><div class="para"> <p>LCIS, pleomorphic</p></div></td><td><span id="v56201666" class="anchor"></span><div class="para"> <p>Surgical excision to negative margins</p></div><span id="v56201667" class="anchor"></span><div class="para"> <p>Chemoprevention with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tamoxifen</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>raloxifene</span> for some patients</p></div></td></tr><tr class="even"><td><span id="v56201670" class="anchor"></span><div class="para"> <p>Stages I and II (early-stage) cancer</p></div></td><td><span id="v56201672" class="anchor"></span><div class="para"> <p>Preoperative chemotherapy to optimize chances for breast-conserving surgery (in patients with T2 or higher-grade breast cancer)</p></div><span id="v56201673" class="anchor"></span><div class="para"> <p>Breast-conserving surgery, followed by radiation therapy</p></div><span id="v56201674" class="anchor"></span><div class="para"> <p>Mastectomy with or without breast reconstruction</p></div><span id="v56201675" class="anchor"></span><div class="para"> <p>Systemic therapy (eg, postoperative chemotherapy, endocrine therapy, anti-HER2 medications, or a combination) based on results of tumor tests (eg, analysis for hormone receptors and HER2 protein), except possibly in some postmenopausal women with hormone receptor-positive tumors with low to intermediate Oncotype Dx scores</p></div></td></tr><tr class="odd"><td><span id="v56201678" class="anchor"></span><div class="para"> <p>Stage III (locally advanced) cancer, including inflammatory breast cancer</p></div></td><td><span id="v56201680" class="anchor"></span><div class="para"> <p>Preoperative systemic therapy, usually chemotherapy</p></div><span id="v56201681" class="anchor"></span><div class="para"> <p>Breast-conserving surgery or mastectomy if tumor is resectable after preoperative therapy</p></div><span id="v56201682" class="anchor"></span><div class="para"> <p>Mastectomy for inflammatory breast cancer</p></div><span id="v56201683" class="anchor"></span><div class="para"> <p>Usually, postoperative radiation therapy</p></div><span id="v56201684" class="anchor"></span><div class="para"> <p>Postoperative chemotherapy, endocrine therapy, or both</p></div></td></tr><tr class="even"><td><span id="v56201687" class="anchor"></span><div class="para"> <p>Stage IV (metastatic) cancer</p></div></td><td><span id="v56201689" class="anchor"></span><div class="para"> <p>If cancer is symptomatic and multifocal, endocrine therapy, ovarian ablation therapy, or chemotherapy</p></div><span id="v56201690" class="anchor"></span><div class="para"> <p>If HER2 is overexpressed, anti-HER2 medications (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>trastuzumab</span>, sometimes with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>pertuzumab</span>)</p></div><span id="v56201691" class="anchor"></span><div class="para"> <p>For brain metastases, local skin recurrences, or isolated symptomatic bone metastases, radiation therapy</p></div><span id="v56201692" class="anchor"></span><div class="para"> <p>For bone metastases, IV bisphosphonates to reduce bone loss and bone pain</p></div></td></tr><tr class="odd"><td><span id="v56201695" class="anchor"></span><div class="para"> <p>Paget disease of the nipple</p></div></td><td><span id="v56201697" class="anchor"></span><div class="para"> <p>Usually, based on type of underlying breast cancer if any</p></div><span id="v56201698" class="anchor"></span><div class="para"> <p>Occasionally, local excision only</p></div></td></tr><tr class="even"><td><span id="v56201701" class="anchor"></span><div class="para"> <p>Locally recurrent breast cancer</p></div></td><td><span id="v56201703" class="anchor"></span><div class="para"> <p>Mastectomy or surgical resection (if mastectomy has already been done), sometimes preceded by chemotherapy or endocrine therapy</p></div><span id="v56201704" class="anchor"></span><div class="para"> <p>Radiation therapy for some patients</p></div><span id="v56201705" class="anchor"></span><div class="para"> <p>Chemotherapy or endocrine therapy</p></div></td></tr><tr class="odd"><td><span id="v56201708" class="anchor"></span><div class="para"> <p>Phyllodes tumors </p></div></td><td><span id="v56201710" class="anchor"></span><div class="para"> <p>Wide excision</p></div><span id="v56201711" class="anchor"></span><div class="para"> <p>Sometimes radiation therapy (if borderline or malignant)</p></div><span id="v56201712" class="anchor"></span><div class="para"> <p>Mastectomy if the mass is large </p></div></td></tr></tbody> <tfoot><tr><td colspan="2"><span id="v56201642" class="anchor"></span><div class="para"> <p>* Wide excision or breast-conserving surgery may be used alone, especially if the lesion is <span class='symbol'></span> 2.5 cm and histologic characteristics are favorable, or with radiation therapy if size and histologic characteristics are less favorable.</p></div></td></tr><tr><td colspan="2"><span id="v56201645" class="anchor"></span><div class="para"> <p>DCIS <span class='symbol'>=</span> ductal carcinoma in situ; HER2 = human epidermal growth factor receptor 2; LCIS <span class='symbol'>=</span> lobular carcinoma in situ.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v56201155'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v1065726"></span> <div class="TableHalfPage" id="v56201155"> <h3 class="title">Risk of Being Diagnosed With Invasive Breast Cancer</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56201168" class="anchor"></span><div class="para"> <p>Age (years)</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56201171" class="anchor"></span><div class="para"> <p>10-year Risk (%)</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56201174" class="anchor"></span><div class="para"> <p>20-year Risk (%)</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56201177" class="anchor"></span><div class="para"> <p>30-year Risk (%)</p></div></p></th><th style='text-align:left' scope='col'><span id="v56201179" class="anchor"></span><div class="para"> <p>Lifetime Risk (%)</p></div></th><th style='text-align:left' scope='col'><span id="v56201181" class="anchor"></span><div class="para"> <p>Lifetime Risk of Dying of Invasive Breast Cancer (%)</p></div></th></tr></thead> <tbody><tr class="odd"><td><span id="v56201190" class="anchor"></span><div class="para"> <p>30</p></div></td><td><span id="v56201192" class="anchor"></span><div class="para"> <p>0.5</p></div></td><td><span id="v56201194" class="anchor"></span><div class="para"> <p>2.0</p></div></td><td><span id="v56201196" class="anchor"></span><div class="para"> <p>4.3</p></div></td><td><span id="v56201198" class="anchor"></span><div class="para"> <p>13.0</p></div></td><td><span id="v56201200" class="anchor"></span><div class="para"> <p>2.6</p></div></td></tr><tr class="even"><td><span id="v56201203" class="anchor"></span><div class="para"> <p>40</p></div></td><td><span id="v56201205" class="anchor"></span><div class="para"> <p>1.6</p></div></td><td><span id="v56201207" class="anchor"></span><div class="para"> <p>3.9</p></div></td><td><span id="v56201209" class="anchor"></span><div class="para"> <p>7.1</p></div></td><td><span id="v56201211" class="anchor"></span><div class="para"> <p>12.7</p></div></td><td><span id="v56201213" class="anchor"></span><div class="para"> <p>2.6</p></div></td></tr><tr class="odd"><td><span id="v56201216" class="anchor"></span><div class="para"> <p>50</p></div></td><td><span id="v56201218" class="anchor"></span><div class="para"> <p>2.4</p></div></td><td><span id="v56201220" class="anchor"></span><div class="para"> <p>5.7</p></div></td><td><span id="v56201222" class="anchor"></span><div class="para"> <p>9.1</p></div></td><td><span id="v56201224" class="anchor"></span><div class="para"> <p>11.5</p></div></td><td><span id="v56201226" class="anchor"></span><div class="para"> <p>2.5</p></div></td></tr><tr class="even"><td><span id="v56201229" class="anchor"></span><div class="para"> <p>60</p></div></td><td><span id="v56201231" class="anchor"></span><div class="para"> <p>3.5</p></div></td><td><span id="v56201233" class="anchor"></span><div class="para"> <p>7.2</p></div></td><td><span id="v56201235" class="anchor"></span><div class="para"> <p>9.2</p></div></td><td><span id="v56201237" class="anchor"></span><div class="para"> <p>9.7</p></div></td><td><span id="v56201239" class="anchor"></span><div class="para"> <p>2.3</p></div></td></tr><tr class="odd"><td><span id="v56201242" class="anchor"></span><div class="para"> <p>70</p></div></td><td><span id="v56201244" class="anchor"></span><div class="para"> <p>4.1</p></div></td><td><span id="v56201246" class="anchor"></span><div class="para"> <p>6.4</p></div></td><td><span id="v56201248" class="anchor"></span><div class="para"> <p>—</p></div></td><td><span id="v56201250" class="anchor"></span><div class="para"> <p>7.0</p></div></td><td><span id="v56201252" class="anchor"></span><div class="para"> <p>1.9</p></div></td></tr><tr class="even"><td><span id="v56201255" class="anchor"></span><div class="para"> <p>80</p></div></td><td><span id="v56201257" class="anchor"></span><div class="para"> <p>3.0</p></div></td><td><span id="v56201259" class="anchor"></span><div class="para"> <p>—</p></div></td><td><span id="v56201261" class="anchor"></span><div class="para"> <p>—</p></div></td><td><span id="v56201263" class="anchor"></span><div class="para"> <p>3.8</p></div></td><td><span id="v56201265" class="anchor"></span><div class="para"> <p>1.5</p></div></td></tr></tbody> <tfoot><tr><td colspan="6"><span id="v56201185" class="anchor"></span><div class="para"> <p>Data from 2015–19. Based on <a rel="nofollow" target="_blank" href="https://seer.cancer.gov/">seer.cancer.gov</a>. Accessed April 17, 2023. </p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v56201424'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v9009185"></span> <div class="TableFullPage" id="v56201424"> <h3 class="title">Anatomic Staging of Breast Cancer*</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56201438" class="anchor"></span><div class="para"> <p>Stage</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56201441" class="anchor"></span><div class="para"> <p>Tumor</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56201444" class="anchor"></span><div class="para"> <p>Regional Lymph Node/Distant Metastasis†</p></div></p></th></tr></thead> <tbody><tr class="odd"><td><span id="v56201495" class="anchor"></span><div class="para"> <p>0</p></div></td><td><span id="v56201497" class="anchor"></span><div class="para"> <p>Tis</p></div></td><td><span id="v56201499" class="anchor"></span><div class="para"> <p>N0/M0</p></div></td></tr><tr class="even"><td><span id="v56201502" class="anchor"></span><div class="para"> <p>IA</p></div></td><td><span id="v56201504" class="anchor"></span><div class="para"> <p>T1‡</p></div></td><td><span id="v56201506" class="anchor"></span><div class="para"> <p>N0/M0</p></div></td></tr><tr class="odd"><td><span id="v56201509" class="anchor"></span><div class="para"> <p>IB</p></div></td><td><span id="v56201511" class="anchor"></span><div class="para"> <p>T0</p></div></td><td><span id="v56201513" class="anchor"></span><div class="para"> <p>N1mi/M0</p></div></td></tr><tr class="even"><td><span id="v56201516" class="anchor"></span><div class="para"> <p></div></td><td><span id="v56201518" class="anchor"></span><div class="para"> <p>T1‡</p></div></td><td><span id="v56201520" class="anchor"></span><div class="para"> <p>N1mi/M0</p></div></td></tr><tr class="odd"><td><span id="v56201523" class="anchor"></span><div class="para"> <p>IIA</p></div></td><td><span id="v56201525" class="anchor"></span><div class="para"> <p>T0</p></div></td><td><span id="v56201527" class="anchor"></span><div class="para"> <p>N1§M0</p></div></td></tr><tr class="even"><td><span id="v56201530" class="anchor"></span><div class="para"> <p></div></td><td><span id="v56201532" class="anchor"></span><div class="para"> <p>T1‡</p></div></td><td><span id="v56201534" class="anchor"></span><div class="para"> <p>N1§/M0</p></div></td></tr><tr class="odd"><td><span id="v56201537" class="anchor"></span><div class="para"> <p></div></td><td><span id="v56201539" class="anchor"></span><div class="para"> <p>T2</p></div></td><td><span id="v56201541" class="anchor"></span><div class="para"> <p>N0/M0</p></div></td></tr><tr class="even"><td><span id="v56201544" class="anchor"></span><div class="para"> <p>IIB</p></div></td><td><span id="v56201546" class="anchor"></span><div class="para"> <p>T2</p></div></td><td><span id="v56201548" class="anchor"></span><div class="para"> <p>N1/M0</p></div></td></tr><tr class="odd"><td><span id="v56201551" class="anchor"></span><div class="para"> <p></div></td><td><span id="v56201553" class="anchor"></span><div class="para"> <p>T3</p></div></td><td><span id="v56201555" class="anchor"></span><div class="para"> <p>N0/M0</p></div></td></tr><tr class="even"><td><span id="v56201558" class="anchor"></span><div class="para"> <p>IIIA</p></div></td><td><span id="x000123" class="anchor"></span><div class="para"> <p>T0</p></div></td><td><span id="x000124" class="anchor"></span><div class="para"> <p>N2/M0</p></div></td></tr><tr class="odd"><td><span id="x000120" class="anchor"></span><div class="para"> <p></div></td><td><span id="v56201560" class="anchor"></span><div class="para"> <p>TI‡</p></div></td><td><span id="v56201562" class="anchor"></span><div class="para"> <p>N2/M0</p></div></td></tr><tr class="even"><td><span id="v56201565" class="anchor"></span><div class="para"> <p></div></td><td><span id="v56201567" class="anchor"></span><div class="para"> <p>T2</p></div></td><td><span id="v56201569" class="anchor"></span><div class="para"> <p>N2/M0</p></div></td></tr><tr class="odd"><td><span id="v56201572" class="anchor"></span><div class="para"> <p></div></td><td><span id="v56201574" class="anchor"></span><div class="para"> <p>T3</p></div></td><td><span id="v56201576" class="anchor"></span><div class="para"> <p>N1/M0</p></div></td></tr><tr class="even"><td><span id="v56201579" class="anchor"></span><div class="para"> <p></div></td><td><span id="v56201581" class="anchor"></span><div class="para"> <p>T3</p></div></td><td><span id="v56201583" class="anchor"></span><div class="para"> <p>N2/M0</p></div></td></tr><tr class="odd"><td><span id="v56201586" class="anchor"></span><div class="para"> <p>IIIB</p></div></td><td><span id="v56201588" class="anchor"></span><div class="para"> <p>T4</p></div></td><td><span id="v56201590" class="anchor"></span><div class="para"> <p>N0/M0</p></div></td></tr><tr class="even"><td><span id="v56201593" class="anchor"></span><div class="para"> <p></div></td><td><span id="v56201595" class="anchor"></span><div class="para"> <p>T4</p></div></td><td><span id="v56201597" class="anchor"></span><div class="para"> <p>N1/M0</p></div></td></tr><tr class="odd"><td><span id="v56201600" class="anchor"></span><div class="para"> <p></div></td><td><span id="v56201602" class="anchor"></span><div class="para"> <p>T4</p></div></td><td><span id="v56201604" class="anchor"></span><div class="para"> <p>N2/M0</p></div></td></tr><tr class="even"><td><span id="v56201607" class="anchor"></span><div class="para"> <p>IIIC</p></div></td><td><span id="v56201609" class="anchor"></span><div class="para"> <p>Any T</p></div></td><td><span id="v56201611" class="anchor"></span><div class="para"> <p>N3/M0</p></div></td></tr><tr class="odd"><td><span id="v56201614" class="anchor"></span><div class="para"> <p>IV</p></div></td><td><span id="v56201616" class="anchor"></span><div class="para"> <p>Any T</p></div></td><td><span id="v56201618" class="anchor"></span><div class="para"> <p>Any N/M1</p></div></td></tr></tbody> <tfoot><tr><td colspan="3"><span id="v56201448" class="anchor"></span><div class="para"> <p>* Adapted from: Hortobagyi GN, Connolly JL, D’Orsi CJ, Edge SB, Mittendorf EA, et al: Breast. In: Amin MB, Edge S, Greene F, et al, eds; American Joint Committee on Cancer. AJCC cancer staging manual. 8th ed. New York, NY: Springer. 2017. Version 9 changes, when available, can be found on the American Joint Committee on Cancer (AJCC) site <a rel="nofollow" target="_blank" href="https://www.facs.org/quality-programs/cancer-programs/american-joint-committee-on-cancer/version-9/">AJCC Version 9 Cancer Staging System</a>.</p></div></td></tr><tr><td colspan="3"><span id="v56201454" class="anchor"></span><div class="para"> <p>† Classification of regional lymph nodes (N) is divided into clinical (cN) and pathologic (pN), which have slightly different descriptions.</p></div></td></tr><tr><td colspan="3"><span id="v56201457" class="anchor"></span><div class="para"> <p>‡ T1 includes T1mi.</p></div></td></tr><tr><td colspan="3"><span id="v56201460" class="anchor"></span><div class="para"> <p>§ Here, N1 excludes N1mi.</p></div></td></tr><tr><td colspan="3"><span id="v56201463" class="anchor"></span><div class="para"> <p>Tis <span class='symbol'>=</span> ductal carcinoma in situ or Paget disease of the nipple with no tumor (Paget disease with a tumor is classified by tumor size); T1 <span class='symbol'>=</span> tumor <span class='symbol'>≤</span> 2 cm; T1mi <span class='symbol'>=</span> tumor <span class='symbol'>≤</span> 0.1 cm; T2 <span class='symbol'>=</span> tumor <span class='symbol'>></span> 2 but <span class='symbol'>≤</span> 5 cm; T3 <span class='symbol'>=</span> tumor <span class='symbol'>></span> 5 cm; T4 <span class='symbol'>= </span>any size tumor with extension to chest wall and/or skin and with ulceration or skin nodules or inflammatory cancer.</p></div></td></tr><tr><td colspan="3"><span id="v56201466" class="anchor"></span><div class="para"> <p>NX <span class='symbol'>=</span> Nearby nodes not assessable (for example, because removed previously); N0 <span class='symbol'>=</span> no spread to nearby nodes or only isolated tumor cells; N1 <span class='symbol'>=</span> spread to 1–3 ipsilateral movable, low or midaxillary nodes and/or metastases detected by sentinel lymph node biopsy in clinically negative internal mammary lymph nodes (pN1); N1mi = N1 nodes with micrometastases (about 200 cells > 0.2 mm, but none > 2 mm); N2 <span class='symbol'>=</span> any of the following:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v56201469" class="anchor"></span><div class="para"> <p>Spread to ipsilateral low or midaxillary nodes that are fixed or matted, detected by clinical examination (cN2)</p></div></li><li class="topic__listitem"><span id="v56201471" class="anchor"></span><div class="para"> <p>Spread to 4–9 axillary lymph nodes, detected by testing (pN2)</p></div></li><li class="topic__listitem"><span id="v56201473" class="anchor"></span><div class="para"> <p>Spread to internal mammary nodes but not axillary nodes as detected by clinical examination or imaging</p></div></li></ul></div><span id="v56201474" class="anchor"></span><div class="para"> <p>N3 <span class='symbol'>=</span> any of the following:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v56201477" class="anchor"></span><div class="para"> <p>Spread to <span class='symbol'>ipsilateral internal mammary nodes plus axillary nodes as detected by clinical examination or imaging</span></p></div></li><li class="topic__listitem"><span id="v56201479" class="anchor"></span><div class="para"> <p>Spread to infraclavicular nodes</p></div></li><li class="topic__listitem"><span id="v56201481" class="anchor"></span><div class="para"> <p>Spread to supraclavicular nodes</p></div></li><li class="topic__listitem"><span id="v56201483" class="anchor"></span><div class="para"> <p>Spread to ≥ 10 axillary lymph nodes</p></div></li><li class="topic__listitem"><span id="v56201485" class="anchor"></span><div class="para"> <p>Spread to > 3 axillary lymph nodes and micrometastases or macrometastases by sentinel lymph node biopsy in clinically negative internal mammary nodes (pN3)</p></div></li></ul></div></td></tr><tr><td colspan="3"><span id="v56201488" class="anchor"></span><div class="para"> <p>M0 <span class='symbol'>=</span> no distant metastases; M1 <span class='symbol'>=</span> distant metastases present.</p></div></td></tr><tr><td colspan="3"><span id="v56201491" class="anchor"></span><div class="para"> <p>Adapted from the American Joint Committee on Cancer, <i>AJCC Cancer Staging Manual, Eighth Edition (2017)</i>. Springer New York, Inc. </p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v56201424'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v9009185"></span> <div class="TableFullPage" id="v56201424"> <h3 class="title">Anatomic Staging of Breast Cancer*</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56201438" class="anchor"></span><div class="para"> <p>Stage</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56201441" class="anchor"></span><div class="para"> <p>Tumor</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56201444" class="anchor"></span><div class="para"> <p>Regional Lymph Node/Distant Metastasis†</p></div></p></th></tr></thead> <tbody><tr class="odd"><td><span id="v56201495" class="anchor"></span><div class="para"> <p>0</p></div></td><td><span id="v56201497" class="anchor"></span><div class="para"> <p>Tis</p></div></td><td><span id="v56201499" class="anchor"></span><div class="para"> <p>N0/M0</p></div></td></tr><tr class="even"><td><span id="v56201502" class="anchor"></span><div class="para"> <p>IA</p></div></td><td><span id="v56201504" class="anchor"></span><div class="para"> <p>T1‡</p></div></td><td><span id="v56201506" class="anchor"></span><div class="para"> <p>N0/M0</p></div></td></tr><tr class="odd"><td><span id="v56201509" class="anchor"></span><div class="para"> <p>IB</p></div></td><td><span id="v56201511" class="anchor"></span><div class="para"> <p>T0</p></div></td><td><span id="v56201513" class="anchor"></span><div class="para"> <p>N1mi/M0</p></div></td></tr><tr class="even"><td><span id="v56201516" class="anchor"></span><div class="para"> <p></div></td><td><span id="v56201518" class="anchor"></span><div class="para"> <p>T1‡</p></div></td><td><span id="v56201520" class="anchor"></span><div class="para"> <p>N1mi/M0</p></div></td></tr><tr class="odd"><td><span id="v56201523" class="anchor"></span><div class="para"> <p>IIA</p></div></td><td><span id="v56201525" class="anchor"></span><div class="para"> <p>T0</p></div></td><td><span id="v56201527" class="anchor"></span><div class="para"> <p>N1§M0</p></div></td></tr><tr class="even"><td><span id="v56201530" class="anchor"></span><div class="para"> <p></div></td><td><span id="v56201532" class="anchor"></span><div class="para"> <p>T1‡</p></div></td><td><span id="v56201534" class="anchor"></span><div class="para"> <p>N1§/M0</p></div></td></tr><tr class="odd"><td><span id="v56201537" class="anchor"></span><div class="para"> <p></div></td><td><span id="v56201539" class="anchor"></span><div class="para"> <p>T2</p></div></td><td><span id="v56201541" class="anchor"></span><div class="para"> <p>N0/M0</p></div></td></tr><tr class="even"><td><span id="v56201544" class="anchor"></span><div class="para"> <p>IIB</p></div></td><td><span id="v56201546" class="anchor"></span><div class="para"> <p>T2</p></div></td><td><span id="v56201548" class="anchor"></span><div class="para"> <p>N1/M0</p></div></td></tr><tr class="odd"><td><span id="v56201551" class="anchor"></span><div class="para"> <p></div></td><td><span id="v56201553" class="anchor"></span><div class="para"> <p>T3</p></div></td><td><span id="v56201555" class="anchor"></span><div class="para"> <p>N0/M0</p></div></td></tr><tr class="even"><td><span id="v56201558" class="anchor"></span><div class="para"> <p>IIIA</p></div></td><td><span id="x000123" class="anchor"></span><div class="para"> <p>T0</p></div></td><td><span id="x000124" class="anchor"></span><div class="para"> <p>N2/M0</p></div></td></tr><tr class="odd"><td><span id="x000120" class="anchor"></span><div class="para"> <p></div></td><td><span id="v56201560" class="anchor"></span><div class="para"> <p>TI‡</p></div></td><td><span id="v56201562" class="anchor"></span><div class="para"> <p>N2/M0</p></div></td></tr><tr class="even"><td><span id="v56201565" class="anchor"></span><div class="para"> <p></div></td><td><span id="v56201567" class="anchor"></span><div class="para"> <p>T2</p></div></td><td><span id="v56201569" class="anchor"></span><div class="para"> <p>N2/M0</p></div></td></tr><tr class="odd"><td><span id="v56201572" class="anchor"></span><div class="para"> <p></div></td><td><span id="v56201574" class="anchor"></span><div class="para"> <p>T3</p></div></td><td><span id="v56201576" class="anchor"></span><div class="para"> <p>N1/M0</p></div></td></tr><tr class="even"><td><span id="v56201579" class="anchor"></span><div class="para"> <p></div></td><td><span id="v56201581" class="anchor"></span><div class="para"> <p>T3</p></div></td><td><span id="v56201583" class="anchor"></span><div class="para"> <p>N2/M0</p></div></td></tr><tr class="odd"><td><span id="v56201586" class="anchor"></span><div class="para"> <p>IIIB</p></div></td><td><span id="v56201588" class="anchor"></span><div class="para"> <p>T4</p></div></td><td><span id="v56201590" class="anchor"></span><div class="para"> <p>N0/M0</p></div></td></tr><tr class="even"><td><span id="v56201593" class="anchor"></span><div class="para"> <p></div></td><td><span id="v56201595" class="anchor"></span><div class="para"> <p>T4</p></div></td><td><span id="v56201597" class="anchor"></span><div class="para"> <p>N1/M0</p></div></td></tr><tr class="odd"><td><span id="v56201600" class="anchor"></span><div class="para"> <p></div></td><td><span id="v56201602" class="anchor"></span><div class="para"> <p>T4</p></div></td><td><span id="v56201604" class="anchor"></span><div class="para"> <p>N2/M0</p></div></td></tr><tr class="even"><td><span id="v56201607" class="anchor"></span><div class="para"> <p>IIIC</p></div></td><td><span id="v56201609" class="anchor"></span><div class="para"> <p>Any T</p></div></td><td><span id="v56201611" class="anchor"></span><div class="para"> <p>N3/M0</p></div></td></tr><tr class="odd"><td><span id="v56201614" class="anchor"></span><div class="para"> <p>IV</p></div></td><td><span id="v56201616" class="anchor"></span><div class="para"> <p>Any T</p></div></td><td><span id="v56201618" class="anchor"></span><div class="para"> <p>Any N/M1</p></div></td></tr></tbody> <tfoot><tr><td colspan="3"><span id="v56201448" class="anchor"></span><div class="para"> <p>* Adapted from: Hortobagyi GN, Connolly JL, D’Orsi CJ, Edge SB, Mittendorf EA, et al: Breast. In: Amin MB, Edge S, Greene F, et al, eds; American Joint Committee on Cancer. AJCC cancer staging manual. 8th ed. New York, NY: Springer. 2017. Version 9 changes, when available, can be found on the American Joint Committee on Cancer (AJCC) site <a rel="nofollow" target="_blank" href="https://www.facs.org/quality-programs/cancer-programs/american-joint-committee-on-cancer/version-9/">AJCC Version 9 Cancer Staging System</a>.</p></div></td></tr><tr><td colspan="3"><span id="v56201454" class="anchor"></span><div class="para"> <p>† Classification of regional lymph nodes (N) is divided into clinical (cN) and pathologic (pN), which have slightly different descriptions.</p></div></td></tr><tr><td colspan="3"><span id="v56201457" class="anchor"></span><div class="para"> <p>‡ T1 includes T1mi.</p></div></td></tr><tr><td colspan="3"><span id="v56201460" class="anchor"></span><div class="para"> <p>§ Here, N1 excludes N1mi.</p></div></td></tr><tr><td colspan="3"><span id="v56201463" class="anchor"></span><div class="para"> <p>Tis <span class='symbol'>=</span> ductal carcinoma in situ or Paget disease of the nipple with no tumor (Paget disease with a tumor is classified by tumor size); T1 <span class='symbol'>=</span> tumor <span class='symbol'>≤</span> 2 cm; T1mi <span class='symbol'>=</span> tumor <span class='symbol'>≤</span> 0.1 cm; T2 <span class='symbol'>=</span> tumor <span class='symbol'>></span> 2 but <span class='symbol'>≤</span> 5 cm; T3 <span class='symbol'>=</span> tumor <span class='symbol'>></span> 5 cm; T4 <span class='symbol'>= </span>any size tumor with extension to chest wall and/or skin and with ulceration or skin nodules or inflammatory cancer.</p></div></td></tr><tr><td colspan="3"><span id="v56201466" class="anchor"></span><div class="para"> <p>NX <span class='symbol'>=</span> Nearby nodes not assessable (for example, because removed previously); N0 <span class='symbol'>=</span> no spread to nearby nodes or only isolated tumor cells; N1 <span class='symbol'>=</span> spread to 1–3 ipsilateral movable, low or midaxillary nodes and/or metastases detected by sentinel lymph node biopsy in clinically negative internal mammary lymph nodes (pN1); N1mi = N1 nodes with micrometastases (about 200 cells > 0.2 mm, but none > 2 mm); N2 <span class='symbol'>=</span> any of the following:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v56201469" class="anchor"></span><div class="para"> <p>Spread to ipsilateral low or midaxillary nodes that are fixed or matted, detected by clinical examination (cN2)</p></div></li><li class="topic__listitem"><span id="v56201471" class="anchor"></span><div class="para"> <p>Spread to 4–9 axillary lymph nodes, detected by testing (pN2)</p></div></li><li class="topic__listitem"><span id="v56201473" class="anchor"></span><div class="para"> <p>Spread to internal mammary nodes but not axillary nodes as detected by clinical examination or imaging</p></div></li></ul></div><span id="v56201474" class="anchor"></span><div class="para"> <p>N3 <span class='symbol'>=</span> any of the following:</p></div><div class="list"> <ul data-mmanualobjecttype="List" class="bulleted"><li class="topic__listitem"><span id="v56201477" class="anchor"></span><div class="para"> <p>Spread to <span class='symbol'>ipsilateral internal mammary nodes plus axillary nodes as detected by clinical examination or imaging</span></p></div></li><li class="topic__listitem"><span id="v56201479" class="anchor"></span><div class="para"> <p>Spread to infraclavicular nodes</p></div></li><li class="topic__listitem"><span id="v56201481" class="anchor"></span><div class="para"> <p>Spread to supraclavicular nodes</p></div></li><li class="topic__listitem"><span id="v56201483" class="anchor"></span><div class="para"> <p>Spread to ≥ 10 axillary lymph nodes</p></div></li><li class="topic__listitem"><span id="v56201485" class="anchor"></span><div class="para"> <p>Spread to > 3 axillary lymph nodes and micrometastases or macrometastases by sentinel lymph node biopsy in clinically negative internal mammary nodes (pN3)</p></div></li></ul></div></td></tr><tr><td colspan="3"><span id="v56201488" class="anchor"></span><div class="para"> <p>M0 <span class='symbol'>=</span> no distant metastases; M1 <span class='symbol'>=</span> distant metastases present.</p></div></td></tr><tr><td colspan="3"><span id="v56201491" class="anchor"></span><div class="para"> <p>Adapted from the American Joint Committee on Cancer, <i>AJCC Cancer Staging Manual, Eighth Edition (2017)</i>. Springer New York, Inc. </p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v56201626'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v1066195"></span> <div class="TableFullPage" id="v56201626"> <h3 class="title">Treatment by Type of Breast Cancer</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56201635" class="anchor"></span><div class="para"> <p>Type</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56201638" class="anchor"></span><div class="para"> <p>Possible Treatments</p></div></p></th></tr></thead> <tbody><tr class="odd"><td><span id="v56201649" class="anchor"></span><div class="para"> <p>DCIS</p></div></td><td><span id="v56201651" class="anchor"></span><div class="para"> <p>Mastectomy </p></div><span id="v56201652" class="anchor"></span><div class="para"> <p>Breast-conserving surgery in some patients (with lesions confined to one quadrant) with or without* radiation therapy</p></div><span id="v56201653" class="anchor"></span><div class="para"> <p>Endocrine therapy for some patients</p></div></td></tr><tr class="even"><td><span id="v56201656" class="anchor"></span><div class="para"> <p>LCIS, classic</p></div></td><td><span id="v56201658" class="anchor"></span><div class="para"> <p>Surgical excision to exclude cancer in certain cases</p></div><span id="v56201659" class="anchor"></span><div class="para"> <p>If negative, observation with regular examinations and mammograms</p></div><span id="v56201660" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tamoxifen</span> or, for some postmenopausal women, <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>raloxifene</span> or aromatase inhibitors to reduce risk of invasive cancer</p></div><span id="v56201661" class="anchor"></span><div class="para"> <p>Bilateral prophylactic mastectomy (rarely)</p></div></td></tr><tr class="odd"><td><span id="v56201664" class="anchor"></span><div class="para"> <p>LCIS, pleomorphic</p></div></td><td><span id="v56201666" class="anchor"></span><div class="para"> <p>Surgical excision to negative margins</p></div><span id="v56201667" class="anchor"></span><div class="para"> <p>Chemoprevention with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tamoxifen</span> or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>raloxifene</span> for some patients</p></div></td></tr><tr class="even"><td><span id="v56201670" class="anchor"></span><div class="para"> <p>Stages I and II (early-stage) cancer</p></div></td><td><span id="v56201672" class="anchor"></span><div class="para"> <p>Preoperative chemotherapy to optimize chances for breast-conserving surgery (in patients with T2 or higher-grade breast cancer)</p></div><span id="v56201673" class="anchor"></span><div class="para"> <p>Breast-conserving surgery, followed by radiation therapy</p></div><span id="v56201674" class="anchor"></span><div class="para"> <p>Mastectomy with or without breast reconstruction</p></div><span id="v56201675" class="anchor"></span><div class="para"> <p>Systemic therapy (eg, postoperative chemotherapy, endocrine therapy, anti-HER2 medications, or a combination) based on results of tumor tests (eg, analysis for hormone receptors and HER2 protein), except possibly in some postmenopausal women with hormone receptor-positive tumors with low to intermediate Oncotype Dx scores</p></div></td></tr><tr class="odd"><td><span id="v56201678" class="anchor"></span><div class="para"> <p>Stage III (locally advanced) cancer, including inflammatory breast cancer</p></div></td><td><span id="v56201680" class="anchor"></span><div class="para"> <p>Preoperative systemic therapy, usually chemotherapy</p></div><span id="v56201681" class="anchor"></span><div class="para"> <p>Breast-conserving surgery or mastectomy if tumor is resectable after preoperative therapy</p></div><span id="v56201682" class="anchor"></span><div class="para"> <p>Mastectomy for inflammatory breast cancer</p></div><span id="v56201683" class="anchor"></span><div class="para"> <p>Usually, postoperative radiation therapy</p></div><span id="v56201684" class="anchor"></span><div class="para"> <p>Postoperative chemotherapy, endocrine therapy, or both</p></div></td></tr><tr class="even"><td><span id="v56201687" class="anchor"></span><div class="para"> <p>Stage IV (metastatic) cancer</p></div></td><td><span id="v56201689" class="anchor"></span><div class="para"> <p>If cancer is symptomatic and multifocal, endocrine therapy, ovarian ablation therapy, or chemotherapy</p></div><span id="v56201690" class="anchor"></span><div class="para"> <p>If HER2 is overexpressed, anti-HER2 medications (<span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>trastuzumab</span>, sometimes with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>pertuzumab</span>)</p></div><span id="v56201691" class="anchor"></span><div class="para"> <p>For brain metastases, local skin recurrences, or isolated symptomatic bone metastases, radiation therapy</p></div><span id="v56201692" class="anchor"></span><div class="para"> <p>For bone metastases, IV bisphosphonates to reduce bone loss and bone pain</p></div></td></tr><tr class="odd"><td><span id="v56201695" class="anchor"></span><div class="para"> <p>Paget disease of the nipple</p></div></td><td><span id="v56201697" class="anchor"></span><div class="para"> <p>Usually, based on type of underlying breast cancer if any</p></div><span id="v56201698" class="anchor"></span><div class="para"> <p>Occasionally, local excision only</p></div></td></tr><tr class="even"><td><span id="v56201701" class="anchor"></span><div class="para"> <p>Locally recurrent breast cancer</p></div></td><td><span id="v56201703" class="anchor"></span><div class="para"> <p>Mastectomy or surgical resection (if mastectomy has already been done), sometimes preceded by chemotherapy or endocrine therapy</p></div><span id="v56201704" class="anchor"></span><div class="para"> <p>Radiation therapy for some patients</p></div><span id="v56201705" class="anchor"></span><div class="para"> <p>Chemotherapy or endocrine therapy</p></div></td></tr><tr class="odd"><td><span id="v56201708" class="anchor"></span><div class="para"> <p>Phyllodes tumors </p></div></td><td><span id="v56201710" class="anchor"></span><div class="para"> <p>Wide excision</p></div><span id="v56201711" class="anchor"></span><div class="para"> <p>Sometimes radiation therapy (if borderline or malignant)</p></div><span id="v56201712" class="anchor"></span><div class="para"> <p>Mastectomy if the mass is large </p></div></td></tr></tbody> <tfoot><tr><td colspan="2"><span id="v56201642" class="anchor"></span><div class="para"> <p>* Wide excision or breast-conserving surgery may be used alone, especially if the lesion is <span class='symbol'></span> 2.5 cm and histologic characteristics are favorable, or with radiation therapy if size and histologic characteristics are less favorable.</p></div></td></tr><tr><td colspan="2"><span id="v56201645" class="anchor"></span><div class="para"> <p>DCIS <span class='symbol'>=</span> ductal carcinoma in situ; HER2 = human epidermal growth factor receptor 2; LCIS <span class='symbol'>=</span> lobular carcinoma in situ.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div><div id="hiddentblcontents" style="display:none"><div id='hidden_v56201727'> <div data-mmanualobjecttype="Table" class="table-box"> <span id="v26442706"></span> <div class="TableFullPage" id="v56201727"> <h3 class="title">Preferred Breast Cancer Adjuvant Systemic Therapy*</h3> <div class="tableWrapper"> <table> <thead><tr tablehead1=""><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56201739" class="anchor"></span><div class="para"> <p>Axillary Lymph Node</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56201742" class="anchor"></span><div class="para"> <p>ER+ and/or PR+</p></div></p></th><th style='text-align:left' scope='col'><p class="tableHead1"><span id="v56201745" class="anchor"></span><div class="para"> <p>ER− and PR−</p></div></p></th></tr></thead> <tbody><tr class="odd" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v56201762" class="anchor"></span><div class="para"> <p>Premenopausal</p></div></p></td></tr><tr class="even"><td><span id="v56201765" class="anchor"></span><div class="para"> <p>Negative†</p></div></td><td><span id="v56201767" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Tamoxifen</span> with or without chemotherapy</p></div><span id="v56201769" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Trastuzumab</span> if HER2+ (sometimes with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>pertuzumab</span>)</p></div></td><td><span id="v56201772" class="anchor"></span><div class="para"> <p>Chemotherapy</p></div><span id="v56201773" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Trastuzumab</span> if HER2+ (sometimes with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>pertuzumab</span> )</p></div></td></tr><tr class="odd"><td><span id="v56201776" class="anchor"></span><div class="para"> <p>Positive</p></div></td><td><span id="v56201778" class="anchor"></span><div class="para"> <p>Chemotherapy plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tamoxifen</span></p></div><span id="v56201779" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Trastuzumab</span> plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>pertuzumab</span> if HER2+</p></div></td><td><span id="v56201781" class="anchor"></span><div class="para"> <p>Chemotherapy </p></div><span id="v56201782" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Trastuzumab</span> plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>pertuzumab</span> if HER2+</p></div></td></tr><tr class="even" tablehead2=""><td colspan="3"><p class="tableHead2"><span id="v56201786" class="anchor"></span><div class="para"> <p>Postmenopausal</p></div></p></td></tr><tr class="odd"><td><span id="v56201790" class="anchor"></span><div class="para"> <p>Negative†</p></div></td><td><span id="v56201792" class="anchor"></span><div class="para"> <p>An aromatase inhibitor or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tamoxifen</span> (or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>raloxifene</span>) with or without chemotherapy</p></div><span id="v56201793" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Trastuzumab</span> if HER2+ (sometimes with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>pertuzumab</span>)</p></div></td><td><span id="v56201795" class="anchor"></span><div class="para"> <p>Chemotherapy</p></div><span id="v56201796" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Trastuzumab</span> if HER2+ (sometimes with <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>pertuzumab</span> )</p></div></td></tr><tr class="even"><td><span id="v56201799" class="anchor"></span><div class="para"> <p>Positive</p></div></td><td><span id="v56201802" class="anchor"></span><div class="para"> <p>Chemotherapy plus an aromatase inhibitor or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>tamoxifen</span> (or <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>raloxifene</span>)</p></div><span id="v56201803" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Trastuzumab</span> plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>pertuzumab</span> if HER2+</p></div></td><td><span id="v56201805" class="anchor"></span><div class="para"> <p>Chemotherapy </p></div><span id="v56201807" class="anchor"></span><div class="para"> <p><span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>Trastuzumab</span> plus <span class='disableDrug' tabindex='0' role='link' onclick='javascript:void(0);'>pertuzumab</span> if HER2+</p></div></td></tr></tbody> <tfoot><tr><td colspan="3"><span id="v56201749" class="anchor"></span><div class="para"> <p>* For all protocols involving chemotherapy, enrollment in a clinical trial is often considered.</p></div></td></tr><tr><td colspan="3"><span id="v56201752" class="anchor"></span><div class="para"> <p>† Treatment of node-negative tumors also depends on tumor size and grade.</p></div></td></tr><tr><td colspan="3"><span id="v56201755" class="anchor"></span><div class="para"> <p>ER <span class='symbol'>= </span><span class="genericDrug" data-showrollover="false">estrogen</span> receptor; HER2 = human epidermal growth factor receptor 2; PR = <span class="genericDrug" data-showrollover="false">progesterone</span> receptor.</p></div></td></tr></tfoot> </table> </div> </div> <button class="btn print" onclick="printPopupContent();"><i class="fa fa-print"></i></button> <button class="btn show-tab"><i class="fa fa-arrows-alt"></i><i class="fa fa-times"></i></button> </div></div></div></body>
<div class="bottomnav__gotolink bottomnav__gotolink--next"></div>  <div class="fixed-footer fixed-width" align="right" id="setbackgrnd"><table class="fixed-width"><tr class="fixed-width"><td id="tdsearch" align="right" class="tdsearch"><input type="text" id="search" onkeyup="search(id)" placeholder="Find on page..." class="form-control search"></td><td id="tdbtn" align="left" class="tdbtn"><button onclick="myFunction()" id="button" class="button"></button></td></tr></table></div>
</html>